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ABSTRACT:
The cerebrovasculature modulates its resistance to flow in order to match blood supply
with the high metabolic demand of the brain. While it is accepted that vascular smooth
muscle cells are capable of modulating blood flow resistance through arterioles, whether
pericytes can similarly regulate blood flow through capillaries has been a topic of debate
for over 100 years. First we used new transgenic mice to characterize the structural
spectrum of pericytes in the brain, and found a wide range of pericyte shapes that could
be grouped into two main pericyte types. We then mapped where these “ensheathing
pericytes” and “capillary pericytes” live along the cerebrovascular tree, and stimulated
one or two of them at a time in vivo using two photon optogenetics through a cranial
window. We found that both types of pericytes can constrict their underlying blood vessel
in a way that decreases local blood flow. Importantly, vascular smooth muscle cells
exhibited much more dramatic constriction upon stimulation, indicating that pericytes
modulate blood flow in a slower and subtler way than do vascular smooth muscle cells.
To investigate if pericytes use this ability to modulate blood flow under physiological
conditions, we ablated one or two capillary pericytes in the living brain. We were
surprised to find that 3 days after ablation we observed a dilation of capillaries left
uncovered by the pericyte ablation, which corresponded with a doubling in the number of
red blood cells flowing through that capillary. Critically, we did not observe any
hemodynamic changes in control animals that either did not express optogenetic
proteins, or did not have any pericytes ablated. The results therefore suggest that
pericytes play a role in shaping capillary blood flow through the brain. This will inform the
longstanding debate, and could lead to new ways of correcting blood flow abnormalities
that plague numerous neurological diseases like traumatic brain injury, epilepsy, and
stroke.
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Chapter 1: Introduction

The brain constantly demands blood
Michelangelo’s sculptures, Marie Curie’s curiosity, and Stalin’s terror have
something in common: they were born out of unthinkably complex ensembles of brain
activity. How did the brain, this instrument capable of extreme beauty and terror, become
so complicated? Many theories exist on how the brain developed its intricate
interconnections and computing power, but one thing is clear: nothing is free in nature,
and this cerebral complexity and capability is very expensive (Lennie 2003). The
expense is the great amounts of energy required to run such a fine-tuned machine, and
we pay for it in blood (Figure 1).
The human brain is about 2% of our body weight, but receives ~20% of our blood
volume at any given moment (Xing et al. 2017). Although all vertebrate brains receive
more blood than the brain’s weight would suggest, the human brain is a uniquely selfish
organ. Using fossils to identify the size of the carotid foramen, where the internal carotid
artery enters the skull, it appears that the amount of blood pumping into our brains has
increased exponentially over the course of hominid evolution, presumably in order to
support an increasing intellect and brain size (Fig. 1) (Seymour et al. 2015; Seymour,
Bosiocic, and Snelling 2016). These findings tell us that the brain, especially the human
brain, is a Ferrari -- an ultra-high performance machine with terrible gas mileage. Just
like if the Ferrari runs out of gas, if the brain doesn’t receive blood, it stops functioning.
This is because the brain has no alternative source of energy besides a constant supply
of oxygen and glucose-rich blood -- the brain runs continuously on oxidative
phosphorylation and does not have appreciable stores of energy like the liver has
glycogen, or as muscle has creatine and fat (Zheng et al. 2016), or as a Prius has
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battery power. As a result, brain cells start dying by the millions within minutes after
blood stops flowing to the brain, as occurs during a stroke (Saver 2006). The point is that
the brain, especially our human brain, needs a lot of blood, all the time. That’s the cost of
being able to video chat our family, and write grants and metaphors.

Figure 1 The brain needs blood to grow: Estimates of blood flow rate from fossil measurements of
carotid foramina show that cerebral blood flow increased exponentially to support the evolution of our
intelligence. From Seymour, et al. 2016, open access.

The cerebrovasculature supplies the brain with blood
How does all this blood get to the brain? If an engineer were instructed to build
theFigure
perfect
blood
machine,
she
wouldofbeblood
asked
accommodate
the following
2 The
brainsupply
needs blood
to grow:
Estimates
flow to
rate
from fossil measurements
of
carotid foramina show that cerebral blood flow increased exponentially to support the evolution of our
intelligence. From Seymour, et al. 2016.
parameters:

1. The human brain is about the size of a small cantaloupe, with 100 billion cells
distributed throughout its volume. All of these cells need oxygenated blood to survive.
2. The environments inside and outside the brain, and thus the energy supply and
demand, are constantly changing.
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3. Space in the brain, and blood in the body, are limited and fixed quantities.

Nature engineered a solution to the blood delivery problem nearly 600 million
years ago, evident in the hagfish, our oldest extant vertebrate cousin. This evolutionary
conservation is very convenient for us, because we can map findings from zebrafish,
mouse, rat, and cat vasculature onto humans (Roman and Weinstein 2000). Here is how
the natural engineering process of evolution accommodated these parameters, in their
order of presentation above:

1. How do we feed 100 billion cells? It is a logistical nightmare that Amazon.com
probably couldn’t solve, but here is the way nature solved it. The heart pumps
oxygenated blood through the carotid and vertebral arteries, which then branch into
smaller cerebral arteries that meander along the surface of the brain within the
subarachnoid space. The cerebral arteries are responsible for feeding large territories of
the brain with fresh blood, and a clot or rupture in these vessels can produce lethal
strokes and bleeds. Cerebral arteries continue to branch into successively smaller
vessels, eventually giving rise to pial arterioles that are roughly the size of a strand of
hair. Pial arterioles sit in the subarachnoid space and form a loose net on our brain’s
surface; the net-like interconnections between pial arterioles ensure that if one arteriole
stops flowing, other “collaterals” can pick up the bill and provide flow to needy areas
(Schaffer et al. 2006; Shih et al. 2009). Blood is carried from the surface and into the
depths of the brain by branches of pial arterioles called penetrating arterioles. When
penetrating arterioles are occluded, as putatively occurs during microinfarcts that
accumulate in dementia, small columns of brain tissue are starved and die (Shih et al.
2013). These penetrating arterioles are columns filled with blood that rapidly flows into
Page 11

the brain--in order to broadly distribute the oxygenated blood within penetrating
arterioles to billions of cells, penetrating arterioles divide into smaller branches called
pre-capillary arterioles. And finally, pre-capillary arterioles divide into numerous
capillaries, the brain’s smallest vessels, measuring around 5 microns in diameter. To
summarize efficient blood delivery in two words: vessel branching (Fig. 2).
Capillaries are the primary location for nutrient and metabolite exchange between
the blood and the brain. Oxygen carried by red blood cells passively diffuses through the

Figure 2 The brain is full of different types of vessels: The resin vascular cast of a mouse brain before (A,
left), and after (A, right) casting. From (Walker, Shen, Young, & Su, 2011), open access. (B) A column of
mouse cortex, with relative pressures experienced by each vessel type (red-arterioles with higher pressures,
blue-venules and low pressure). (C) Different types of vessels within the cerebral cortex and direction of
flow. From Gould, Tsai, Kleinfeld, & Linninger, 2017. Reprint permission granted license 4373690706158.
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capillary wall and into the brain, whereas glucose floating in plasma enters the brain
through GLUT1 transporters in the vessel wall (Zhao et al. 2015). The intense need that
the brain has for capillary-derived nutrients is illustrated by the finding that neurons are
typically located less than a mere 15 microns away from a capillary in the mouse brain
(Tsai et al. 2009). After these neurons extract their needed oxygen and glucose, the
expired blood flows into post-capillary venules, then coalesces into ascending venules
that carry blood to the surface. Ascending venules connect to pial venules on the
surface, and these further coalesce into cerebral veins. Finally, cerebral veins drain into
cerebral sinuses that send blood back to the heart via the jugular vein to eventually be
refreshed in the lungs (Fig. 2).
In total, the brain harbors roughly 400 miles of vasculature, with capillaries
comprising the vast majority of this length (Cipolla 2009). A bolus of blood travels this
entire journey in just a few seconds. One question we can address in this dissertation is
How many of the 400 miles of our cerebrovasculature can modulate blood flow?
Because this dissertation is mostly about capillaries, I’m going to spend some time here
discussing why having hundreds of miles of tiny vessels is a good design for feeding the
brain.
The simplest theoretical design would have one hose of blood running into and
out of the brain. The next simplest design would have multiple large hoses running into
and out of the brain, similar to the way that penetrating arterioles and ascending venules
do. However, a circulatory design this simple isn’t adequate for the earthworm “brain”
(al-Yousuf et al. 1992), and so certainly would not be adequate for Michelangelo’s brain.
The reason is that some parts of the brain would be close to these large tubes, but most
parts of the brain would be quite far, and nutrients would be unable to diffuse to these
remote areas. Capillaries create a meandering and circuitous connection for blood to
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percolate between the arterial and venous flow. This long path of capillaries situates
capillaries in close physical proximity to the cells that need blood nutrients for their
survival. Chemically, Fick’s diffusion laws say that decreasing the distance between the
blood and the surrounding tissue will increase the tissue concentration of nutrients that
diffuse out of the blood, like oxygen (Wong et al. 2013). Fick’s law also tells us that this
mesh of capillaries helps to broadly distribute the sources of oxygen, making the
concentration of oxygen more uniform throughout the tissue (Sakadžić et al. 2014).
Furthermore, this mesh-like capillary architecture accomplishes a very high surface area
that increases the ‘collision rate’, and thus the reaction rate, between blood nutrients and
surrounding tissue, by extension of the Arrhenius equation. Put simply, granulated sugar
dissolves more easily and uniformly in tea than does a sugar cube--capillaries deliver
blood nutrients to the tissue in the “granulated” form, whereas arteries deliver blood
nutrients in bulk, like a sugar cube that doesn’t dissolve very well.
Another important feature of capillary design is that their small size, just wide
enough to allow a single-file march of red blood cells, generates high resistance to flow.
Indeed, modeling studies show that the pressure drop across the capillary bed is the
largest pressure drop in the entire cerebrovasculature, indicating that the capillary
network is the point of highest hemodynamic resistance in the cerebrovasculature
(Gould et al. 2017). This serves the important function of slowing down blood flow to
allow enough time for oxygen to passively diffuse into the tissue. Indeed, modeling
studies suggest that faster-than-normal capillary blood flow yields poor tissue
oxygenation (Jespersen and Østergaard 2012). Additionally, if blood flow is too slow,
then expired blood deprived of nutrients will sit around too long. The happy-medium of
capillary blood flow is obtained by having some capillaries flow quickly, and others flow
slowly. This variety in capillary blood flow speeds, so-called “capillary transit time
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heterogeneity”, provides optimum tissue oxygenation according to several computational
models, with mounting experimental evidence, showing for example that disruptions in
capillary blood flow heterogeneity are observed in stroke and dementia (Eskildsen et al.
2017; Jespersen and Østergaard 2012). Interestingly, capillary blood flow speeds are
very similar in several species, with an average speed of ~1 mm/s in mice, rats, and cat
brains (Unekawa et al. 2010; Yamaguchi, Yamakawa, and Niimi 1992), providing
evidence that there is a particular flow pattern that is physico-chemically ideal for
delivering nutrients to the brain.
Thus we see that by connecting arterial and venous flow with a meandering
meshwork of capillaries, evolution has engineered a way to efficiently distribute blood
nutrients to the 100 billion cells of the human brain. A very similar blueprint is used to
feed the brains of all known vertebrates, including ancient living relatives like the hagfish.
More specifically, the amount of blood flow per neuron, and the average length of
capillary per neuron, is kept fairly constant across rodents, cats, primates, and humans
(Karbowski 2014; Unekawa et al. 2010; Yamaguchi, Yamakawa, and Niimi 1992).

2. The hierarchical structure of the vasculature discussed above, with capillaries being
the locus of nutrient exchange, is an efficient structure to distribute blood throughout the
brain. However, the brain is part of a changing world, and as a result blood flow to the
brain must change accordingly for optimum function.
Changing vessel diameter, which thereby changes local resistance to flow, is the
body’s ingenious way of locally regulating blood delivery. Arteries, arterioles, and
possibly capillaries, have different inputs that instruct these vessels to change their
diameter. This design creates several levels of control on cerebral blood flow that
operate at different scales, like a ‘coarse’ and ‘fine’ focus knob on a microscope. In their
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normal basal state, arteries and arterioles are slightly constricted, enabling them to
respond to stimuli with either a constriction or dilation to respectively increase or
decrease the resistance to incoming pressurized flow (Dabertrand, Nelson, and Brayden
2013). For example, when a cluster of neurons in the visual cortex fires in response to a
flashing bar of light, the neurons’ energetic demand increases because they need
energy to restore their ionic gradients back to resting state (Howarth, Gleeson, and
Attwell 2012). Nearby arterioles then dilate to supply this cluster of neurons with
additional blood. According to the fluid dynamics Law of Poiseulle, fluid flow is directly
proportional to r4, or radius to the 4th power. Poiseulle’s Law thus states that the
observed 20% dilation in response to strong sensory stimuli theoretically doubles the
volume flow rate of blood through that vessel (Drew, Shih, and Kleinfeld 2011; O’Herron
et al. 2016). This increased rush of blood in response to local metabolic activity is called
functional hyperemia. Blood vessel diameter, and therefore blood flow, is highly dynamic
in order to respond to changes in the local environment, such as neural activity. It is
worth noting that the few empirical tests of Poiseulle’s Law show that it overestimates
the effect of diameter on the flux of red blood cells; simultaneous diameter-flow
measurements in retinal arterioles showed that a 50% increase in diameter will lead to a
doubling of flux of red blood cells, closer to an r2 relationship (Kornfield and Newman
2015).
This direct correlation between neural activity and blood flow occurs by
communication between neurons and vessels, a process called neurovascular coupling
(Fig. 3). Neurovascular coupling is putatively important for replenishing the energy
expended by recent bursts of neural activity, and it is involved in generating the BOLD
response in fMRI imaging. Although the details of neurovascular coupling are hotly
debated, a consensus has been reached on some aspects of physiological
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neurovascular coupling: it begins with neural activity, then blood flow increases in
subsurface vessels, and later penetrating and pial arterioles dilate and increase their
flow rate (Iadecola 2017). Cell types like astrocytes, pericytes, smooth muscle cells,
endothelial cells, and red blood cells are proposed liaisons between neural activity and
blood flow changes. The signals that have been reported to communicate neural activity
to the vasculature range from nucleosides (Mishra et al. 2016; Wang and Venton 2017)
to eicosanoid derivatives (Mishra et al. 2016), to K+ ions (Filosa et al. 2006; Longden et
al. 2017). Despite the wide range of reported cellular and molecular mechanisms,
studies very consistently find a correlation between impaired neurovascular coupling and
progression of numerous neurological diseases (Hillman 2014). The relevance for fMRI
BOLD imaging and clinical disease make the confusing knots of neurovascular coupling
worth unraveling. The data in this dissertation will touch on the potential role of pericytes
in neurovascular coupling, a topic currently mired in debate (Attwell et al. 2016).

Figure 3 Vessels respond to neural activity: Pial arteries are innervated by sympathetic nerves, while
arterioles and capillaries are innervated by noradrenergic and cholinergic terminals. Vessels also dilate in
response to nearby neural activity in a process called functional hyperemia. The mechanisms by which
vessels and neurons communicate, called neurovascular coupling, likely involves glial, endothelial, or
erythrocyte liaisons. From Girouard & Iadecola, 2006. Permissions not required by the source.
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The rapid blood flow changes that occur as part of neurovascular coupling are
superimposed upon slower changes in systemic parameters like blood pressure,
atmospheric oxygen content, heart rate, and autonomic tone. If you’re riding a ski lift in
Vail, Colorado, then your cerebral vessels dilate, and global cerebral blood flow
increases to compensate for the low atmospheric oxygen found at 10,000 feet elevation
(Hoiland et al. 2016). If you’re about to go down the slope, and your sympathetic
nervous system is ramped up because you’re terrified, then sympathetic activity will
cause your cerebral arteries to constrict in order to protect the brain from skyrocketing
blood pressure (ter Laan et al. 2013). Much of this vascular response to pressure and
oxygen change occurs independently from neural input, hence the name ‘myogenic
response’. Even vessels extracted from the brain and placed in a dish will gradually
constrict in response to increased perfusion pressure thanks to pressure-sensitive ion
channels (Yao Li et al. 2014). The myogenic response plays a large role in the ability of
the brain to regulate its own blood flow in a process called ‘autoregulation’ (Pires et al.

Figure 4 Autoregulation occurs by the myogenic response: Vessels respond to systemic blood pressure
changes in attempts to keep cerebral blood pressure high enough to avoid ischemia, and low enough to
avoid vasogenic edema and damage. The circles at the top represent the vessel dilating or constricting.
From Pires, et al. 2013. Permissions not required by source.
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2013). Autoregulation is a critical function of the cerebrovasculature because it works to
maintain optimal perfusion pressure of the brain in a dynamic world--if the perfusion
pressure is too low we might faint when we stand up from our chair, and if it is too high
we might sustain damage to our smaller blood vessels, as occurs in chronic
hypertension (Fig. 4 (Pires et al., 2013)). The vasculature detects pressure and flow
changes through stretch-activated cation TRPM4 and TRP6 on SMCs, which allow
cations in when increased pressure is detected, thus depolarizing the SMC (Koller and
Toth 2012). The stretch-induced depolarization activates voltage-gated calcium channels
that allow calcium in and cause constriction via the mechanisms discussed later.
Although autoregulation is intact throughout normal healthy aging, it is dysfunctional in
numerous neurological disorders, particularly stroke (Aries et al. 2010).
The cerebrovasculature is thus constantly trying to integrate numerous cues from
its environment, such as levels of oxygen and neural activity, and then dilate or constrict
in order to deliver the right amount of blood for optimal brain function. The
cerebrovasculature discerns and delivers an ideal flow rate primarily through
autoregulation and neurovascular coupling (Dabertrand, Nelson, and Brayden 2013).
Arteries participate in autoregulation; arterioles participate in all forms of blood flow
dynamics; pre-capillary arterioles appear to participate in neurovascular coupling without
any investigations into their ability to autoregulate; capillaries dubiously participate in
neurovascular coupling without any investigations into their ability to autoregulate; and
venules and veins don’t appear to actively modulate cerebral blood flow in any capacity.

3. The final parameter for ideal blood flow delivery is that space in the brain, and blood in
the body, are limited and fixed quantities. This imposes a limit on how much blood the
brain can receive at one time, and reminds us why cerebral vessels must be so dynamic.
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If we did have unlimited blood and space, we could maximally perfuse the whole
brain all the time and be rid of all these complicated dynamics. Additionally, this
parameter explains why dynamics need to be regionally paired with local neural activity.
If one nucleus of the brain is active, we cannot irrigate the whole brain with blood -- there
is not enough space and not enough blood to go around. This might be why large
arteries show a smaller and delayed response to sensory stimuli compared to
penetrating arterioles near the active tissue (Phillips et al. 2016). But how tight does this
regional supply-demand chain need to be? If arteries are too big to be involved in
neurovascular coupling, are capillaries then ideal for increasing or decreasing cerebral
blood flow to very localized, precise regions? Possibly, but we don’t know if capillaries
are even capable of modulating their own blood flow; we will find out in Chapter 3.
In an effort to feed the brain without starving the body, the cerebrovasculature
remains partially constricted in the normal basal state, which increases resistance and
prevents excessive blood from entering the brain. As mentioned, there are physiological
times when this setpoint resistance needs to be changed -- high altitude or high blood
pressure, as examples. There are also pathological examples when setpoint resistance
needs to be changed. For example, if someone’s right internal carotid artery is nearly
clogged by accumulated atherosclerosis, then resistance to blood flow will be very high
on the right side of their brain, placing this person at risk of hypoperfusion that can lead
to stroke and dementia. In an attempt to compensate for reduced incoming flow, the
arteries and arterioles distal to the stenosis dilate from their physiological resting state.
The ability to change from the physiological resting state to dilated pathological states is
called ‘cerebrovascular reserve’. While we know that arteries and arterioles participate in
establishing the resistance setpoint for basal blood flow, we have no clue about the
ability of capillaries to do this (Maddula et al. 2017). This is an important question
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because capillaries are the point of highest resistance throughout the
cerebrovasculature, and if bundles of capillaries dilated or constricted in concert, this
would drastically affect basal perfusion of the brain. Low basal perfusion, termed
‘hypoperfusion’, doubles one’s risk of dementia, confirming that a proper resistance
setpoint is critical for brain health (Wolters et al. 2017).
This completes the section on how the cerebrovasculature is designed for the
functions and conditions it must carry out for brain health. We’ve seen that the
hierarchical structure of the cerebrovasculature offers an efficient way to distribute blood
nutrients to 100 billion cells in the brain. Additionally, the ability for vessels to
dynamically modulate their diameter in response to environmental cues offers a means
of delivering the ideal amount of blood for a given circumstance.

The cerebrovasculature is made of endothelial cells and mural cells
It is remarkable that responsive targeting and delivery of nutrients by the
vasculature is carried out by only two cell types: endothelial cells and mural cells.
Endothelial cells form a thin tube that becomes the lumen of all vessels, and mural cells
wrap around the endothelium. In development, the endothelium of the aorta and cardinal
veins is the first part of the cardiovascular system to appear in a process called
vasculogenesis (Swift and Weinstein 2009). Then smaller vessels branch off of these
larger ones in a process called angiogenesis. As angiogenesis progresses, the heart
begins pumping blood, and all formed vessels recruit mural cells that perform three
major functions during development: 1. They regulate sprouting and pruning of new
vessels (Losa et al. 2017; von Tell, Armulik, and Betsholtz 2006), 2. They offer structural
reinforcement to prevent vessel damage and hemorrhage (Dave et al. 2018; Hellström et
al. 1999; Lindahl et al. 1997), and 3. They help form the blood-brain barrier and other
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barriers in the vasculature (Armulik et al. 2010; Daneman et al. 2010). We know this
because there are angioarchitecture abnormalities, blood brain barrier dysfunction
and/or hemorrhages in mice and zebrafish models where mural cells are selectively
absent or dysfunctional. Most models of pericyte deficiency started from conception, but
some recent studies have manipulated pericytes in adult mice. One study found that
adult deletion of Foxf2 causes the blood-brain barrier leakage as did constitutive deletion
of Foxf2 (Reyahi et al. 2015). However, another study surprisingly found no blood brain
barrier leakage when massively deleting pericytes in the adult brain (Park et al. 2017).
The roles of pericytes in the adult brain are thus still uncertain and cannot always be
predicted from their development. In the brain, the interplay between endothelial and
mural cells is particularly important because of the physiological importance of the bloodbrain barrier (BBB), and the uniquely localized metabolic demands of the brain that
occur with neural activity.
The coordination of endothelial cells and mural cells is necessary for proper
vascular structure and function, and thus survival. These two cell types have many
interconnected functions, such as blood-organ barrier formation, and influence over
blood flow. There are a few functions that are exclusive to mural cells, such as physically
altering blood vessel diameter, and a few functions that are exclusive to endothelial
cells, such as transporting glucose and other nutrients into organs.
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Figure 5 Vessels are made of endothelial cells (peach) and two types of mural cells, SMCs and
pericytes (green): Here is shown a simplified circuit of blood, which flows into the brain via
arterioles, through the brain via capillaries, and out of the brain via venules.

Mural cells are subdivided into pericytes and SMCs
We have created functional vasculature with two main cell types: endothelial cells
and mural cells. It seems simple, but recall that all vessels are not created equal--the
blood pressure experienced by arteries is much higher than that experienced by veins
and capillaries, and so the arteries are in greatest need of the structural reinforcement
offered by mural cells. However, capillaries and venules also need mural cells to provide
proper vessel stability, barriers, and shape (Eilken et al. 2017). Evolution has found a
way to satisfy the universal need for vessel stability along with the variable need for
structural reinforcement by creating two main types of mural cells: vascular smooth
muscle cells (SMCs), and pericytes. SMCs are ring-shaped and possess many

Figure 6 Vessels are made of endothelial cells (peach) and two types of mural cells, SMCs and
pericytes (green): Here is shown a simplified circuit of blood, which flows into the brain via
contractile
filaments, whereas mid-capillary pericytes have longer, more delicate
arterioles, through the brain via capillaries, and out of the brain via venules.

branches extending from a central soma with fewer contractile filaments. Arteries, which
experience high pressures, are lined by a continuous sheath of many concentric layers
of SMCs. Arterioles, which experience moderate pressures, are lined by a continuous
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sheath of one or two concentric layers of SMCs. Meanwhile, capillaries and venules,
which experience low pressures, are contacted by thin strands of pericyte processes that
do not fully encircle the underlying endothelium. Thus, we see that the hierarchy of
pressures experienced by a vessel, which is established by that vessel’s proximity to the
heart, parallels a hierarchy of mural cell arrangements: vessels with higher pressures
have a thick coat of SMCs, while vessels with low pressures are adorned with a ribbon
of pericytes (Fig. 5). Large veins also have SMCs, presumably to help direct slowflowing blood back to the heart by providing tone (Saphirstein et al. 2015b). In this
dissertation, we will see that this arrangement of mural cell structure relates to mural cell
function.

Mural cells are more diverse than just SMCs and pericytes
Canonically, SMCs are muscular rings around arteries and arterioles, and
pericytes are like stringy vines draped upon capillaries. However, the division of mural
cells into SMCs and pericytes is an oversimplification. In reality, mural cells form a
gradient of shapes and sizes as they smoothly transition from ring-like SMCs on
arterioles to stringy pericytes on capillaries (Takahashi et al. 1997; Ushiwata and Ushiki
1990). In between these canonical forms are many ‘transitional’ pericyte forms, which
were described nearly 100 years ago, but remain amorphous and undefined (Krueger
and Bechmann 2010). Ask two different biologists if a 10 micron vessel is a capillary or
an arteriole, or if the cell on that vessel is a pericyte or a SMC, and you will likely start a
fight. This has been the case for many decades, as Zweifach in 1946 acknowledged that
“One of the difficulties in evaluating the published data is...the capillary blood vessel still
awaits definition” (Chambers and Zweifach 1946).
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Although this will be covered in more depth in Chapter 2, now I will present the
general idea that all pericytes are defined by their protruding ovoid cell body and
longitudinal shape, with processes of varying shapes that run parallel with the course of
the vessel. Some pericytes near the arterial pole of the circulation fully cover the
underlying vessel, and express alpha smooth muscle actin (αSMA), an important
contractile protein in SMCs. These “ensheathing pericytes”, as we recently named them
(Grant et al. 2017), are transitional cells that are sometimes referred to as SMCs, and
other times referred to as pericytes in the literature (Attwell et al. 2016). More distal to
the sourcing arteriole, there are “capillary pericytes” that possess the more classic
pericyte shape, and these pericytes do not express αSMA in several
immunofluorescence studies (Fig. 6). SMCs have less structural variation and appear to
always have a ring shape around arterioles. They always express αSMA, and their cell
bodies do not protrude from the vessel. Trying to divide a gradient into distinct mural cell
types seems futile at first, but in fact SMCs, ensheathing pericytes, and capillary
pericytes have quantifiable differences in cell shape, vascular territory, and αSMA
expression (Grant et al. 2017). Moreover, SMCs, ensheathing pericytes, and capillary
pericytes have unique transcriptomes based on a single-cell RNAseq study of mural
cells (Vanlandewijck et al. 2018). However, the names are arbitrary, and this mural cell
diversity has led to inconsistency in mural cell and microvessel nomenclature, which has
led to disagreements on mural cell function and biochemistry, some of which I will try to
clarify throughout this dissertation.
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Figure 6 Sparse transgenic labeling of mural cells (red) illustrates the diversity of mural cell shapes: Smooth
muscle cells (SMC) and ensheathing pericytes (EP) completely wrap around the endothelium and express
αSMA (C), but EP’s are longer and have an ovoid cell body. Meanwhile, capillary pericytes do not cover the
endothelium (B, labeled with lectin in green), and do not express αSMA (C). From Grant, et al. 2017.

Can developmental trajectory of SMCs and pericytes explain their differences?
How this brain mural cell arrangement develops in the embryo is an interesting
and unanswered question. It is relevant for us because we point out many differences
between SMCs and pericytes in chapters 2 and 3 of this dissertation. The regions
supplied by the anterior circulation (frontal, temporal, and parietal cortices, retina,
thalamus) boast mural cells derived from the neural crest (Etchevers et al. 2001; Korn,
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Christ, and Kurz 2002). Meanwhile, the regions supplied by the posterior circulation
(occipital lobe, cerebellum, midbrain, brainstem) are infused with mural cells from the
mesoderm (Majesky 2007). These circulations, and their differing origins of mural cells,
intersect at the Circle of Willis -- imprecise migration and conjoining of these mural cell
origins may explain why the majority of people do not have a complete Circle of Willis
(Etchevers et al. 2001; RIGGS and RUPP 1963; Ryan et al. 2015) (endothelial cells are
all from mesoderm). The point here is that all mural cells in the forebrain have the same
embryological origin, but this is different than the origin of all mural cells in the hindbrain,
or kidney, or aorta, etc. This shared embryology probably means that mural cells
differentiate into SMCs or pericytes after they arrive at their target tissue, and SMCs and
pericytes likely share many properties.
After mural cells migrate from the neural crest to the forebrain, they then wait on
the surface of the brain for endothelial cells to penetrate developing brain tissue
(Daneman et al. 2010). Developing mural cells are identified by their expression of
PDGFRBeta (platelet derived growth factor receptor - Beta). PDGFRBeta+ precursors
home to arteries and capillaries that express the PDGFRBeta cognate ligand, PDGF-BB
(platelet-derived growth factor-homodimer of isoform B) (Hellström et al. 1999; Lindahl et
al. 1997). Once endothelial cells form new tubes in the brain, the mural cells descend
and land on nascent endothelial tubes, guided by PDGF-BB and other signals sent by
the endothelium (J. Chen et al. 2017; Etchevers et al. 2001). If PDGF-PDGFRBeta
signaling is disrupted, the blood-brain barrier does not form properly, indicating that
mural cell covering of the endothelium is necessary for blood-brain barrier development
(Armulik et al. 2010; Daneman et al. 2010).
It is unknown when and how these newly-attached mural cells decide to become
SMCs or pericytes. One study in the heart shows that some pericytes are precursors for
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SMCs, and shortly after the onset of blood flow (E13 in mice) pericytes transdifferentiate
into SMCs in response to Notch3 - Jagged1 signaling (Volz et al. 2015). Interestingly,
this Jagged1 signaling is amplified by the onset of high-pressure blood flow, and the
authors found that the mechanical stimulus of high pressure blood flow causes pericytes
to differentiate into SMCs soon after the heart begins beating. It thus appears that
pressure, and/or endothelial-mural cell signaling decides the fate of mural cells to
become SMCs or pericytes.

Mural cells regulate blood flow to ensure optimal brain function
Resting blood flow, and the dynamics of blood flow, are regulated by mural cells.
In animal models where mural cells are reduced in number, resting blood flow and
functional hyperemia are also reduced; this is associated with tissue hypoxia, and in
aged animals, neurodegeneration (Bell et al. 2010; Montagne et al. 2018). Decreased
numbers of brain mural cells are also found in chronic human diseases with cerebral
hypoperfusion and blunted functional hyperemia, like dementia and traumatic brain injury
(Y. K. Choi et al. 2016; Dziewulska and Lewandowska 2012; Montagne et al. 2018;
Sengillo et al. 2013). The correlation between blood flow deficits and mural cell deficits
has been found in numerous studies in many acute and chronic neurological diseases,
and provides a strong clinical impetus for studying the influence of mural cells on
cerebral blood flow.
Beyond clinical correlations, there is substantial causal evidence from humans
and rodents that mural cells regulate brain blood flow. Topical application onto the brain
of molecules that only act on mural cells, such as nitroprusside (Lu et al. 1995) or
thromboxane analogs (Mayhan 1998), dilate or constrict pial arterioles and increase or
decrease local cerebral blood flow in vivo. Isolated ex vivo preparations of cerebral
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arterioles, even with the endothelium removed, respond similarly as they did in the in
vivo experiments, thus proving that mural cells directly alter cerebral vessel diameter in
response to physiologically relevant stimuli like norepinephrine, serotonin, or angiotensin
(Russell and Watts 2000). After decades of selectively manipulating mural cells either
genetically or pharmacologically, it is now widely accepted that SMCs around arteries
and arterioles control the amount of blood that enters the brain. This fits the anatomical
picture, since concentric layer(s) of bulky mural cells are wrapped around a thin
endothelium.

Established mechanisms by which SMCs control vessel diameter
Subsequent studies have worked to deduce the mechanisms by which mural
cells dilate or constrict blood vessels (Fig. 7). Nearly all this work has been done in
isolated artery or arteriole preps, and therefore applies to SMC physiology, with
unknown relevance for pericyte physiology. It is worth noting that recent single cell
transcriptomic data shows pericytes express nearly all parts of SMC contractile
machinery, but the role of this machinery in vivo remains unclear.
Calcium is the master regulator of the state of SMC contractility. High intracellular
calcium induces contraction of SMCs, accomplished by actin-myosin cross-bridging,
resulting in a change in SMC shape and a decrease in vessel diameter. Just as in other
forms of muscle, vascular smooth muscle intracellular calcium is tightly regulated by
SERCA pumps that shuttle excess calcium inside of the sarcoplasmic reticulum, and
membrane channels that exchange calcium for ions like sodium and ATP (Dabertrand,
Nelson, and Brayden 2013). There is always some calcium inside SMCs, keeping some
tone on the vessel, and allowing SMCs to constrict or dilate from this baseline tone. In
response to a contractile stimulus, such as endothelin (Gq ET1 receptor) or angiotensin
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II (Gq AT2 receptor), intracellular calcium rises because of the phosphorylation and
opening of voltage-gated calcium channels as well as IP3 production by PLC, and IP3Rmediated sarcoplasmic reticulum calcium release (Brozovich et al. 2016; Tykocki,
Boerman, and Jackson 2017b). This intracellular calcium increase triggers a chain of
stereotyped events: calcium binds and activates calmodulin → myosin light chain kinase
(MLCK) is activated by calmodulin → MLCK phosphorylates and activates myosin light
chain (MLC) → the myosin heavy chain (MyH) bound to ATP is then permitted to bind
actin → ATP is transformed into ADP and myosin-actin cross bridging shortens, eliciting
contraction → fresh ATP relaxes the contraction. The canonical myosin for SMCs
involves myosin heavy chain 11, and myosin light chain 9. The canonical actin is alpha
smooth muscle actin because it is the most abundant actin in arteries (Gabbiani et al.
1981a; Vanlandewijck et al. 2018).
These are the canonical players in SMC contractility (Fig. 7). Constitutive, wholebody knockouts of αSMA have reduced blood pressure, dysmorphic SMCs, and
impaired hyperemic response to increased body temperature (SCHILDMEYER et al.
2000). One study by the Grutzendler laboratory does have some functional evidence
that αSMA is critical for contractility, but it has many caveats and will be discussed later
(Hill et al. 2015). In addition to αSMA, a large role for cytoskeletal actins in generating
contractions in SMCs has recently been discovered. Indeed, multiple studies have found
negligible phosphorylation of MLC during a sustained myogenic response, suggesting
actin-myosin cross-bridging did not occur. However, they observed a large increase in
polymerized cytoskeletal actins that was necessary for cerebral artery myogenic
response (Moreno-Domínguez et al. 2014; Tejani and Rembold 2010). One
interpretation of recent data is that calcium-triggered actomyosin cross-bridging
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mediates rapid contraction events, while sustained contraction involves cytoskeletal
actin polymerization.
When a ligand binds its receptor on SMCs, it activates another important
pathway that does not involve calcium. This parallel, or ‘calcium-independent’ pathway
intersects with the canonical contraction pathway by turning up or down the sensitivity of
the machinery to calcium (Mizuno et al. 2008; Szasz and Webb 2017). Every time
endothelin, or another G-coupled vasoactive molecule, binds its receptor, it activates
RhoA → activates Rho Kinase (ROCK) → phosphorylates and inactivates myosin light
chain phosphatase (MLCP) → increases phosphorylation and activity of MLCK →

Figure 7 Established SMC contractile mechanisms: 1. A ligand like angiotensin II binds a GPCR like AT1. 2.
GPCR signaling causes calcium release from the sarcoplasmic reticulum (SR, 2a.) and influx through
voltage-gated calcium channels (VGCC, 2b.). 3. Increased cytosolic calcium binds calmodulin, which
activates myosin light chain kinase (MLCK). 4. MLCK phosphorylates myosin light chain (MLC). 5. Myosin
heavy chain (MHC) is permitted to interact with alpha smooth muscle actin (αSMA) filaments, producing cell
contraction. 6. Myosin phosphatase cleaves the phosphate from MLC and actin and myosin separate,
causing relaxation. 7. Rho kinase promotes SMC contractility by inhibiting MLC phosphatase and promoting
polyermization of cytoskeletal actins. Interpreted from Borozovich (2016), and Tykocki, Boerman, and
Jackson (2017).
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strengthens the propensity for contraction. Because it increases the likelihood that
MLCK will phosphorylate and activate MLC, the ROCK pathway is the primary
modulatory mechanism for enhancing the effects of calcium on SMC contractility.
Importantly, ROCK also acts to promote cytoskeletal actin polymerization by
phosphorylating cofilin, which stabilizes filamentous (polyermized) actin. In chapter 2, we
use fasudil, which inhibits ROCK, and thereby dilates vessels by two mechanisms: 1.
permitting action of MLCP to inactivate MLCK, thus decreasing the sensitivity of mural
cells to calcium, and 2. preventing cofilin phosphorylation, which has the effect of
destabilizing actin filaments (El-Yazbi and Abd-Elrahman 2017).

Do pericytes regulate cerebral blood flow? Depends who you ask.
Our knowledge on SMC contractile mechanisms has yielded numerous drugs
useful for controlling blood pressure, as arterioles are the main resistance vessels in the
body (vasodilators are used in hypertension, vasoconstrictors are used in hypotension
like in sepsis or shock). Although these studies and the drugs they discovered have
saved millions of lives, they have left us in the dark about pericytes. This is because any
genetic manipulations affecting mural cells have, so far, affected all mural cell types, or
strictly SMCs. There are no genetic studies that affect pericytes and not SMCs.
Additionally, known vasoactive pharmacological agents impact arterioles, which will then
influence downstream blood flow through capillaries; we don’t know of any substance
that operates on pericytes but not SMCs. How can we determine the role of pericytes in
controlling blood flow when capillary blood flow is connected to, and influenced by,
arteriole blood flow? Studies have taken 3 main approaches: 1. Pericyte histology
looking for contractile elements relevant for SMC contractility; 2. Stimulating a vascular
response with neural activity, pharmacology, or electrical stimulation and simultaneously
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observing pericytes; 3. Using animal models with decreased numbers of pericytes. Even
with all these approaches, and 150 years of science, there remains considerable debate
and disagreement on whether pericytes are even capable of influencing blood flow.
Plaguing all of these studies is a general disagreement about the semantics of what to
call a pericyte. To clarify the definition of pericytes, and the ability of pericytes to
modulate blood flow, I use these same 3 main approaches respectively in chapters 2
and 3 of this dissertation. Now I’ll describe the seminal findings in the literature that use
each approach, with emphasis on the central nervous system when possible (retina is
part of the CNS).

1. Pericyte histology began with Eberth in 1871, and Rouget in 1873 looking at frogs.
They drew and described spindly cells that rested atop the vasculature. Rouget
proposed they regulate blood flow based on their anatomical location and shape, and we
have been looking for conclusive proof ever since. Fifty years after Rouget,
Zimmermann refined the imaginative drawings of pericytes from Rouget and Eberth, and
gave them their name ‘pericytes’ because of their peri-vascular location (Armulik,
Genové, and Betsholtz 2011). They were distinguished from SMCs by their anatomy and
morphology -- pericytes have a protruding ovoid cell body (‘bump on a log’) and cover a
long stretch of small vessels while SMCs are rings around larger vessels. However,
Zimmermann in 1923 noted that there is a gradient of mural cell morphology. Between
the ring-shaped smooth muscle cells and spindly capillary pericytes, there are
transitional mural cells that ensheath the vessel like SMCs, but are elongated and have
an ovoid cell body like pericytes (Krueger and Bechmann 2010).
Decades after Zimmermann, electron microscopy emerged and allowed closer
study of pericytes. Early electron microscopy provided us with a few universal rules of
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pericytes: they are ensconced in the endothelial basement membrane; they have
bulbous, nucleated cell bodies from which extend thin processes; they have direct
contact with the endothelium through peg and socket and adherens junctions; and
capillary pericytes do not fully ensheathe the endothelium. It is a very powerful
technique, but remember that with electron microscopy, we typically lose information
about where within the vascular network we are looking, and it is very difficult to perform
quantitative analyses in populations of cells, making it unclear how often certain
phenomena occur.
Considering these caveats, electron microscopic findings provide the structural
foundation for determining if pericytes can feasibly modulate blood flow. Electron
microscopy shows that inside brain pericytes there is a network of overlapping
microfilaments 6 nm in diameter, consistent in appearance with actin fibers. Further,
when brain slices are incubated with muscle myosin before electron microscopic
imaging, these actin microfilaments become much larger, indicating that they bind to
myosin (Le Beux and Willemot 1978). Their observed pericyte processes were
discontinuous around the vessel, indicating that this study was investigating capillary
pericytes because they by definition do not ensheathe the vessel. Furthermore, there
was some evidence that dissociating native actin-myosin complexes with ATP or
pyrophosphate revealed myosin filaments, suggesting that brain capillary pericytes have
endogenous actin and myosin. They did not find similar actin-myosin complexes in
subjacent endothelial cells (Le Beux and Willemot 1978). The same actin filaments were
found by another group in the monkey retina, and again pericytes that enveloped the
vasculature were excluded, indicating these were also capillary pericytes (Fig. 8)
(Wallow and Burnside 1980). Immunogold staining with electron microscopy of
peripheral tissues later showed that these microfilaments were probably αSMA, even in
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tiny capillary pericyte processes (Skalli et al. 1989). This biochemically confirmed that
pericytes, at least in peripheral tissues, have similar actin filaments as do SMCs.
Notably, there were much less αSMA-stained microfilaments in pericytes than in SMCs
(Skalli et al. 1989). When looking in the brain, immunogold staining again showed that
pericytes express αSMA, but in this study it was unclear if these were capillary pericytes
or ensheathing pericytes (Bandopadhyay et al. 2001).
The general picture is that pericytes throughout the body, including brain and
retina, have actin and myosin filaments localized towards the luminal edges of pericyte
processes and soma. The apposition of this actin sole towards the endothelial cells
predicts that pericytes in the middle of the capillary bed can exert force on the
endothelial wall (Le Beux and Willemot 1978; Skalli et al. 1989; Wallow and Burnside
1980). These microfilaments are probably αSMA in peripheral pericytes, but this is
unclear in brain pericytes. In contrast, SMCs are filled with actin throughout the cell, not
just near the endothelial contact, and most of these filaments are certainly αSMA
(Bandopadhyay et al. 2001; Wallow and Burnside 1980). Interestingly, even in SMCs,
immunogold labeling is spotty, and does not label every microfilament, opening the
possibility that the SMC contractile apparatus is a mixture of αSMA and other forms of
actin (Skalli et al. 1989). All actins isoforms are extremely similar in structure, amino acid
sequence, and antigenicity, so it is difficult to know the precise subcellular localization
and identity of all actin filaments in a cell (Ampe and Van Troys 2016).
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Figure 8 Electron microscopy of capillary pericytes supports their contractility: This monkey retina
tissue is swollen and vacuolated because of pre-treatment with glycerine to allow exogenously added
myosin to enter the cells. It shows actin-myosin complexes, which have a characteristic size and
arrowhead appearance localized near the pericyte-endothelial border (large arrows). Intermediate
filaments present in pericytes and endothelial cells (small arrows) do not bind myosin and so do not
have the same appearance. From Wallow and Burnside, 1980. Reprint license ID: 4373700598509
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For a contractile force to be transferred to the endothelium in a way that
influences blood flow, pericytes must have a strong grip on the endothelium. Indeed,
throughout the entire body there are adherens junctions, peg and socket junctions, and
fibronectin ‘plaques’, the latter having microfilaments possibly made of actin running
through it (Courtoy and Boyles 1983). These give pericytes the grip they need, and the
contractile fibers allow them to squeeze the underlying endothelium. One remarkable
paper by Tilton (1979) perfused strong vasoconstrictors like noradrenaline and
vasopressin through skeletal muscle, and found corrugations/invaginations beneath
capillary pericyte processes, without any such corrugations along the endothelium not
covered by a pericyte. The same did not occur in the heart (Tilton et al. 1979). A similar
study reported no capillary pericyte constriction in retinae injected with endothelin-1, but
their method of measuring constriction was not sensitive to focal corrugations as in
Tilton, et al. 1979 (Butryn et al. 1995). This type of study has not been done for the
brain, but one study in the brain did find an example of corrugated endothelium
selectively beneath a capillary pericyte in normal tissue without any vasoconstrictors.
This was not observed in peri-infarct tissue, which corresponds with a capillary dilation in
peri-infarct tissue (Nahirney, Reeson, and Brown 2015). Finally, studies in the brain
found that pericytes are occasionally contacted by adrenergic and cholinergic boutons,
suggesting that capillaries receive some forms of neural input to modulate blood flow
(Itakura et al. 1977). Overall, the preponderance of electron microscopy data support the
ability and action of pericytes in modulating blood flow in the brain, but several
uncertainties remain.
Since the advent of immunostaining, people have quested for pieces of canonical
SMC contractile machinery inside pericytes. Unlike EM, with immunohistochemistry, one
can keep the topology of the vasculature mostly intact, allowing you to investigate
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populations of cells, and also to pinpoint whether you are looking at a capillary near or
far from an arteriole. In all pericytes, including capillary pericytes of peripheral tissues,
smooth muscle tropomyosin (Joyce, Haire, and Palade 1985a), and smooth muscle
myosins (Joyce, Haire, and Palade 1985b) were immunopositive, albeit in less
abundance than in SMCs. Endothelial cells, on the other hand, lacked these proteins.
These findings were confirmed in electron microscopy looking at DAB precipitates.
Meanwhile, cytoskeletal, non-muscle actins appear in higher abundance in pericytes
than in SMCs (Herman and D’Amore 1985). Later immunostaining studies in brain and
retina found that pericytes near arterioles express αSMA, but pericytes in the middle of
the capillary bed do not, which adds biochemical heterogeneity to the structural
heterogeneity of mural cells that has long been known (Boado and Pardridge 1994;
Nehls and Drenckhahn 1991). This is in contrast to electron microscopy findings above
that found mid-capillary pericytes to express αSMA in peripheral tissues (Skalli et al.
1989). A very recent study showed that our ability to detect αSMA
immunohistochemically depends on the fixation method, as it depolymerizes very quickly
in pericytes but not SMCs. Using a different method of fixation, or stabilizing polymerized
actin with phalloidin, pericyte αSMA could be immunohistochemically detected in the
mid-capillary bed of the retina (Alarcon-Martinez et al. 2018). In sum,
immunohistochemical similarities between pericytes and SMCs remind us that these
cells are embryologically and anatomically related, and they may share the function of
modulating blood flow. Because smooth muscle contractile proteins appear less
abundant in pericytes, while ubiquitous cytoskeletal proteins are more abundant in
pericytes, it appears that pericytes are biochemically less specialized than SMCs in their
ability to modulate blood flow, which befits their dainty structural appearance.
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Although much pericyte histology has been done, this was nearly all done in two
dimensional slices. There are still many structural and biochemical questions about
pericytes, particularly in the brain. What do individual pericytes look like? How many
‘transitional’ pericyte types are there? How does αSMA content relate to pericyte
morphology and function? Do pericytes cover all of the brain’s capillaries? These
questions are answered in this dissertation thanks to the development of new tools to
study pericyte structure and function.

2. Like pericyte histology, the method of stimulating a vascular response while observing
pericytes also dates back to the 19th century. Reports of capillary constriction were first
described by Stricker in 1874. Many subsequent studies, usually in frogs, used direct
electrode stimulation, mechanical stimulation, or vasoconstrictors to elicit a vascular
response (Tilton 1991). By placing the stimulus on top of, or in between, protruding
pericyte cell bodies, they believed that they were respectively stimulating the pericytes or
endothelium (Bensley and Vimtrup 1928; Field 1935). The result of 50 years of these
studies was a quagmire. Some studies did not find any capillary constriction. Of the
studies that did find capillary constriction, about half claimed it was caused by
endothelial cell swelling, and the other half claimed it was pericyte contraction around
capillaries (Tilton 1991). Somewhere in the debate, it was suggested that capillaries and
pericytes have a wandering definition (Chambers and Zweifach 1946). It was known that
pericytes have a spectrum of morphologies, some similar to SMCs and others uniquely
spindly. Many investigators acknowledged that this likely contributed to the
inconsistencies in the literature. To further explain the inconsistencies, the important
distinction was made between studies using summer frogs and other studies using
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winter frogs, with summer frogs being more active, and thus having different vascular
reactivity of their excised tissue (Bensley and Vimtrup 1928).
I think it is remarkable that pericyte studies of the modern era have used updated
methods to arrive at a similar debate as occurred over 50 years ago. The first wave of
studies stimulated cultured retinal pericytes, typically with vasoactive molecules, and
consistently showed their ability to contract by observing changes in cell shape
(Chakravarthy et al. 1992), or changes in the wrinkles of thin sheets of silicone on which
pericytes were cultured (Anderson and Davis 1996; Haefliger, Zschauer, and Anderson
1994). However, the cell culture environment drastically changes pericyte phenotype
from that in vivo, as multiple studies have found differences in expression of αSMA
between cultured pericytes and ex vivo tissue (Boado and Pardridge 1994; Newcomb
and Herman 1993). The freshly isolated retina approach was thus born, and its first use
found constriction and dilation along the entire capillary in response to superfused
vasoconstrictors and vasodilators, respectively (Schönfelder et al. 1998). They attribute
a contractile role to pericytes in this study, but their bath-applied vasoactive molecules
could affect any cell type in the tissue, and their definition of pericyte was nebulous.
The first study to visualize and record, in real time, specific manipulations of
pericytes in their native tissue, was by Peppiatt, from Attwell’s lab (Peppiatt et al. 2006).
It was essentially the same experiment performed in the early 1900’s, but with a video
camera, and looking in mammalian CNS tissue. When they stimulated individual
pericytes by applying a current through an electrode placed on top of a pericyte soma,
they observed constriction near pericyte somata in 90% of their sample of cells. The
observed constrictions were concentrated around pericyte soma, but sometimes
occurred over 10 microns from the soma/stimulation point. When placing the electrode
on parts of the vessel wall that were not near a soma, no constriction was noted (though
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this experiment is not clearly demonstrated). They then bath-applied vasoactive
neurotransmitters like ATP, glutamate, and noradrenaline and observed lumen diameter
changes in the vessels subjacent to ~30% of sampled pericytes (Peppiatt et al. 2006).
This is a seminal study, and was foundational for modern pericyte biology, but
leaves many open questions. All pericytes responses were quite slow, taking many
seconds, sometimes minutes, to develop. Because they did not compare pericyte
responses to those of SMCs, it is unknown if this slowness is a trait of pericytes or of
their stimulation design/experimental preparation. It is also unknown where within the
vasculature they were looking; the vessel diameters they provide are from 4-9 microns,
and this is in living, unperfused tissue, making it difficult to exactly translate these
diameters to those found in histology or in vivo. It is also unclear why responses are
expected at pericyte soma but not elsewhere, considering that electron microscopy
shows that the soma is mostly chromatin in the nucleus, and the processes appear to
have as many contractile filaments as the soma. This obfuscates their interpretation of
the data because they compare soma vs non-soma responses to prove that pericytes
are modulating diameter in response to electric or pharmacologic manipulation (Peppiatt
et al. 2006).
The next landmark was a study of brain pericytes in vivo. Fernandez-Klett et al.
found that superfusing a potent vasoconstrictor (U46619) in brain slices, and in vivo,
produces a widespread capillary constriction that is exaggerated near the pericyte soma.
The fact that capillary constriction was observed in brain slice without vessel perfusion,
and also occurred in the context of inconsistent surface arteriole responses in vivo,
suggests that this is an active pericyte constriction rather than a passive deflation
resulting from upstream constriction and loss of flow. Further support of pericyte
contraction is that these reductions in capillary diameter (~10%) yielded a linear
Page 41

decrease in capillary blood flow in vivo. To test if pericytes modulate capillary diameter in
the face of neural activity, they triggered massive neural activity with a cortical spreading
depression and measured vessel diameter. They found dilations in all vessel types,
including a 20% diameter increase in capillaries. However, because there was no
difference in diameter change between pericyte soma positions, and non-soma
positions, they assumed that pericytes must not be effecting this change in diameter.
Their interpretation was that this 20% dilation is a passive response because of
upstream dilation and increased perfusion pressure. Thus their final conclusion was that
pericytes are contractile, but they do not mediate functional hyperemia (Fernandez-Klett
et al. 2010). This is another seminal study with open questions: what type of pericytes
were they studying--capillary or ensheathing? Did upstream flow influence capillary
diameter changes? Is a soma vs. non-soma comparison good evidence that pericytes
are not doing anything to actively dilate capillaries?
Next, Attwell’s group showed that prostaglandin E2 dilates and 20-HETE
constricts pericytes in isolated retinae in response to neural activity or neurotransmitters.
They also showed in vivo that capillary diameter changes occur prior to arteriole
diameter changes during sensory stimulation in the cortex, and they attribute this early
capillary response to pericyte activity (Hall et al. 2014; Mishra et al. 2016). In these
studies, responses at pericyte somata and pericyte processes were equal, in contrast to
the soma-specific responses of their earlier studies. These studies have some of the
same caveats as above -- what types of pericytes and vessels were they studying? In
vivo studies focused on the first branch coming off of the penetrating arteriole, which in
their view is a capillary covered by a pericyte. It was unclear where along the vascular
tree the ex vivo studies were conducted. In vivo, they only report vessel dilation in
vessels up to the fourth ‘branch order’, a measure of the number of branch points
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between the penetrating arteriole and a given vessel of interest (Hall et al. 2014). Based
on recent studies, the 4th branch order could harbor ensheathing pericytes, or capillary
pericytes (Grant et al. 2017; Hill et al. 2015).
The Nedergaard group corroborated the finding that capillary flow increases prior
to arteriole blood flow in response to sensory stimulation, but they do not think pericytes
are involved. They compared capillary regions ‘with’ versus ‘without’ an NG2-DsRed
labeled pericyte, and did not see any difference in diameter or velocity changes. They
went on to show that red blood cells themselves can change shape in response to
activity-induced decreases in tissue oxygen, allowing them to flow more easily through
the capillary, explaining the early increase in capillary flow velocity. This was beautiful
work, but again it was unclear how they defined capillaries in vivo, and thus it is
unknown which type of pericytes they measured during their hyperemia studies (Wei et
al. 2016). Furthermore, ‘pericyte’ or ‘no pericyte’ is a false dichotomy because as we will
see in Chapter 2, pericytes cover the entire vasculature, and there is no such thing as
‘no pericyte’ regions in a healthy brain (Hartmann, Underly, Grant, et al. 2015).
Another study by the Nedergaard group, and studies by the Attwell group, use
the same ‘pericyte vs no pericyte region’ dichotomy to discern the role of pericytes in
modulating blood flow (Hall et al. 2014; McConnell et al. 2016). This false dichotomy
arose because the pericyte processes in the NG2-DsRed mouse are very dim and hard
to see, making it falsely appear that large lengths of the vasculature are not covered by
pericyte processes (Hartmann, Underly, Watson, et al. 2015). In the next chapter, we
introduce a means of filling pericytes with a much brighter fluorescent dye that reveals
pericyte processes to be everywhere along the vasculature.
And finally, the most sophisticated in vivo study of pericytes reacting to stimuli is
also the most controversial. The Grutzendler lab separated SMCs and pericytes based
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on αSMA content, regardless of the morphology of the mural cell, calling any mural cell
with αSMA a SMC, and any mural cell without αSMA a pericyte. They then show that
pericytes on capillaries are inert cells that do not respond to neural activity, as they did
not observe a calcium or diameter change during sensory stimulation. Furthermore,
capillaries did not show a diameter change in response to stroke, cortical spreading
depression, or brief one or two photon stimulation of channelrhodopsin (ChR2) in mural
cells. They conclude that pericytes do not modulate capillary diameter. In many ways,
this study was consistent with the previous in vivo studies, who all found that diameter
responses are negligible deep in the capillary bed, even in the face of massive neural
stimulation like in cortical spreading depression (Fernandez-Klett et al. 2010; Hall et al.
2014). However, this study was very inconsistent with previous definitions of pericytes,
because they show many examples of cells with pericyte features that they called SMCs
(Attwell et al. 2016). Aside from this semantic issue, they did not try different ‘doses’ of
optogenetic stimulation, and did not account for the fact that the lower vessel coverage
of pericytes means that their optical stimulation intersected fewer molecules of ChR2 in
pericytes than in SMCs. They likely did not try higher amounts of light because they
were concerned with inducing phototoxicity or off-target effects, which could have been
controlled for with animals not expressing ChR2. Caveats aside, this was a great step
forward because it was the first study to provide a clear definition of the cells they
investigated based on αSMA content (although the name they chose is unusual), and it
was the first study to attempt a cell-type specific stimulation in their use of optogenetics
(Hill et al. 2015).
Altogether, by stimulating vessel responses and observing vessel dynamics, we
have learned a great deal since the studies of the summer frog. We have advanced in
technical sophistication and rigor, but we are faced with many of the same debates
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today as in the early 1900’s, and it is still unclear if pericytes can modulate capillary
diameter. The debates are centered around how we should define pericytes and
capillaries, which types of pericytes can control blood flow, and which stimuli do
pericytes respond to.

3. The final approach used to study pericytes in the brain is to measure the effects of
reducing the number of pericytes, like a knockout study. This began with studies
showing that pericytes are critical for vascular development and blood brain barrier
formation (Armulik et al. 2010; Crosby et al. 1998; Daneman et al. 2010; Lindahl et al.
1997). Some of these same genetic deletion models, namely the PDGRBeta+/- and
PDGFRBeta F7/F7 models, were then used to show that chronic pericyte loss is
correlated with decreases in cerebral blood flow at rest and during functional hyperemia
(Bell et al. 2010; Kisler, Nelson, Rege, et al. 2017; Montagne et al. 2018). Although this
suggests a role for pericytes in modulating blood flow, interpretation is complicated by
possible developmental anomalies, concomitant inflammation due to blood-brain barrier
rupture, and death of SMCs, endothelial cells and neurons (Bell et al. 2010; Montagne et
al. 2018). Furthermore, because it is a whole-body genetic deletion since conception, it
is unknown how peripheral pericyte loss impacts systemic hemodynamics that could
then affect the brain. The genetic manipulation affects SMCs as well as pericytes
because all mural cells express PDGFRBeta from development through adulthood (Jung
et al. 2018). These studies are thus important for establishing a pericyte role in brain
health, but are less useful in pinpointing their role in modulating cerebral blood flow.
Serendipitously, because these genetic conditions generate a chronic loss of
pericytes, the Zlokovic group realized there was a time window in early adulthood when
pericytes were the predominate cell affected by the PDGFRBeta+/- genotype, and other
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cell types including SMCs appeared normal (Kisler, Nelson, Rege, et al. 2017). Using
these animals at this early time point, they found that capillaries with a 20% decrease in
pericyte coverage exhibited a blunted and delayed hyperemic response to neural
activity. According to several in vivo imaging measures, these mice also had poorly
oxygenated tissues at rest and during sensory stimulation. They took painstaking steps
to show that SMCs, neurons, endothelium, and glia were unaffected by the genetic
manipulation at this time point. However, because defects in all these cell types do occur
beyond 6 months of age (Bell et al. 2010), it is difficult to be sure that all these other cells
types are perfectly normal at age 2 months. In all these genetic deletion models,
capillary density is reduced, which they sometimes control for by using the Meox2-/model that also has reduced capillary density but fully functional pericytes and more
normal blood flow (Kisler, Nelson, Rege, et al. 2017). In sum, the Zlokovic group has
done a lot of work suggesting a role for pericytes in modulating blood flow, but the
interpretation of these findings is obfuscated by the widespread effects induced by
genetically reducing PDGFRBeta signaling from the time of conception.
Another genetic pericyte deletion model, wherein Notch3 is modified or deleted,
produces similar results as the PDGFRBeta deletion models. In one study of the R169C
Notch3 mutation, which causes the genetic vascular dementia disorder CADASIL in
humans, a pathological accumulation of the protein around pericytes led to a progressive
reduction in pericyte coverage in the brain, blood-brain barrier leakage, and a diminished
blood flow response to hypercapnia measured by doppler flowmetry (Ghosh et al. 2015).
Importantly, there did not appear to be histological reduction of αSMA staining or
capillary density, and pial arteriole responses to hypercapnia were normal. The caveats
of the Notch3 studies are the same as in the PDGFRBeta studies -- a genetic
modification in a gene known for proper development of all mural cells will have farPage 46

reaching effects that are difficult to fully control for. Indeed, other studies using the same
model did find functional defects in SMCs (Dabertrand et al. 2015). Future studies that
can induce brain-specific, and pericyte-specific cell loss in adults are now the holy grail
of pericyte research. Even these might be complicated by the inflammatory cascade that
ensues from blood-brain barrier rupture, but they will be a leap forward.
By ablating a single pericyte with a 725nm two photon laser, Andree-Anne in our
lab circumvented nearly all the caveats of previous genetic studies. After ablating a
pericyte, she then watched the effects of pericyte ablation over time. Surprisingly, there
was no blood-brain barrier permeability to a 1kDa cadaverine dye, but there was a 10%
capillary dilation specifically in the area of the capillary that was uncovered by the
pericyte ablation (Berthiaume et al. 2018). Once the neighboring pericytes stretched out
their processes to re-establish coverage of that area, the diameter returned to its
baseline value. It is unknown if these diameter changes were because of laser-induced
damage near the vessel wall, or if these fluctuations in diameter are simply due to daily
changes in capillary diameter -- there was not a control group in her studies. I use this
same technique in chapter 3, and add a control group to try to address these limitations.

Open questions that I’ll address with the work in this dissertation
In sum, pericytes are biologically interesting because they have entwined the
capillaries of vertebrates for over 600 million years, and we have wondered about their
ability to modulate blood flow for hundreds of years (Rouget 1873). Just as they are
ubiquitous across all vertebrates, pericytes are ubiquitous across all of our organs,
covering thousands, of miles of vasculature. The brain is of particular interest because of
its large and dynamic need for blood supply. Pericytes are clinically interesting because
they sit on capillaries, which collectively provide most of the hemodynamic resistance in
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the brain and the body (Gould et al. 2017). They are therefore relevant targets for
enhancing cerebral blood flow in dementia, stroke, and other diseases characterized by
hypoperfusion. They also may be important in modulating cerebral, or systemic, blood
pressure.
Pericytes have been studied for a long time, but we still grapple with questions
about their identity (i.e. how to differentiate them from SMCs?), and their ability to
modulate blood flow (i.e. are blood flow changes observed in previous studies because
of upstream flow changes?). The biological and clinical curiosity with pericytes drives us
into the next chapters, where we provide a map of how to categorize pericytes in the
brain, then we visit different points on this map and test their ability to modulate blood
flow.
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Chapter 2: What do pericytes look like?

INTRODUCTION TO CHAPTER 2
After searching through the literature for the right mice to label pericytes, we
arrived at two mice that might put Cre in all mural cell types: PDGFRBeta-Cre and NG2CreERTM mice (Hartmann, Underly, Watson, et al. 2015). In this chapter, we characterize
these mice. Along the way, we realized that we didn’t really know what pericytes look
like. It seemed like there were more cartoons than real images of pericytes at the time.
We especially didn’t know how SMCs transition into pericytes as you move along the
arteriole-capillary axis. With these new mice, we were able to see pericytes and their
structural relationship to SMCs easily because tdTomato is the brightest fluorescent
protein in widespread use (Drobizhev et al. 2009), allowing us to visualize finer cell
structures. In addition, in the NG2-CreERTM mouse, we could label individual cells and
visualize the territory of one cell without confusing overlap from neighboring cells. We
published this work in the journal Neurophotonics in early 2015. In the Discussion of
Chapter 2, I also add updated concepts of the mural cell continuum from work published
in 2017 by Ian Grant in our lab. I add it because it is important for understanding
subsequent chapters, and because I played a role in conceptualizing and carrying out
the experiments for the Grant, et al. paper. Ian Grant performed analysis for Fig 17, and
Ashley Watson for Fig 14.

BACKGROUND
Pericytes play diverse roles in the brain, including maintenance of blood-brain
barrier (BBB) integrity (Armulik et al. 2010; Daneman et al. 2010), angiogenesis
(Gerhardt and Betsholtz 2003), putative regulation of cerebral blood flow (Bell et al.
2010; Hall et al. 2014), clearance of cellular debris (M. D. Sweeney, Ayyadurai, and
Zlokovic 2016), and generation of pluripotent cells (Dore-Duffy 2008). Defects in pericyte
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function also promote tissue injury in stroke (Hall et al. 2014; Yemisci et al. 2009)
and neurodegeneration by impairing cerebral microcirculation and BBB stability.
This provides a strong impetus to understand the beneficial and deleterious roles
of pericytes in health and disease.
Much of our understanding of these enigmatic cells comes from ex vivo
studies using histology, electron microscopy, or slice physiology, where pericytes
can be identified by morphology or staining with a battery of protein markers
(Armulik, Genové, and Betsholtz 2011). However, the translation of this work to
an in vivo preparation has been hampered by a lack of tools to selectively target
pericytes with transgene expression. In particular, methods to specifically
express bright fluorescent proteins in pericytes would aid their identification
during fluorescence imaging studies. Further, targeted expression of geneticallyencoded tools to observe (T.-W. Chen et al. 2013) or modulate (Madisen et al.
2012) cell activity can provide significant advances in our understanding of
pericyte physiology. At the time of writing this paper, in vivo fluorescence imaging
of pericytes has been restricted to two transgenic mouse lines: NG2-DsRed (Hall
et al. 2014) and β-actin-GFP mouse (Fernandez-Klett et al. 2010). Both lines are
sufficient to report the location of pericytes based on their stereotyped ovoid cell
bodies that protrude from the vasculature, but they do not support future goals to
genetically target cerebral pericytes with transgenes for interactive studies of
pericyte physiology. Moreover, neither line enables visualization of the farreaching processes, which constitute the majority of the vascular coverage
offered by pericytes, and are likely essential to blood-brain barrier stability.
Cre-lox recombination is a widely used method to edit the mouse genome (Nagy
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2000). Expression of the viral Cre protein can be linked with the activity of any promoter,
and if this promoter is active in specific cell types, then one can achieve cell-specific
gene editing at Cre-binding sites, so-called LoxP sites. Here, we evaluate two Cre lines,
one driven by the promoter for neural/glial antigen 2 (NG2) proteoglycan (Ozerdem et al.
2001), and the other by platelet-derived growth factor receptor β (PDGFRβ) (Cuttler et al.
2011), to determine the specificity and extent of pericyte targeting by these Cre drivers.
Both promoters drive genes that encode proteins that are widely accepted
immunohistochemical markers for pericytes (Armulik, Genové, and Betsholtz 2011).
However, these proteins are expressed by other brain cells, and thus we need to verify
Cre specificity by breeding our Cre animals with “Cre reporter” animals that express
bright fluorescent proteins strictly in cells that have Cre. The importance of verifying Cre
specificity with reporter animals was exemplified in past work, where we found that
constitutive expression of Cre by the NG2 promoter led to widespread targeting of
neurons, oligodendrocyte precursors and pericytes, rendering these animals unusable
for in vivo imaging due to the sheer density of labeling (Hartmann, Underly, Watson, et
al. 2015). Here we test animals with tamoxifen-inducible expression of NG2-driven Cre,
which restricts Cre activity to cells with an active NG2 promoter at the time of tamoxifen
injection (Zhu et al. 2011).
Our results show that the NG2-CreERTM and PDGFRβ-Cre lines possess
complementary attributes for studies of pericyte structure and function. The combined
use of these animals will facilitate in vivo studies from the level of single pericytes to
populations of pericytes comprising tens to hundreds of cells. Sparse labeling provided
by the NG2-CreERTM line presents the first clear view of the structure of single pericytes,
while broad homogeneous labeling with the PDGFRβ-Cre line provides key information
Page 51

about the distribution and topological localization of pericytes in the cerebral
microvasculature.

RESULTS
Heterozygous male NG2-creERTM and PDGFRβ-cre driver mice were
bred with female Ai14 reporter mice (Madisen et al. 2010) created by the Allen
Institute to induce expression of the bright red fluorescent protein, tdTomato
(Shaner et al. 2004). The progeny of these crosses were termed NG2-tdTomato
and PDGFRβ-tdTomato mice, respectively. The NG2-tdTomato line was inducible
and required a period of tamoxifen injections during adulthood to initiate
tdTomato expression, whereas the PDGFRβ-tdTomato line expressed tdTomato
constitutively. We focused primarily on transgene expression in the cerebral
cortex where in vivo two-photon imaging is commonly performed.

Pericyte labeling in the CNS of NG2-tdTomato and PDGFRβ-tdTomato mice.
We first direct our attention to the NG2-tdTomato line (Fig. 9A-C). This
mouse line targets pericytes, but also oligodendrocyte precursors and neurons.
However, tdTomato fluorescence appeared brightest in pericytes allowing for
straightforward identification in histology based on morphology and perivascular
localization (ovoid cell body with processes running along the microvasculature)
(Fig. 9C). Pericyte labeling was found to be incomplete with a common regimen
of tamoxifen injections (100 mg/kg tamoxifen i.p. per day for 5 days (Madisen et
al. 2010). The distribution of labeled pericytes was heterogeneous, with regions
that exhibited near-complete pericyte labeling, referred to as hotspots, and other
areas nearly devoid of labeling. In contrast to the heterogeneity observed in the
NG2-tdTomato line, pericyte labeling was contiguous in the capillary beds of
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PDGFRβ-tdTomato mice (Fig. 9D-F). Pericyte processes were found to cover the entire
microvasculature such that the vascular topology could be distinguished without the
need for a separate vascular label. While the

Figure 9 Extent of tdTomato expression in pericytes of two Cre mouse lines: (A to C) Images from the
cortices of mice resulting from a cross between NG2-CreERTM and Ai14 reporter mice (NG2-tdTomato). (D
to F) Images from cortices of mice resulting from a cross between PDGFRβ-Cre and Ai14 mice (PDGFRβtdTomato). Top row, endogenous tdTomato fluorescence from each mouse line. Center row, co-staining of
tdTomato with CD31, a marker of the endothelial wall, and Hoechst to label cell nuclei. Bottom row, Highresolution confocal images from cortex showing the perivascular orientation of tdTomato labeled pericytes in
each mouse line (arrows). Note additional labeling of parenchymal cells (arrowheads), likely oligodendrocyte
precursors, in the NG2-tdTomato line that are absent in the PDGFRβ-tdtomato line.
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Table 1:Quantification of pericyte targeting in NG2-tdtomato and PDGFRβ-tdTomato mice

Genotype

Number of CD13+
pericytes per mm2
(mean ± s.d.)

Sensitivity

False Positive Rate

NG2-tdtomato
(1827 pericytes from 6
mice)
PDGFRβ-tdtomato
(952 pericytes from 3
mice)

227.9 ± 30.7

35.6 ± 8.4%

4.3 ± 2.4%

237.5 ± 12.4

99.4 ± 0.7%

0.3 ± 0.3%

Figure 10: Validating pericyte targeting in NG2-tdTomato mice: Left column shows endogenous
tdTomato fluorescence from regions in the sensory cortex. The center column shows cstaining with
verified immunohistochemical pericyte markers. Three established pericyte markers, CD13 (A), PDGFRβ
(B) and NG2 (C) were examined. The right column shows an overlay of endogenous and stained
fluorescence. All images are maximal projections of image stacks collected by confocal imaging.

Page 54

cell bodies of pericytes could be easily detected, the shape of a single cell was no longer
discernible as there was no obvious separation between processes of neighboring cells
(Fig. 9F).
To further characterize the extent and specificity of pericyte labeling, we tested
several antibodies specific for established pericyte markers, namely CD13
(Aminopeptidase N)(Kunz et al. 1994), PDGFRβ (Lindahl et al. 1997; Winkler, Bell, and
Zlokovic 2010) and NG2 (Ozerdem et al. 2001) (Figs. 10, 11). While all antibodies were
capable of labeling pericytes, in our hands, only CD13 staining provided the specificity
that was necessary for quantitative analysis of pericyte number (Figs. 10A and 11A).
This was because the NG2 and PDGFRβ antibodies used labeled other cell types with
higher or equivalent density such that pericytes could not be distinguished from
observing the stain alone (Fig. 10B,C and 11-B,C). Using CD13 as a normalization
factor for all pericytes within the tissue section, we found that NG2-tdTomato mice
labeled ~35% percent of CD13-positive pericytes (Table 1, sensitivity). However, the
variance was high, with sensitivity ranging between 0 to 86%, when small, randomly
placed regions of interest were examined. In areas of sparse labeling, the complete
morphology of individual pericytes could be visualized (Figs. 9C and 10).
Immunohistochemical analysis of PDGFRβ-tdTomato mice revealed that ~99%
of CD13-positive pericytes were labeled (Table 1, sensitivity), and that labeling was
homogeneous throughout the cortex (Fig. 9D and 11). The specificity of tdTomato
expression for pericytes was remarkably high, as only a rare neuron was found labeled
within the parenchyma. Notably, since CD13 appeared to co-label all the pericytes in this
line, we suggest that CD13 is an all-encompassing detector for pericytes in mouse
cortex (Alliot et al. 1999). In line with this remarkable specificity, the PDGFRβ-tdTomato
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line showed a much lower false-positive rate (mistaking a non-pericyte tdTomatopositive cell for a pericyte) than the NG2-tdTomato line (Table 1, false positive rate).
Finally, pericyte labeling in other CNS areas, including hippocampus, striatum,
olfactory bulb, cerebellum and spinal cord, were similar to that described for the
cortex (Fig. 12). Both lines may also be useful for visualizing pericytes in organs
other than the brain, although this was not examined in the current study.

In vivo imaging of pericytes in the sensory cortex.
After validating that tdTomato is expressed in pericytes, we examined if
both mouse lines were suitable for visualizing pericytes with in vivo two-photon
microscopy (Shih et al. 2012). We created thinned-skull cranial windows and
imaged upper cortical layers using a 975 nm excitation (Drew et al. 2010). As
expected, tdTomato-positive pericytes fluoresced brightly from the cell body
down to distal processes in both lines (Fig. 13). In the heterogeneously labeled
NG2-tdTomato line, it was possible to find imaging fields rich with pericytes
directly adjacent to fields with sparse labeling all within a single cranial window
(Fig. 13, top row). As expected from histological examination, the PDGFRβtdTomato line showed contiguous labeling of all pericytes (Fig. 13, bottom row).
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Figure 11: Validating pericyte targeting in PDGFRBeta-tdTomato mice: Left column shows
endogenous tdTomato fluorescence from regions in the sensory cortex. The center column shows
cstaining with verified immunohistochemical pericyte markers. Three established pericyte markers,
CD13 (A), PDGFRβ (B) and NG2 (C) were examined. The right column shows an overlay of
endogenous and stained fluorescence.

Morphological characteristics of individual cortical pericytes.
The true structure of a pericyte has remained elusive because immunohistochemical
labeling either reports subcellular structures or leads to contiguous staining that does not
allow adjacent pericytes to be visually separated. Regions of sparse pericyte labeling in
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the NG2-tdTomato line thus provided a unique opportunity to define the morphology of
individual pericytes including fine distal processes. Using confocal microscopy, we
collected high-resolution volumetric data from isolated, single cells. Pericytes as a
population were highly variable in structure (Fig. 14). The processes extending from the
cell body, however, were sufficiently stereotyped to allow for categorization. We
organized the various pericyte processes in the following way: we call a process a
“primary trunk” if it protrudes directly from the cell body, and a “primary branch” if it is a
longitudinal branch that splits from the primary trunk (Fig. 14A). Smaller branches
occasionally emerged perpendicularly from primary trunks or branches, and partly
encircled the microvessel lumen (Fig. 14B). We called these secondary processes,
consistent with past work (Armulik, Genové, and Betsholtz 2011).

Figure 12: Transgene expression in different brain regions of adult NG2-tdTomato and PDGFRBetatdTomato mice: Epifluorescence images for each animal showing endogenous tdTomato fluorescence (top
row) and overlaid with CD31 and Hoechst labeling (bottom row).
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In their simplest form, primary trunks and branches were thin singular strands of
approximately 2 μm in diameter that branched into thinner secondary processes (Fig.
14B, F). Primary processes, either trunks or branches, sometimes existed as pairs that
coursed along a microvessel on opposing sides of the lumen. These pairs often
appeared twisted, forming helical structures that were interwoven by fine connections
(Fig. 14D, E). In their most complex form, primary trunks formed a mesh-like sheath that
surrounded the entire vessel (Fig. 14C, G). These pericytes were more common to
microvessels of larger diameter, such as precapillary arterioles or postcapillary venules.
An additional feature of pericytes was the location of their cell bodies along the
microvasculature. The cell bodies could be located at the bifurcation of vessels, i.e.,
junctional, or along the capillary segment between junctions, i.e. en passant (Fig. 14D,
E).
We further characterized pericyte processes by measuring their numbers and
lengths. Pericytes picked at random extended between 2 to 4 primary trunks, with a
median of 3 (n = 14 cells) (Fig. 14H). Individual primary trunks would then split once, at
most, to generate two primary branches. The total number of branches per cell,
however, was highly variable ranging from 0 to 7 with a median of 4. Primary branches
were also shorter than primary trunks, averaging 41 ± 31 μm and 67 ± 41 μm in length,
respectively (mean ± s.d., p = 0.003; Kolmogorov-Smirnov test) (Fig. 14I). Given these
parameters, we estimate that a single capillary pericyte covers ~300 μm of total capillary
length. This is much longer than the proposed 70 um in the literature, based on distance
between pericyte cell bodies in the brain (Tilton 1991).
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Figure 13 Visualization of pericytes in vivo with two photon microscopy: Pericytes imaged in the upper
cortical layers of NG2-tdTomato (top row) or PDGFRβ-tdTomato mice (bottom row). Images are
maximally projected stacks spanning 50 μm of tissue thickness at various depths below the pial surface. A
hotspot enriched with pericytes was imaged in the NG2-tdTomato mouse.

Past work has suggested that the pericytes more closely associated with
penetrating arterioles are regulators of blood flow (Hall et al. 2014). It is thus
conceivable that such pericytes are distinct in structure compared with their
counterparts deeper in the capillary beds. To identify these pericytes, we
immunohistochemically stained for α-smooth muscle actin (α-SMA). While we
were unable to detect strong α-SMA expression in pericytes as reported in some
peripheral vascular beds (Herman and D’Amore 1985), labeling of parenchymal
arterioles was very robust. In these tissues, we could follow the hierarchy of
arteriole branches as they ramified from penetrating arterioles to precapillary
arterioles to capillaries and the mural cell types covering each topological level
(Figs. 15A–15G). Here, we specifically define precapillary arterioles as

Figure 13 Visualization of pericytes in vivo with two photon microscopy: Pericytes imaged in the upper
cortical layers of NG2-tdTomato (top row) or PDGFRβ-tdTomato mice (bottom row). Images are
subsurface
branches of the penetrating arterioles immediately preceding the αmaximally projected stacks spanning 50 μm of tissue thickness at various depths below the pial surface. A
hotspot enriched with pericytes was imaged in the NG2-tdTomato mouse.

SMA lacking capillary bed. This transition point was referred to as an arteriole–
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capillary interface (Figs. 15A, H, I). We identified isolated tdTomato-positive pericytes
that were directly juxtaposed to α-SMA-rich cells at this interface (Figs. 15J and 15K).
These pericytes expressed very low levels of α-SMA comparatively (Fig. 15I), always
exhibited mesh processes, and appeared to tightly interlock with a smooth musclepericyte hybrid cell type (see below) on the arteriolar side of the interface. We quantified
the processes of these “mesh” pericytes as before. Their primary trunks (n = 7 cells
examined) were typically fewer in number (median of 2 versus 3) and shorter in length
(40 ± 35 μm versus 70 ± 40 μm, p = 0.001, mean ± s.d.; K-S test) compared with the
pericytes of the capillaries (Figs. 14H and 14I). The primary trunks also exhibited a
slightly higher surface to volume ratio (1.8 ± 0.3 versus 1.6 ± 0.4, p = 0.02, mean ± s.d.;
K-S test), suggesting a greater structural complexity that may be important for contractile
function. In contrast, we found no significant differences in the morphology of primary
branches between mesh pericytes and capillary pericytes. Finally, we also observed
mesh pericytes enwrapping larger diameter subsurface microvessels that were not
associated with α-SMA that were likely postcapillary venules. Collectively, these data
support the idea that the cerebral pericytes are a diverse group of cells that vary in
morphology along the cerebral vascular topology and likely serve different functions in
blood flow control and blood-brain barrier maintenance.
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Figure 14 Structure of individual pericytes in NG2-tdTomato mice: (A) Schematic of a junctional pericyte with
classification of its processes. (B) Three-dimensional rendering of a pericyte with three primary trunks, which
extend directly from the cell body. Small secondary processes extend perpendicularly from the primary
process, which is in this case a primary trunk. Soma shown in white. (C) Mesh-like process that wraps the
microvascular lumen (inset from B). (D) Example of a junctional pericyte, and an en passant pericyte. (E). A
pericyte with four primary trunks, one of which splits into two primary branches. (G) Example of a mesh
pericyte wrapping a post-capillary venule. (H) Histogram and cumulative fraction plot of the number of each
process type, primary trunk or branch, possessed by individual pericytes. (I) Histogram and cumulative fraction
plot of the length of each process type. Scale bars 50 μm, except panel C, which is 10 μm.
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A continuum of cerebrovascular mural cells.
In addition to the labeling of pericytes, NG2-tdTomato mice also revealed
expression in other spatially isolated mural cells. All pial arteries and arterioles exhibited
intermittent labeling of smooth muscle cells that appeared as concentric rings
surrounding the lumen (Fig. 16A). Smooth muscle cells maintained their ring shape well
into the parenchyma along penetrating arterioles. As penetrating arterioles ramified into
smaller precapillary arterioles, the mural cells exhibited a mixed phenotype of smooth
muscle and pericyte. These cells appeared more elongated than smooth muscle cells,
enveloped the endothelium with finger-like processes, and possessed protruding, ovoid
cell bodies similar to those of pericytes (Fig. 16B). It is likely that these hybrid cells make
direct contact with the arteriole-associated pericytes (Fig. 15F). On collecting venules,
we observed stellate-shaped cells that ensheathed the vessel lumen with broad “leaflike” processes, as previously described in ultrastructural studies (Ushiwata and Ushiki
1990) (Fig. 16C). These cells have been categorized as smooth muscle cells of venules
by past work (Armulik, Genové, and Betsholtz 2011). The similarities between our
results and those of previous ultrastructural electron microscopy studies (Ushiwata and
Ushiki 1990) suggests that tdTomato is present throughout the pericyte cytoplasm. In the
PDGFRβ-tdTomato line, we observed complete labeling of mural cells from the pial
surface down to the capillary beds (Fig. 16D, E). Similarly, labeling of cells along
venules was also contiguous (Fig. 16F).
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Figure 15 Mural cells of the arteriole-capillary interface: (a) Immunostaining reveals the point of transition
between α-SMA-rich arterioles and α-SMA-poor capillaries, the “arteriole–capillary interface”. Maximum projection
confocal image in cortex of an NG2-tdTomato animal. Separation of the (b) tdTomato and (c) green α-SMA
channels illustrates individual mural cells along this transition. (d, e) A smooth muscle cell on the penetrating
arteriole expressing α-SMA. (f, g) A smooth muscle-pericyte hybrid located on the first branch off the penetrating
arteriole. Note the substantial expression of α-SMA and brightly labeled ovoid cell body, but lack of classic
pericyte phenotype. (h, i) Magnified view of an arteriole–capillary interface. A tdTomato-expressing smooth
muscle-pericyte hybrid and mesh pericyte are adjacent to each other and thus not visually separable. However, αSMA labeling ceases at the interface between the two cells. The mesh pericyte downstream of the interface
exhibits comparatively minute levels of α-SMA. (j, k) Two examples of isolated tdTomato-positive mesh pericytes
at the arteriole–capillary interface. These mesh pericytes interlock, rather than overlap, with smooth musclepericyte hybrids. The pericyte soma is pseudocolored white.
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Figure 16 Arteriolar and venular mural cell labeling in NG2-tdTomato and PDGFRβ-tdTomato mice: (A) Highresolution confocal image projections of concentric smooth muscle rings in pial arterioles of NG2-tdTomato
mice. Note that incomplete labeling allows individual cells to be discerned. (B) Hybrid smooth muscle-pericyte
cells residing on precapillary arterioles (arrows) exhibit ovoid cell bodies but lack the long-reaching processes
common to capillary pericytes (arrowhead). (C) Stellate-shaped smooth muscle cells cover the walls of a
collecting venule. Note the flat “leaf-shaped” processes that spread over the vessel surface (arrows). (D to E)
Equivalent vascular structures imaged in the PDGFRβ-tdTomato line are contiguous throughout the
cerebrovasculature. Thus, individual cell shapes cannot be readily discerned.

Wide-field imaging of pericyte distribution in optically cleared tissues.
Large-scale characterizations of pericyte distribution may improve our
understanding of blood flow regulation or differential vascular vulnerabilities in disease.
The near-complete labeling of pericytes in the PDGFRβ-tdTomato line provided a means
to obtain these metrics when combined with optical tissue clearing and high-resolution
imaging. TdTomato fluorescence was well preserved in cleared tissues, providing image
stacks with strong signal over the entire depth of cortex. As an initial realization of this
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optical clearing approach, we examined three data sets to test the possibility that
pericyte numbers co-vary with increased neural density, perhaps as a means to more
precisely modulate blood flow for local metabolic demand. We focused on
cortical layers I and II/III, which are readily accessible by in vivo imaging. Layer
II/III exhibits an approximately 4-fold higher cell density compared to layer I,
mostly attributable to an increase in neurons (Tsai et al. 2009). Surprisingly, we
found that pericyte numbers decreased by 40% in layer II/III (Fig. 17E). This was
not due to a commensurate decrease in vascular volume, as only a modest
reduction of 7% was observed in layer II/III compared to layer I (Fig. 17F). This
suggests that pericyte density is not static through different cortical layers, and
their distribution may impact flow in a layer specific manner.
Pericytes located at capillary junctions may be capable of regulating red
blood cell passage through two or more routes of flow, and may thus be more
potent modulators than their en passant counterparts. Of all pericytes examined
(n = 105), 56% of pericytes had cell bodies located at a capillary junction, while
38% were en passant (Fig 17B,C). The remaining 6% were undefined due to
their location at the edge of the imaged tissue volume. These relative
percentages did not change significantly between layers I and II/III. In addition,
only 28% of all capillary junctions examined (n = 217) harbored the cell body of a
pericyte.
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Figure 17 Large-scale imaging of vascular mural cells using optical tissue clearing and two-photon imaging
of PDGFRβ-tdTomato tissues. (A) A volume of cortical tissue spanning 300 by 300 μm in the lateral plane
and 1000 μm in depth below the pia, imaged ex vivo after tissue clearing with SeeDB. Detailed
characterizations of pericyte number and location (B), vascular volume (C) and parenchymal cell density
(D) in layers I and II/III were collected from these larger data sets. (E to G) Statistical comparison of
measured parameters between layers I and II/III.

DISCUSSION
We have characterized two Cre-recombinase mouse lines that enable genetic
targeting of cerebrovascular pericytes. We show that a tamoxifen-inducible Cre line,
driven by the NG2 promoter (Zhu et al. 2011), provides regions of sparse labeling that
enabled us to define pericyte structures that we could not otherwise resolve with
immunostaining. These data show that pericyte processes are highly varied, with shapes
ranging from thin singular strands that run parallel to the microvasculature to more
complex mesh-like processes that enwrap the entire vessel lumen. Pericytes residing
more proximal to the precapillary arteriole, which are reported to be involved in blood
flow control (Hall et al. 2014), exhibit more complete processes that may be essential to
Figure 17 Large-scale imaging of vascular mural cells using optical tissue clearing and two-photon imaging
of PDGFRβ-tdTomato tissues. (A) A volume of cortical tissue spanning 300 by 300 μm in the lateral plane
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and 1000 μm in depth below the pia, imaged ex vivo
after
characterizations of pericyte number and location (B), vascular volume (C) and parenchymal cell density
(D) in layers I and II/III were collected from these larger data sets. (E to G) Statistical comparison of
measured parameters between layers I and II/III.

their contractile function (Fig. 18). While many of the morphologies we observed
have been previously described (Nehls and Drenckhahn 1991; Tilton 1991;
Ushiwata and Ushiki 1990), to our knowledge, this is the first characterization of
pericyte branch patterns and process lengths, and of the existence of mesh-like
pericytes on either poles of the capillary bed.

Figure 18 Summary of mural cell organization in the brain: (A) A tissue volume from a PDGFRβ-tdTomato
mouse imaged after optical clearing. (B) Distribution of pericytes and smooth muscle-pericyte hybrids in an
arteriole-capillary-venule loop. The cell bodies are labeled in white. (C) Schematic showing the continuum of
mural cell types along the cerebral vasculature. Smooth muscle cells form concentric rings on arterioles.
Hybrid smooth muscle-pericyte cells reside on precapillary arterioes and interlock with mesh pericytes as
the vasculature ramifies into the capillary bed. Pericytes in capillary beds exhibit long processes that
traverse the microvasculature in single strands or pairs that twist in a helical fashion. Mesh pericytes
become more prevalent again as capillaries turn into postcapillary venules. Stellate-shaped smooth muscle
cells cover the walls of parenchymal venules.

In a second mouse Cre line driven constitutively by the PDGFRβ
promoter, we find that nearly all pericytes are labeled, and that their processes
cover the entire capillary bed. Their stereotyped ovoid cell bodies are easily
detected in optically cleared ex vivo specimens, allowing for large-scale
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quantification of pericyte distribution and topological localization. Our studies suggest
that the combined use of NG2-CreERTM and PDGFRβ-Cre driver lines will allow
characterization of pericytes in any vascular bed of the brain, which can then inform in
vivo structure-function studies and computational approaches to understand cerebral
blood flow control.
We further provide details on the transition of mural cell types from arterioles to
capillaries to postcapillary venules (Fig. 18). In particular, imaging of NG2-tdTomato
mice revealed smooth muscle-pericyte hybrid cells abutted against pericytes with meshlike processes. The ovoid cell bodies of these hybrid cells appear much like those of
classic pericytes seen within the capillary bed.

How many distinct pericyte types are there?
Here we observed that as we travel from the proximal branches of the
penetrating arteriole deeper into the capillary bed, we see a loss of aSMA expression, an
elongation of pericyte processes, and a decrease in vessel coverage. Although the
heterogeneity in pericyte morphology has been discussed for over 100 years (Tilton
1991), there have been no attempts to quantify and organize this heterogeneity into
distinct subtypes of pericytes. Using the same techniques used in this chapter, in a
subsequent study we quantified mural cell aSMA expression, morphology, and location
within the vasculature to test if these features can demarcate statistically distinguishable
populations of pericytes (Grant et al. 2017). We found statistical differences between two
pericyte subtypes: ensheathing pericytes and capillary pericytes. Ensheathing pericytes
exhibit aSMA expression and vessel coverage equivalent to that of VSMCs, but possess
a protruding ovoid cell body and longer processes than VSMCs. Meanwhile, capillary
pericytes were both very different from VSMCs and ensheathing pericytes because they
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lacked aSMA labeling, they exhibited less coverage of the endothelium, and their
processes were much longer (Fig. 19). Importantly, these pericyte subtypes occupy
different vascular territories. Ensheathing pericytes are on proximal branches off
of the penetrating arteriole, from branch order 1 to 4, whereas capillary pericytes
exist in more distal branches. Important findings for future in vivo studies are that
immunohistochemical aSMA expression is undetectable beyond the 5th branch
order, and full coverage of a vessel by a pericyte coincides with positive aSMA
expression. These findings allow us to estimate aSMA expression using branch
order and mural cell morphology, which circumvents the need for an aSMA label
in vivo (Grant et al. 2017).

Limitations of this study
The NG2-tdTomato animals label many more cell types than just
pericytes. In contrast the PDGFRBeta-tdTomato animals showed nearly
exclusive mural cell labeling. However, a limitation is that we did not quantify the
extent of non-pericyte labeling in either model, which makes it difficult to assess
how specific a genetic manipulation using Cre would be in these mouse lines.
The focus here was on using the models for imaging studies with a vascular
label.
Another limitation is that here, and in follow up studies (Grant et al. 2017),
we perfused animals with paraformaldehyde, which reportedly allows the
depolymerization of aSMA and obscures its detection in capillary pericytes by
immunohistochemistry. Future studies should pre-incubate the brain with
phalloidin, or fix tissue with cold methanol, which reportedly prevents
depolymerization of pericyte aSMA, and better preserves aSMA
Page 70

immunohistochemical labeling (Alarcon-Martinez et al. 2018). Another limitation is that
both of these models label a small population of recently-identified perivascular
fibroblasts that rest on penetrating vessels. These fibroblasts will be difficult to
distinguish from mural cells, particularly when trying to study the mural cell response to
injuries where fibroblasts are known to proliferate, like spinal cord injury (Vanlandewijck
et al. 2018).

SUMMARY AND CONCLUSIONS
In Hartmann, et al. 2015, and Grant, et al. 2017, we used two novel combinations
of transgenic mice to visualize and characterize mural cell morphology, aSMA
expression, and location within the mouse cortical vasculature. Similar to previous
reports, we observed a gradient of mural cell shapes that gradually morphs from ringshaped VSMCs to stringy pericytes when going from arteriole to capillary. This gradual
change in shape is interrupted by an abrupt change in aSMA expression, which
demarcates the switch from ensheathing pericytes to capillary pericytes, and also
demarcates the switch from pre-capillary arteriole to capillary by our definitions. These
are the first studies to quantify these features of pericytes, and the first to perform highresolution imaging on individual pericytes, which enabled us to test if there are truly
different subtypes like Zimmermann described nearly 100 years ago. We find that there
are at least two types of pericytes based on these features: ensheathing pericytes and
capillary pericytes. Because follow-up studies in our lab mapped where along the
vasculature these pericyte types exist, we can now test the ability of these different
mural cells to modulate blood flow in vivo. The result of these studies are two updated
and accurate views (Fig 10 and Fig 11) of the continuum of mural cells in the brain.
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Figure 19 Updated summary of mural cell organization in the cerebrovasculature from Grant, et al. (2017).
This schematic shows the graded transition in morphology from ring-like smooth muscle cell to
ensheathing pericyte, to capillary pericyte, interrupted by an abrupt drop in alpha smooth muscle actin
content (green) when going from ensheathing pericytes to capillary pericytes. While the current chapter
presented images to construct the hypothesis that there are distinguishable mural cell types along the
arteriole-capillary axis, Grant et al. rigorously proved this hypothesis, and arrived at this schematic of
stereotyped pericyte subtypes. Note that each mural cell type occupies a particular branch order of the
vasculature, with SMC’s on the penetrating arteriole, ensheathing pericytes on the proximal branches, and
capillary pericytes beyond that point.

METHODS
Animals and surgery
TdTomato reporter mice (Ai14) on a C57/BL6 background were
purchased from The Jackson Laboratory (stock no. 007914) (Madisen et al.
2010). These mice were bred with two different Cre driver lines: NG2-CreERTM
mice (Jackson Labs; stock no. 008538) (Zhu et al. 2011) and PDGFRβ-Cre mice
(Cuttler et al. 2011). Mice were maintained in standard cages on a 12 hour lightdark cycle.
Malesummary
and female
mice
2 to 6 months
of age were used.
Figure
19: Updated
of mural
cellof
organization
in the cerebrovasculature
fromPericyte
Grant, et al. (2017).
This schematic shows the graded transition in morphology from ring-like smooth muscle cell to
ensheathing pericyte, to capillary pericyte, interrupted by an abrupt drop in alpha smooth muscle actin
density was not expected to change between 1 and 16 months of age in normal
content (green) when going from ensheathing pericytes to capillary pericytes. While the current chapter
presented images to construct the hypothesis that there are distinguishable mural cell types along the
mice (Bell et al.axis,
2010).
PDGFRβ-tdTomato
mice and
were
identified
by
arteriole-capillary
GrantBigenic
et al. rigorously
proved this hypothesis,
arrived
at this schematic
of
stereotyped pericyte subtypes. Note that each mural cell type occupies a particular branch order of the
vasculature,
SMC’s on
the penetratinginarteriole,
ensheathing
pericytes
on the proximal branches, and
observing with
tdTomato
fluorescence
a tail sample
using
an epifluorescence
capillary pericytes beyond that point.
microscope (Olympus SZX16). The tail was fileted in order to observe blood
vessels on the inner surface of the skin. Bigenic NG2-tdTomato mice were
identified by genotyping (Transnetyx). TdTomato expression was then induced in
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successfully crossed mice by intraperitoneal injection of tamoxifen at a dose of 100
mg/kg dissolved in corn oil:ethanol (9:1), every 24 hours for 5 consecutive days. NG2tdTomato mice were then imaged or sacrificed for histology within 2 months after the
final tamoxifen injection.
Prior to two-photon imaging, we generated thinned-skull windows as described
previously (Drew et al. 2010). Anesthesia was induced with isoflurane (Patterson
Veterinary) at 4% mean alveolar concentration (MAC) in 100% oxygen and maintained
at 1 to 2% during surgery. Body temperature was maintained at 37oC with a feedbackregulated heat pad. All animals were administered buprenorphine prior to or immediately
following the surgery at a concentration of 0.05 mg/kg for analgesia. The procedures
were approved by the Institutional Animal Care and Use Committee at the Medical
University of South Carolina.

In vivo two-photon microscopy
Two-photon imaging was performed with a Sutter Moveable Objective
Microscope (MOM) and a Coherent Ultra II Ti:Sapphire laser source set to 975 nm
excitation. Red emission was collected through an ET605/52m bandpass filter (Chroma
Technology Corp.). High-resolution imaging was performed use a water immersion 20-X,
1.0 NA objective lens (Olympus XLUMPLFLN 20XW). Mice were maintained under light
isoflurane (0.8-1% MAC) supplied in moisturized air throughout imaging. Lateral
sampling was 0.4 µm per pixel and axial sampling was 1 µm steps between frames.

Immunohistochemistry
Mice were transcardially perfused with PBS and 4% paraformaldehyde (PFA)
after sacrificing with Euthasol (Patterson Veterinary). Brains were extracted and postPage 73

fixed overnight at 4oC. Whole or hemisected brains were mounted and sliced on
a Vibratome series 1000 system to yield 50 μm thick coronal sections that were
then stored in PBS with 0.02% azide. When staining with α-smooth muscle actin
antibodies (see source below), slices were incubated in PBS with 0.125% trypsin
(Sigma; T4049) for 30 minutes at 37oC prior to antibody staining. This treatment
was necessary for antibody access to the vascular media. For immunostaining,
slices were first placed into a solution containing primary antibodies diluted into
PBS with 10 % (v/v), goat serum (Vector Labs), 2 % (v/v) Triton X-100 (Sigma),
and 0.02 % (w/v) sodium azide (Sigma). Primary antibodies were used at the
following dilutions: 1:500 rat anti-CD13 (Acris Antibodies; AM26636AF-N), 1:100
rabbit anti-PDGFRβ (Abcam; ab32570), 1:200 rabbit anti-NG2 (Millipore;
ab5320), 1:50 rat anti-CD31 (BD Biosciences; 550274), and 1:500 FITCconjugated mouse anti-α-smooth muscle actin (Sigma-Aldrich; F3777). After slow
nutation overnight at room temperature, the slices were washed in PBS and
transferred to secondary antibody, if required, in the same diluent as primary
antibodies for 2 h. These secondary antibodies were used at the following
dilutions: 1:1000 goat anti-rat Oregon Green 488 (Invitrogen; O-6382) and
1:1000 goat anti-rabbit Alexa 488 (Invitrogen; A31628). In some cases, tissues
were additionally incubated with Hoechst for 10 minutes (diluted to 1 μg/mL in
PBS, Invitrogen; H3569) in PBS for 10 minutes. After washing again in PBS,
slices were mounted, dried, and coverslip-sealed with Fluoromount-G (Southern
Biotechnology).
Epifluorescence images were acquired using a 10-X, 0.3 NA air objective
(Olympus UPLFLN10X2) on an Olympus BX53 microscope equipped with a
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QImaging QI Click camera (QImaging). Imaging resolution was 1 μm per pixel. Higher
resolution confocal images of the same slices were collected using an Olympus FV10i
confocal microscope and a 60-X, 1.2 NA oil immersion objective.

Pericyte quantification in histological slices
Pericytes were counted in epifluorescence images of tissues stained with CD13.
One region of interest was selected for three different cortical slices per animal (Table
1). Cells were counted in both tdTomato and CD13 channels independently. They were
categorized as pericytes if they met the following criteria: 1) the cell possessed a small
and well-defined ovoid cell body, and 2) there was at least one process emanating from
the cell body that was comparable in brightness, but thinned in diameter, than the cell
body. Following on overlay of both channels, additional cells with pericyte characteristics
were discovered, indicating that about 10% of pericytes were missed in counting with the
morphological criteria above. Co-labeled cells that were initially missed in one channel
were counted towards the total number of pericytes in the other channel. Sensitivity
reports the number of tdTomato-positive cells successfully categorized as pericytes. To
calculate sensitivity of labeling, the number of pericytes that co-labeled with tdTomato
and CD13 was divided by the total number of CD13 pericytes per region of interest. The
false positive rate reports fraction of cells was mistakenly believed to be pericytes based
on morphology. To calculate false positive rate, the number of cells that were counted as
pericytes using the tdTomato channel, but were not CD13-positive, was divided by the
number of pericytes that were CD13 and tdtomato-positive.

Analysis of pericyte structure
Analyses of pericyte structure was performed on volume rendered data from
high-resolution confocal stacks using Imaris 7.7 software (Bitplane). Care was taken to
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only analyze single pericytes there were completely isolated from other
fluorescent cells. We created surface renderings of each cell in the tdTomato
channel that were smoothed to a level of detail of ~1 um, which was half the
thickness of single-strand pericyte processes. Smaller, non-specific structures in
the background were removed by thresholding for object size. Pericyte
processes were traced in 3-D space using the filament tool to measure their
lengths. Individual processes were then isolated to measure surface area and
cytoplasmic volume.

Tissue clearing and imaging
To obtain high-resolution 3D images of the cortical vasculature, we
utilized the SeeDB optical clearing method (Ke, Fujimoto, and Imai 2013). To
label the vasculature, we injected 10 μL of 2mg/mL FITC-conjugated tomato
lectin (Vector labs; FL-1171) retro-orbitally into PDGFRβ-tdTomato mice. Two
hours after injection, the animal was perfused, and the brain was extracted and
placed in 4% PFA in PBS over night. The brain was then hemisected and placed
into a series of D(-) fructose solutions as described in Ke, et al. Once sufficiently
cleared, the tissue was submerged in SeeDB solution inside of a petri dish, the
surface of the brain was covered with a coverglass and image stacks were
obtained at 925 nm excitation with the two-photon microscope, to capture both
red and green fluorescence through ET605/52m and ET525/50m band pass
filters, respectively. One millimeter deep image stacks were collected with a
lateral resolution of 0.4 to 0.6 µm per pixel and an axial resolution of 1 µm per
frame.
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Analysis of pericyte distribution in cleared tissues
To isolate separate tissue volumes from layers I and II/III, we first
measured parenchymal cell bodies in SeeDB image stacks. Parenchymal cell bodies
were visible in the green channel due to exclusion of extravasated FITC-lectin that was
injected retroorbitally one hour prior to perfusion. These images were inverted and used
to generate a binary mask for cell counts, using previously published algorithms (Tsai et
al. 2009). A plot of cell number by frame was used to map the transition between the
cell-sparse layer I and cell-dense layer II/III. Since layer I is reported as being ~70 μm
thick (DeFelipe, Alonso-Nanclares, and Arellano 2002), we selected the 70 μm
superficial to the transition of cell density as layer I. An equivalent range of stacks deep
to the transition was designated for layer II/III, with the peak cell density set as the center
frame.
Prior to quantification, each image volume was then median filtered (3 x 3 x 1
pixels) in both red and green channels to reduce noise. The vascular volume was
generated based on which pixels in the FITC channel exceeded a mean + 2*standard
deviation intensity threshold for the 70 μm stack under consideration. Parenchymal cells
were enumerated by using size and intensity thresholds in Imaris that were made on a
case-by-case basis. Our counts are likely to underestimate the total cells, as FITC-lectin
may not be excluded from all cells. Quantification of pericytes was performed in 3-D
space in Imaris in order to best detect vessels that projected axially from a capillary
junction, which were easily missed when the data was observed in 2-D. Pericyte cell
bodies were manually counted by an experimenter blind to the cortical layer being
analyzed. Only pericytes with the center of their cell body within the stack were counted
towards the total. They were designated junctional if the center of the cell body was on
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the junction, and if the cell body was evenly distributed across the different
capillaries of that particular junction. All other pericytes were deemed en passant.
Pericytes whose locations could not be determined at the edge of the images
volume were labeled as “undefined”. There were no instances when a pericyte
was too faint to categorize or count.

Statistics
Paired t-tests were conducted in Graphpad Prism software when
comparing quantification from layer I to layer II/III. Three images stacks from one
animal were examined. Kolmogorov-Smirnov tests, which do not require
assumption of normality, were conducted in MATLAB to test for differences in
pericyte structure.
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Chapter 3: In vivo optical manipulation of pericytes

INTRODUCTION TO CHAPTER 3
We have validated the PDGFRBeta-Cre line as a good tool to study mural cells in
vivo, and we have pinpointed SMCs, ensheathing pericytes, and capillary pericytes
within the vascular network. We are now ready to use PDGFRBeta-Cre animals for in
vivo testing of the ability of different types of mural cells to regulate blood flow.

BACKGROUND
Can capillaries modulate the amount of blood flowing through them? This has
been debated in biology for over 100 years (Armulik, Genové, and Betsholtz 2011;
Krueger and Bechmann 2010). It is an important question because if blood flow is
regulated at the level of capillaries, then we can develop novel ways of increasing or
decreasing capillary blood flow, and thus possibly correct blood flow or pressure
abnormalities that occur in hypertension and other diseases (Iadecola 2017; Kisler,
Nelson, Montagne, et al. 2017). Although there are thousands of miles of capillaries
throughout our bodies, capillary blood flow through the brain is of particular interest
because of the brain’s high metabolic demand, and because capillary blood flow deficits
are implicated in the pathogenesis of myriad neurological diseases (Eskildsen et al.
2017).
Structurally, capillaries are composed of a single layer of endothelial cells
abutted by a single layer of pericytes that does not fully encircle the endothelium
(Wallow and Burnside 1980). Some have said that this structure does not support the
function of regulating blood flow (Hill et al. 2015), while others argue that pericytes
occupy the same anatomical niche as vascular smooth muscle cells (SMCs), which wrap
around and control blood flow through arterioles (Tilton 1991). Pericytes and SMCs,
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together called mural cells, indeed share many features such as embryologic origin
(Etchevers et al. 2001; Korn, Christ, and Kurz 2002) and expression of genes for actinmyosin contractility (Alarcon-Martinez et al. 2018; Joyce, Haire, and Palade 1985b;
Vanlandewijck et al. 2018), but we do not know if they share the function of modulating
blood flow. Since Rouget hypothesized that pericytes regulate capillary blood flow in
1873, the results of functional studies have been mixed, with some showing that
pericytes can modulate blood flow (Peppiatt et al. 2006), and others showing that they
cannot (Hill et al. 2015).
There are many reasons why results to date are inconclusive. Firstly, the
definitions of ‘capillary’ and ‘pericyte’ have remained amorphous and inconsistent across
studies. Changes in microvascular blood flow are attributed to SMC activity in some
studies, and to pericyte activity in others, even when it appears they were examining the
same types of cells (Attwell et al. 2016). An additional hurdle has been the inherent
structural connectedness of the vasculature. With capillaries downstream of arterioles, it
is difficult to separate changes in capillary blood flow from changes in upstream arteriole
blood flow in response to pharmacological or other manipulations (Fernandez-Klett et al.
2010). Finally, there has not been a way to genetically manipulate pericytes without also
affecting other cell types. SMCs are particularly difficult to genetically distinguish from
pericytes, because pericytes and SMCs have greatly overlapping gene expression, and
thus both express Cre in published studies of pericyte Cre drivers (Hartmann, Underly,
Watson, et al. 2015). A decrease in pericyte coverage of the vasculature is the
predominate phenotype in some mouse models, and these have pointed to a role for
pericytes in maintaining optimal brain blood flow. However, many other cell types are
directly or indirectly affected in these models, and vascular development could be
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affected by inborn mutations affecting pericytes, making it hard to pinpoint the role of
pericytes in regulating blood flow in the adult brain (Bell et al. 2010; Kisler, Nelson,
Rege, et al. 2017).
Here we use recent technological and biological advances in attempts to
circumvent these obstacles and determine if pericytes throughout the capillary bed can
modulate blood flow. We transgenically label all mural cells in the cerebrovasculature,
and then test the ability of different mural cell types to regulate blood flow in vivo,
adhering to definitions provided by recent maps of the various cerebrovascular mural cell
types (Grant et al. 2017). When we target two photon light to ChR2-YFP expressed in
mural cells along individual vessel segments, we find that pericytes on pre-capillary
arterioles and capillaries constrict and decrease blood flow, but in a slower and less
robust way than do SMCs on pial arterioles. We then ablate one or two pericytes on
capillaries, and find focal dilation and blood flow increases in the segments of capillary
that were left uncovered by pericyte loss.

RESULTS
Stimulating ChR2-YFP in mural cells while measuring hemodynamics
We expressed ChR2-YFP specifically in mural cells by breeding PDGFRβ-Cre
mice with Ai32 reporter mice (Fig. 20). As shown previously, this transgenic strategy
inserts ChR2-YFP into all mural cells across all regions of the vasculature (Grant et al.
2017; Hartmann, Underly, Grant, et al. 2015). In order to investigate the contractile
ability of individual vessel segments, we needed a method of activating mural cell ChR2YFP in a tightly-controlled volume of tissue (Hill et al. 2015). To achieve such spatiallyrestricted ChR2-YFP activation, we used two-photon microscopy, whose properties
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Figure 20. PDGFRBeta ChR2-YFP mouse: (a) Cre expression driven by the platelet-derived growth
factor receptor beta (PDGFRBeta) promoter unlocks ChR2-YFP expression. ChR2-YFP is shuttled to
the membrane where it opens in response to 800 nm two photon (2P) light, allowing cations in. (b) This
mouse labels all mural cells, evidenced by this confocal image showing the similarity between the
ChR2-YFP label and the endothelium labeled in lectin. (c) In vivo two photon imaging shows the mural
cell types from smooth muscle cells (SMCs) on surface arterioles, to ensheathing pericytes (EP) on precapillary arterioles, to capillary pericytes (CP) on capillaries. This image is a projection of 150 microns
deep into the cortex.
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enable stimulation of microvessel segments in the focal plane of the incident laser, thus
minimizing unintended photo-stimulation above or below the vessel segment of interest
(Helmchen and Denk 2005) (Fig. 22A). In addition to its ability to precisely stimulate
ChR2-YFP, two photon microscopy also allows a robust platform for measuring changes
in blood vessel diameter and flow (Kleinfeld et al. 1998). We simultaneously stimulated
ChR2-YFP, and measured hemodynamics in a vessel segment of interest, by instructing
the two photon laser to scan a line across the vessel width five times (to measure vessel
diameter), and longitudinally along the vessel lumen (to measure the velocity and
number of passing red blood cells)(Fig. 22D). The stimulation laser path intersected with
one or two mural cells along a single vessel segment in the focal plane. In capillaries, we
measured the effects of single-vessel ChR2-YFP stimulation on the diameter, velocity,
and number of passing RBCs (i.e. RBC flux) in the stimulated region of the capillary
(Fig. 22E,F). In pial vessels, we could only reliably measure diameter changes in
response to ChR2-YFP activation, because these vessels flowed too quickly to
accurately measure blood velocity and flux. To differentiate if resultant changes in
hemodynamics were the result of ChR2-YFP activation, or rather due to artifacts such as
animal movement or phototoxicity, we used an identical breeding, imaging, and
stimulation protocol in control mice expressing cytosolic YFP (Ai3) or membrane-bound
GFP (mT/mG) in mural cells (Figs. 21, 42). We compare the response of ChR2-YFP
animals to that of the control animals to determine if a given region of the vasculature
possesses contractile ability.
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Figure 21. PDGFRBeta YFP mice: (a) The same genetic strategy as for PDGFRBeta ChR2-YFP
mice generates controls that fluoresce YFP but do not pass current in response to light. (b) Histology
of the cortex shows labeling of all mural cells, some of which label with alpha smooth muscle actin
(αSMA) immunostaining. (c) In vivo two photon imaging shows similar labeling as in ChR2-YFP mice,
though these mural cells have their cytosol filled, so pericyte soma appear more like solid dots than
in the ChR2-YFP mice. These mice serve as controls for comparison with ChR2-YFP, and we used
these mice for ablation studies in conjunction with mT/mG mice, which use the same genetics.
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Figure 22. Simultaneously measuring hemodynamics and stimulating ChR2-YFP with two photon
microscopy: (a) A schematic of the cortical vasculature, showing the hierarchy of the penetrating
arteriole, its subsurface branches, and a penetrating venule. Red lightning demonstrates our method of
stimulating individual vessels along this hierarchy at different times using two photon laser light. (b) An
example 3-D in vivo image stack of the cerebrovascular tree and its branches, the real life version of (a).
The blue inset shows a capillary pericyte from the 3-D image stack in higher detail. This vessel segment
was stimulated and measured. Note how it could be covered by two different pericytes. (d) Schematic of
all that is accomplished by running an 800 nm two photon laser several times through a vessel segment:
1. Activation of ChR2-YFP, allowing cations to rush into the mural cell, 2. We measure diameter by
transecting the vessel, 3. We measure velocity and red blood cell (RBC) flux by bisecting the vessel. (e)
Shows the line scan is drawn on a capillary segment with a pericyte on it, the real-life version of d. (f)
The line scan is collected by repeatedly running the same course at about 600 Hz, generating a time
lapse image where the x axis is the distance along the line, and the y axis is time. The colors correspond
to the parts of the line that are colored in (e). The magenta line measures velocity, which is the slope of
the RBC shadows, and the number of passing RBCs, shown with yellow arrows. The other colors
measure diameter at different points along the vessel.

Pial arterioles and venules were differentiated based on the morphology of the
vessels, and the appearance of mural cells covering these vessels (Fig. 23). Subsurface
microvessels were categorized based on their ‘branching order’ (Fig. 24), defined as the
number of branchpoints encountered when tracing the minimum distance between a
given vessel and its nearest connected penetrating arteriole (Blinder et al. 2013; Hall et
al. 2014; Hill et al. 2015). In some cases we were able to follow capillaries up to the 9th
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branch order (9 branch points away from the
penetrating arteriole). We consider vessels from
1st-9th branch order collectively as subsurface
microvessels, which we later subdivide into precapillary arterioles (1st to 3rd order), and capillaries
(5th to 9th order) based on previous studies (Grant
et al. 2017). We focused primarily on capillary
pericytes, because their contractile ability is most
uncertain.

The effects of ChR2-YFP on surface and
subsurface microvessels
As expected, two-photon optogenetic
stimulation of pial arterioles harboring ring-shaped
smooth muscle cells led to robust and rapid
vasoconstriction that significantly differed from
Figure 23. Distinguishing surface
arterioles from venules: In vivo images
collected on the brain’s surface show
the mural cell wall (shown in green) is
much thicker on arterioles than on
venules. The YFP channel (middle)
shows ring-like morphology of YFP in
arteriole SMCs and spider-like
morphology of mural cells on venules.
Blue arrow points to venule, red arrow
points to arteriole.

control animal responses (Fig. 25A). ChR2-YFP
animals showed a 40% maximal constriction at 20
s, followed by gradual relaxation nearly back to
baseline (Fig. 25A). Pial arterioles in control
animals exhibited a smaller and slower constriction,

reaching 15% by 60s, in line with previous reports showing two photon-induced
vasoconstriction in non-transgenic animals (M. Choi, Yoon, and Choi 2010; Kimbrough
et al. 2015). In contrast to arterioles, there was no significant difference in the relative
diameter change between pial venules of ChR2-YFP and control animals, suggesting
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Figure 24. Mural cell types differ according to branch order. Top Left: the penetrating arteriole is
designated branch order zero. With every subsequent branch, the branch order increases by one. Top
right: Note how mural cell coverage of the vasculature decreases traveling away from the penetrating
arteriole. Bottom: surface arterioles are fully wrapped by smooth muscle cells. Low order branches are
fully wrapped by ensheathing pericytes, which have a protruding ovoid cell body not seen on smooth
muscle cells. High order branches are draped with capillary pericytes that do not fully cover the capillary.

that activation of mural cells covering venules cannot alter vessel diameter (Fig. 25B).
Meanwhile, we found that activating ChR2-YFP in pericytes on subsurface microvessels
(1st through 9th order) caused a constriction with very different kinetics than what we
saw in ChR2-YFP-expressing arterioles, gradually reaching a ~20% reduction in
diameter at the end of the 60s stimulation and imaging period. Critically, these diameter
changes were significantly greater than those observed in vessels from control animals
that were illuminated at laser powers and depths that were identical to those used in
ChR2-YFP animals (Figs. 25C, 43). Further, the vasoconstriction we observed in
subsurface microvessels was associated with decreases in blood cell velocity and flux,
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Figure 25. Diameter and blood flow decrease response to 60s of two photon ChR2-YFP activation: (a)
Surface arterioles expressing ChR2-YFP, shown in the green trace, quickly and robustly constrict during
stimulation, but then relax back towards baseline near the end of the stimulus. The dotted line represents no
change from the baseline. Control vessels are much less responsive, shown in black. Panels on the right
show an example time course of the change in diameter during the 60s line scan. (b) Venules from ChR2YFP or control animals show minimal response to equivalent stimulation as applied to arterioles. (c)
Subsurface microvessels expressing ChR2-YFP show a gradual, slight decrease in diameter over time.
Control vessels show much less of a change, but still slightly decrease in diameter due to damage or
movement out of the imaging plane. The examples to the right are 6 th branch order vessels. (d) The slight
constriction observed in ChR2-YFP expressing subsurface microvessels translates to an overall decrease in
blood cell velocity. Importantly, vessels that stopped flowing during the scan could not be accurately
analyzed on a continuous time scale and are not included here. Mean + SEM of vessels is shown.

confirming that the diameter changes were not a result of the target vessel shifting from
the imaging plane (Figs. 25D, 26). In line with the ability of pericytes on subsurface
microvessels to modulate blood flow on a protracted time-scale, we observed a
complete lack of flow in 30% of ChR2-YFP, but only 3% of YFP microvessels, in an
image stack collected 1-3 minutes after line scan stimulation, indicating this result cannot
be explained by light and heat-induced thrombus formation (Fig. 27). In sum, we find
that ChR2-YFP activation in pericytes can constrict microvessels and modulate blood
flow, but with different kinetics than ChR2-YFP activation of smooth muscle cells on
arterioles.
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Figure 26. RBC flux is decreased during ChR2 activation: (a) ChR2 activation, but not line scanning in
control animals, leads to a 40% decrease in the number of counted RBCs over time (p<0.0001 by Wilcoxon
rank sum test comparing 60 s flux to 1s flux. (b) Example of a vessel exhibiting a 50% decrease in RBC flux
at the end of 60s of ChR2 stimulation. (c) RBC flux through a control vessel does not change during scan.

Pericytes with and without aSMA constrict in response to ChR2-YFP
stimulation
Pericytes occupying subsurface microvessels from 1st to 9th branch order exhibit
heterogeneous morphology (Fig. 24) and expression of aSMA, a protein believed to be
required for vascular contractile ability (Fig 21). Recent studies have shown that
pericytes with aSMA have processes that cover the entire vessel, called “ensheathing
pericytes”, whereas pericytes without aSMA have thin processes that leave much of the
vessel uncovered, called “capillary pericytes” (Grant et al. 2017). With stark differences
in morphology and aSMA expression between these pericyte types, are there also
differences in their contractile ability and kinetics in our paradigm? This is an important
Figure 26. RBC flux is decreased during ChR2 activation: (a) ChR2 activation, but not line scanning in
control animals,
leads over
to a 40%
decrease
the number of countedis
RBCs
over time
(p<0.0001
by lacking
Wilcoxon
question
because
90%
of the incerebrovasculature
covered
by mural
cells
rank sum test comparing 60 s flux to 1s flux. (b) Example of a vessel exhibiting a 50% decrease in RBC flux
at the end of 60s of ChR2 stimulation. (c) RBC flux through a control vessel does not change during the
aSMA,
and we do not know if these regions are capable of regulating capillary blood flow
scan.

Page 89

(Hill et al. 2015) (Fig. 28D). To answer this, we subdivided our subsurface microvessel
data based on the likelihood that a given vessel expressed aSMA with the help of
previous studies from several groups. Mural cells on branch orders 1-3, with
circumferential processes that cover the entire vessel, have a high likelihood of
expressing aSMA, while mural cells on branch orders 5-9 with spindly longitudinal
processes have a very low likelihood of aSMA expression according to standard
immunohistochemistry techniques (Grant et al. 2017; Hill et al. 2015; Wei et al. 2016)
(Fig. 28C). We saw a significant difference in the diameter change between ChR2-YFP
and control animals for all vessel types except venules (Fig. 28E). As expected,

Figure 27. ChR2-YFP activation causes delayed stalls in flow: (a) Example image stack collected before
(top) and after (bottom) scanning in the region shown in the red line. Before the stimulus, RBCs are seen
moving as dark shadows against a brightly-labeled plasma (arrow). Roughly 1-3 minutes after the
stimulus, there is no movement of RBCs between frames, indicating they are stuck (arrowheads). (b)
Proportion of stalled/total vessels was significantly different among groups.***p<0.001, **p<0.005 by
Fisher exact test. Branch order 1-9. Mean+ 95% CI shown.
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arterioles showed a significantly greater diameter decrease than all other vessel types
(Fig. 28E). Despite very different levels of aSMA expression, pre-capillary arterioles and
capillaries showed an equivalent relative change in diameter. Because branch orders 13 have larger baseline diameters, the same relative change in diameter equates to a
60% larger decrease in absolute diameter in branch orders 1-3 compared to branch
orders 5-9 (0.91 micron absolute diameter reduction in BO 1-3 vs 0.57 micron absolute
diameter reduction in BO 5-9 on average, p<0.03 Wilcoxon rank-sum test, Fig. 29). In
branch orders 5-9, the velocity significantly decreases (~20% on average) with ChR2
stimulation, confirming our measured decrease in diameter. The velocity also decreases
by an average of 20% in branch orders 1-3, but this is not significantly different from
controls, likely because of the variable response and smaller sample size. RBC flux
could only be measured in branch orders 5-9, and further confirms that capillary pericyte
ChR2 activation alters blood flow.
There are three key implications for these findings. First, it suggests that α-SMApositive SMCs of pial arterioles have distinct contractile kinetics from α-SMA-positive
pericytes on pre-capillary arterioles, and should not be grouped together into one mural
cell type. Second, there are likely to be α-SMA-independent contractile mechanisms at
play throughout the capillary bed. Third, the majority of pericytes in the capillary bed
have the capacity to contract, albeit with slower dynamics compared to surface
arterioles.
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Figure 28. aSMA does not dictate contractility: (a) aSMA persists until usually the 2nd or 3rd branch order,
depicted in blue. (b) Using immunostaining of optically-cleared tissue, we counted the branches and 3dimensional length of vessels with and without aSMA expression. (c) The most distal cells to express actin
are on the 4th order (n=55 αSMA termini from 3 animals). (d) The total length of vasculature covered by mural
cells that express aSMA is roughly 6% (n=2 animals, 2 mm of vascular length measured). (e) All portions of
the vasculature except venules show greater relative diameter decreases than controls in response to ChR2YFP activation (*p<0.005 genotype effect for all ChR2-YFP-control comparisons except venules). Arterioles
showed a significantly greater diameter decrease than all other vessels (p<0.03 arterioles vs pre-capillaries
and arterioles vs capillaries). (f) Blood cell velocity decreases in capillaries, confirming the diameter changes.
Mean + SEM shown. Statistics are Two-Way ANOVA with repeated measures, genotype x branch order.
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Figure 29 Relative and raw diameter response kinetics in vessels with and without aSMA: (a) shows in solid
traces the constriction induced by ChR2-YFP activation. The overlapping red and blue trace indicates that
vessels with and without aSMA have similar relative kinetics to ChR2-YFP activation. (b) Because precapillaries are larger than capillaries, an equal relative response translates into a greater raw diameter
change from baseline in pre-capillaries. Wilcoxon rank sum test shows p=0.03 at 60s. Mean + SEM shown.

Optogenetically-induced pericyte contraction is inhibited by fasudil
The intense activation of this stimulation paradigm might recapitulate the
pathological depolarization previously observed in conditions like ischemia and dementia
(Bere et al. 2014; Hefendehl et al. 2016). We thus asked whether optogenetic pericyte
contraction could be pharmacologically inhibited, and thus possibly improve capillary
blood flow in these and other diseases. We examined if fasudil, a Rho kinase inhibitor
and clinically-used vasodilator, was able to prevent pericyte contraction induced by
optogenetic stimulation. We mixed fasudil into the agarose that sits atop the dura to
ensure a continual source of fasudil throughout our experiments because of its short half

Figure 29 Relative and raw diameter response kinetics in vessels with and without aSMA: (a) shows in solid
traces the constriction induced by ChR2-YFP activation. The overlapping red and blue trace indicates that
life
(Koumura
al. 2011).
Thissimilar
setuprelative
required
high
of drug
to
vessels
with and et
without
aSMA have
kinetics
to concentrations
ChR2-YFP activation.
(b) Because
precapillaries are larger than capillaries, an equal relative response translates into a greater raw diameter
change from baseline
in pre-capillaries.
Wilcoxon
rank sum
test shows
at 60s. Mean
SEM shown.
compensate
for incomplete
diffusion
through
the dura,
andp=0.03
the dilution
of the+ drug
once it

is diffused into the brain parenchyma (Roth et al. 2013). Fasudil readily dissolves in
aqueous solution, and thus the ‘vehicle’ for fasudil is the same as the agarose we have
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always used, allowing us to compare the results with fasudil to the results already
presented (Fig. 30B).
With fasudil, we observed a dose-dependent inhibition of contractility of pericytes
on branch orders 5 to 9, with 1mM fasudil showing a trend, but 10 mM fasudil showing a
significant effect on the change in diameter from baseline (Fig. 30C, E). Further, fasudil
was able to prevent reductions in red blood cell velocity and flux in a similar dosedependent manner (Figs. 30D,F and Fig 31F). An important caveat is that fasudil
changed baseline parameters of blood flow. We covered the cortex with normal agarose
before applying agarose with fasudil, giving us a pre-fasudil and post-fasudil image of
the surface vessels. By eye, we saw a dilation of surface arterioles in post-fasudil
images within minutes (Fig. 31A,B). The two-photon data, collected 1 hr after applying
the fasudil agarose, reflect this arteriole dilation. Baseline diameter of fasudil-treated
vessels is significantly larger compared to animals with normal agarose. Importantly, we
still saw a dose-dependent inhibition of the absolute diameter decrease caused by
optogenetic stimulation in vessels treated with 10 mM fasudil (Fig 31E). Also important
is that the baseline diameters are equal between 1mM and 10mM fasudil, but their
response to ChR2 stimulation is different (Figs. 30C and 31E,F), and baseline velocities
are surprisingly not affected by fasudil (Fig. 31D). Overall, this dose-dependent inhibition
by fasudil is consistent with ChR2-YFP activation triggering a contractile mechanism that
can be inhibited with clinically-relevant drugs.
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Figure 30 Fasudil inhibits ChR2-YFP-induced constriction: (a) Fasudil is a vasodilator that inhibits Rho
kinase, which normally deactivates myosin light chain (MLC) phosphatase, and promotes actin
polymerization. (b) Fasudil was dissolved in the agarose that filled the dura-intact craniotomy. Fasudil dosedependently inhibited the ChR2-YFP-induced constriction (c) and velocity decrease (d) compared to vehicle.
Vehicle data have already been shown in previous figures. (e) Statistics were performed on the fold change
from baseline, showing a significant effect of dose, with only 10mM fasudil being different than vehicle for
diameter. (f) All doses of fasudil effectively prevented the velocity decrease induced by ChR2-YFP
activation. P values shown are the result of Two-way ANOVA with repeated measures (drug x individual
animal to account for multiple data points collected in one animal). N= 160 vessels (10 animals) vehicle, 60
vessels (3 animals) fasudil 1mM and 60 vessels (3 animals) fasudil 10mM.
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Figure 31: Fasudil changes the baseline, but also inhibits the effects of ChR2 activation: A caveat of fasudil
is the arteriole and capillary dilation that is visible in the craniotomy (a,b), and in baseline data from two
photon imaging (c). Fasudil does not affect baseline velocity (d). The larger baseline does not explain the
effect of fasudil on constriction, as 10mM fasudil impacts the absolute diameter change from baseline (e).
Fasudil dose-dependently prevents ChR2 activation from reducing RBC flux. **Vehicle and 10mM flux are
different, p<0.01 by Kruskal-Wallis test with Tukey post-test for RBC flux.n values are vessels(animals).
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Ablating pericytes to test their native role in regulating blood flow
Although the optogenetic data provide strong evidence that pericytes can
constrict capillaries and modulate blood flow, these data do not inform us of the
physiological role of pericytes in regulating blood flow. The slow kinetics with which
optogenetic stimulation decreased capillary diameter and blood flow, and the lack of
evidence for moment to moment diameter changes in the capillary bed (Damisah et al.
2017; Fernandez-Klett et al. 2010; Hill et al. 2015; Wei et al. 2016), make it unlikely that
pericytes control blood flow on rapid timescales, like during functional hyperemia. We
therefore wondered if pericytes are in a partial state of constriction that is needed to
establish the physiological resistance setpoint of the vasculature, analogous to the role
of SMCs in cerebral autoregulation (Dabertrand, Nelson, and Brayden 2013). Giving
credence to this idea, a recent study in our lab showed that ablation of individual
pericytes led to focal capillary dilation that only existed when and where the capillary
was uncovered by pericytes (Berthiaume et al. 2018). We took this study further by
quantifying blood flow near ablation and control sites, with the hypothesis that ablating
one or two pericytes would change local capillary diameter and flow (Fig. 32).
We longitudinally imaged animals with all mural cells labeled with YFP or
membrane-bound GFP, driven by PDGFRBeta-Cre (Fig. 21). On the first day of imaging,
we selected capillary pericytes with a soma clearly protruding off the vessel wall, making
them good candidates for ablation. We then collected baseline image stacks and velocity
line scans of the vessels associated with these pericytes, and randomized which
pericytes would be ablated, and which would become controls. We then ablated cells or
performed off-pericyte controls, respectively, by running a 725 nm two photon laser
through the protruding pericyte cell body, or immediately adjacent to the dextran-labeled
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lumen and not intersecting with any part of a pericyte. The off-pericyte “laser control” is
designed to generate the same amount of collateral damage to the endothelium and
surrounding tissue as does the pericyte ablation. Notably, the laser control behaved
identically to vessels distant from the 725 nm ablation beam path, suggesting that we
are not damaging the endothelium with the laser itself in this ablation paradigm (Fig. 38).
We returned to the same locations three days later and collected follow-up data. This
waiting period was to be certain that the pericyte was dead, and to avoid potential acute
effects of laser ablation. Comparisons focused on the relative change from baseline
diameter, velocity, and red blood cell (RBC) flux at 3 days post-ablation or post-laser
control between the control and ablation groups.

Figure 32 Capillary pericyte ablation outline and hypothesis: (a) A map of the cerebrovasculature. We
performed ablation experiments in the capillary bed, denoted by the red square. (b) In the capillary bed we
ablate a pericyte with two photon light on the soma (skull and crossbones), or perform a control in the same
capillary bed. In controls, we use the same parameters as the ablation, and are the same distance from the
endothelium, but the laser does not intersect any part of a pericyte. We hypothesize that we will see more
red blood cells (RBCs) flowing through segments that lost pericyte coverage, with no change in the controls.
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Pericyte ablation leaves parts of capillaries uncovered
First, we replicated the finding that ablating pericytes leaves behind an
uncovered region of the endothelium (Fig. 33C,D) (Berthiaume et al. 2018). Three days
after the ablation, when we collected follow-up data, there was already some re-growth
of neighboring pericyte processes into the uncovered region (Figs. 33C and 38E)
(Berthiaume et al. 2018). We incidentally collected hemodynamic data in these “recovered” regions, but excluded them from our main analyses (Fig. 38). The result of this
re-growth of neighboring pericytes is that we were left with only small regions of the
vasculature that were unequivocally devoid of pericyte processes after pericyte ablation.
To uncover more of the vasculature, in four of the six animals we ablated two
neighboring pericytes. Surprisingly, ablating two pericytes only uncovered slightly more
endothelium than ablating one pericyte (Fig. 33 vs Fig. 38). The data acquired when
ablating one or two pericytes is statistically equivalent, so we combined all the data
together, regardless of whether it was one or two pericytes ablated (Fig. 37). Only one
ablation vessel, out of 41 ablation attempts, was found to not be flowing on follow-up.
There were never any overt blood-brain barrier (BBB) leakages of 70 kDa dextran dye,
nor changes in pericyte or vessel structure in control regions. Altogether, these results
show that we successfully ablated one or two pericytes with minimal collateral damage
to the vasculature.

Page 99

Figure 33 Pericyte ablation example: (a) This baseline image shows two pericytes (arrowheads) with
apparently connected processes. (b) This region, containing two pericytes, was randomly assigned to the
ablation group. Ablation is performed by running a 725 nm two photon laser through the pericyte somata.
One pericyte is ablated at a time. (c) The pericyte soma and processes are gone after the ablation, indicated
by a lack of GFP covering the vessels near the purple boxes. The pericyte in the solid purple box is shown in
more detail in d-g. (d) The loss of coverage is clear for this vessel segment, which appears dilated postablation. Diameter and velocity measurements are collected using intravenous dye TexasRed-dextran 70
kDa. (e) Our method of collecting diameter uses many evenly-spaced cross sectional lines across the region
left uncovered by the pericyte. This measurement location was determined before knowing if the cell would
belong to the ablation or control group. (f) We average all of the full-width at half-maximum lines from (e) to
give one pre and one post measurement for that segment. A 20% dilation is measured here. (g) We count
the number of red blood cells (RBCs) passing through the same location where diameter was measured.
This vessel shows a doubling of RBC flux between baseline and follow-up.
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Figure 34 Example of control: This region is within the same penetrating arteriole network as the example in
Figure 33, and data were collected minutes apart from the example in Fig 13. Just as in Fig 13, baseline data
are collected in a region containing two pericytes with connected processes (arrowheads). (b) This particular
region was assigned to the control group. To perform controls, we ran a 725 nm two photon laser in the
location denoted by the white line at the same intensity and duration as in ablation cases. In animals such as
this one where two pericytes were ablated per ablation region, two control laser scans were performed per
control region. (c) Coverage was unchanged 3 days after performing control laser scans. (d) A closer view
also shows no change in coverage, and no apparent vessel dilation. (e) We measured diameter at many
locations along the vessel, finding that full-width half maximum shows a slight decrease between imaging
time points (f). RBC flux is minimally different between the two time points (g).
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Figure 35 Pericyte ablation causes vessel dilation: (a) Diameter increased by 19% relative to baseline in
ablation regions on follow-up imaging. This was significantly different from controls (***p<0.001, Wilcoxon
Rank-sum test, n=45 ablation vessels, 57 control vessels from the same 6 animals). (b) Velocity trended
towards an increase in ablated regions, but this was not significant.

Pericyte ablation causes increased blood flow in uncovered regions
The control group showed no average change in capillary diameter from baseline
to follow up (Figs. 34E,F and Fig 35A). Vessel segments left uncovered by pericyte
ablation showed a 19% increase in diameter from baseline, a significant difference from
the control segments (p<0.001, Wilcoxon rank-sum test with n=1 vessel segment; 29
ablation regions, 45 segments vs. 34 regions, 57 segments, all from the same 6 animals)
(Figs. 33E,F and 35A).
This selective dilation in ablation regions, with no changes in nearby vessels
imaged minutes apart, suggests that pericytes modulate flow resistance in capillaries.
Figure 36 Pericyte ablation causes vessel dilation: (a) Diameter increased by 19% relative to baseline in
ablation regions
on follow-up imaging.
significantly
different from
controls
(***p<0.001,
According
to Poiseulle’s
Law, a This
20%was
increase
in diameter
should
translate
into Wilcoxon
a 40%
Rank-sum test, n=45 ablation vessels, 57 control vessels from the same 6 animals). (b) Velocity trended
towards an increase in ablated regions,
but this was not significant.
2
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increase in flow velocity (r ), and a doubling of flow volume (r ) if all other variables are
equal. We saw an average 25% increase in blood cell velocity in uncovered segments,
with only a 2% increase in blood cell velocity in control segments, although this was not
significant (Fig. 35B, Wilcoxon rank sum test, p=0.12). More in line with Poiseulle’s
prediction, we observed a doubling in the number of RBCs passing through capillaries
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left uncovered by the ablation. This was statistically different than the control segments,
which showed no average change in RBC flux over time (Fig. 36; p<0.001 Wilcoxon
rank sum test). Altogether, these data suggest that pericyte ablation leads to vessel
dilation and increased local blood flow.

Figure 36: Red blood cell (RBC) flux is increased in vessels left uncovered by ablation: (a) RBC flux was
stable in control regions (black), but doubled in ablation regions between baseline and follow-up imaging.
This difference was statistically significant (p<0.001, n=39 ablation vessels, n=49 control vessels,
Wilcoxon rank-sum test). (b) The cumulative distribution function of RBC flux shows that ablation causes
a rightward shift in the distribution of RBC flux, indicating that it skews the distribution towards higher RBC
fluxes. Baseline and control follow up values overlap in their distribution. The distributions are particularly
different in the middle of the range, 50-150 cells/s.

Figure 37: Ablating one or two pericytes within an imaging region produces similar results: (a) If we ablate
one or two pericytes does not seem to affect the diameter (a), velocity (b), or red blood cell flux (c) changes.

Figure 37: Red blood cell (RBC) flux is increased in vessels left uncovered by ablation: (a) RBC flux was
stable in control regions (black), but doubled in ablation regions between baseline and follow-up imaging.
This difference was statistically significant (p<0.001, n=39 ablation vessels, n=49 control vessels,
Wilcoxon rank-sum test). (b) The cumulative distribution function of RBC flux shows that ablation causes
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a rightward shift in the distribution of RBC flux, indicating
that it skews the distribution towards higher RBC
fluxes. Baseline and control follow up values overlap in their distribution. The distributions are particularly
different in the middle of the range, 50-150 vessels.

Figure 38: Ablating one or two pericytes within an imaging region produces similar results: (a) If we ablate

Figure 38 Ablation and control examples and data: Ablation and control examples and data: (a) Arrowhead
shows a pericyte that is a candidate for ablation. (b) Line scans in one imaging plane measure capillaries
associated with the pericyte, and any other capillaries that are convenient. (c) The candidate pericyte is then
randomly assigned to be ablated, or a control. Note that the distance from the endothelium is approximately
equal between ablation and control. (d) Images collected 3d after ablation or control show that the controls
do not change in appearance (top), but the ablated regions lose the pericyte soma and processes (bottom).
Sometimes during follow up after ablations, the coverage of a vessel appears different than in baseline
images, indicating that this region was uncovered and then re-covered by neighboring pericytes (location of
yellow line in (e). Vessel segments where velocities were collected are then assigned to one of five groups.
Control groups are assigned based on estimating where pericyte processes would be lost, while ablation
groups are categorized by the presence or absence of pericyte coverage. Diameters are collected in the
same regions as velocities. (f) Shows all diameter data collected from these groups. The “Near” groups
never came close to the ablation laser, and data show they are no different than the control, suggesting the
ablation laser itself has no effect. There is a statistically significant dilation of ablation vessel segments
denoted by asterisks (all data collected from the same 6 animals). (g) Velocity does not differ between
groups. Mean + SEM.
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Diameter and flow increases are correlated
Diameter, velocity, and RBC flux were measured in the exact same locations for
both time points, allowing us to correlate these parameters for single vessels over time.
We observed significant linear correlations between the changes in diameter and
velocity (Fig. 39A), and the changes in diameter and RBC flux (Fig. 39B), for both the
ablation and control groups. There is a near-perfect linear correlation between the
change in velocity and the change in RBC flux in both groups, similar to previous reports
(Fig. 39C) (Kleinfeld et al. 1998). These significant correlations, together with the finding
that pericyte ablation produces a robust capillary dilation, support a scenario where the
ablation of pericytes causes a loss of pericyte tone and a decrease in vascular
resistance that leads to increased blood flow through affected capillaries. This ablation
effect suggests that pericytes are involved in controlling capillary diameter and regulating
basal blood flow in vivo. An interesting possibility is that pericyte control of blood flow
ensures stable flow over time. We find that pericyte ablation de-correlates baseline and
follow-up flow, providing some evidence that normally sustained flow patterns are
disrupted when pericytes are lost (Fig. 39D).

DISCUSSION
We collected two independent data sets that manipulated mural cells on
individual vessel segments in vivo. All data support a role for pericytes in modulating
blood flow on slower time scales than SMCs. Using two photon microscopy to stimulate
ChR2-YFP expressed in mural cells while simultaneously measuring hemodynamics, we
found that mural cells across the entire arteriole and capillary bed had the ability to
contract their underlying vessel and alter blood flow. SMCs on surface arterioles showed
a much more rapid and robust constriction compared to ensheathing pericytes and
capillary pericytes, in line with the known role of SMCs in regulating moment-to-moment
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changes in blood flow (Fig 25, 28) (Iadecola 2017). Surprisingly, ensheathing pericytes
and capillary pericytes showed the same contractile kinetics as one another, even
though only ensheathing pericytes express detectable levels of aSMA in previous
immunohistochemical studies (Fig. 28) (Grant et al. 2017; Hill et al. 2015; Wei et al.
2016). However, the absolute magnitude of constriction was greater with ensheathing
pericytes (Figs. 28, 29). Pericyte contractility was inhibited by topical application of
fasudil, a clinically-used vasodilator, increasing the likelihood that optogenetic activation
triggers a contractile mechanism (Fig. 30) (Hasegawa, Hasegawa, and Miura 2016). To
test if pericytes are contractile under more physiological conditions, we measured the
hemodynamic consequences of ablating one or two capillary pericytes in a longitudinal
study. In locations of the vasculature where pericyte coverage was lost after ablation, we
saw a significant 20% diameter increase, a trend showing a 25% velocity increase, and
a significant doubling in the red blood cell flux increase (Figure 35,36). The strong
positive correlations between the changes in diameter, velocity, and hematocrit in our
ablation studies suggest that pericytes can control blood flow by modulating vessel
diameter (Fig 39).
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Figure 39: Changes in hemodynamic parameters are correlated: (a) Both control and ablation vessel
segments show a significant correlation between the change in diameter and the change in velocity. (b) The
change in diameter is also predictive of the change in RBC flux, suggesting that pericytes could change
blood flow by changing diameter. (c) Changes in velocity and RBC flux are very tightly correlated. (d)
Baseline flux correlates with follow-up flux in control regions, but not in pericyte-ablated regions. Ablation
thus de-correlates, possibly de-stabilizes, blood flow across different days. Shown are Pearson’s
correlations and least-squares linear fits.

Contractility at different branches of the vascular tree
Arterioles surrounded by SMCs are known to rapidly dilate or constrict in vivo in
order to regulate blood flow (Attwell et al. 2010). In line with this, we observed that two
photon optogenetic stimulation of arterioles produced the fastest and most dramatic
constriction of any vessel type. Our observed kinetics of constriction match those of Hill,
et al. who used one photon stimulation of ChR2-YFP (Hill et al. 2015), and match other
in vivo results acquired using the intrinsic reactivity of naïve arterioles to two photon light
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at very high laser powers (Kimbrough et al. 2015). Compared to neurovascular coupling,
where a ~20% maximal dilation to a sensory stimulus occurs in less than 5 seconds
(Drew, Shih, and Kleinfeld 2011; O’Herron et al. 2016), the constriction responses to
SMC light activation are thus very slow. This is likely because we are inducing
constriction by less efficient means than occurs during functional hyperemia. We target
only one cell type (SMCs) whereas neurovascular coupling enacts a coordinated dilatory
response from hundreds or thousands of cells, the endothelium in particular (B. R. Chen
et al. 2014; Longden et al. 2017). Though our optogenetic stimulation of SMCs does not
reproduce physiologically relevant time scales, we find our SMC response a useful
reference point for contractility in the other points of the vascular tree, whose roles in
regulating blood flow are far less known.
We were surprised to find that ensheathing pericytes, which express high levels
of aSMA and have circumferential morphology (Grant et al. 2017; Hill et al. 2015), exhibit
similar contractile kinetics as capillary pericytes that express no or low levels of aSMA
and have delicate processes that do not wrap around the endothelium. It is important to
consider that ensheathing pericytes did produce a greater absolute diameter change
than capillary pericytes, but this is obscured in relative measurements because of the
larger baseline diameter of pre-capillary arterioles (5.2 +/- 1.7 microns, mean +/- SD)
compared to capillaries (2.8 +/- 0.9 microns) (Figs. 28, 29). With this finding, their known
aSMA expression, and the fact that ensheathing pericytes have to overcome greater
flow pressures to produce a constriction, we believe that ensheathing pericytes can exert
more force on the vasculature than capillary pericytes, but their kinetics are similar to
capillary pericytes and different than VMSCs on arterioles.
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Figure 40 Intense stimulation is required for pericyte contractility and blood flow changes: (a) In the same
animals, vessels were randomly assigned stimulation with high or low power. “High” power is what we have
always used. “Low” power is 40% less power than that (b) The contractile kinetics look similar with high and
low powers, but the changes are only statistically different from baseline in the high power group when looking
after 15s of stimulation (d). Significance was determined by the 99% CI not overlapping 1 at 15s**, like Hill, et
al. At 60s, both groups had significantly decreased diameters from baseline. (e) The kinetics of velocity
changes are greatly affected by laser power, with only vessels in the high laser power group showing a
decrease in velocity over time. This was different from baseline in the high power group only at 60s.
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Although we and Hill, et al. agree that mural cells on pre-capillary arterioles
(ensheathing pericytes by our nomenclature) constrict less robustly than arteriole SMCs
in response to ChR2-YFP activation, their reported lack of effect of ChR2-YFP activation
in capillary pericytes is in direct contrast with our results (Hill et al. 2015). We attribute
this disparity to our differing stimulation paradigms, in which we stimulated pericytes at
higher powers and for longer duration. Indeed, in a separate cohort of animals we found
that stimulating pericytes on branch orders 5-9 with lower laser power produced no
significant change from baseline in diameter and velocity after 15 s of two photon line
scan stimulation, similar to their findings using one photon line scanning. They use the
99% confidence interval as the statistical threshold for contractility (Fig. 40D,E). There
was significant constriction, but not velocity changes, after 60 s of stimulation in the lowpower vessels. In these same animals, prolonged stimulation of different vessels at our
usual higher powers recapitulated our main findings that capillary pericyte stimulation
gradually reduces diameter and blood cell velocity, further suggesting that high laser
intensity and a longer stimulus could be why our results differ from Hill, et al. (Fig 21).
Hill, et al. also stimulated ChR2-YFP using one photon blue light in some of their studies,
which was later shown to cause arteriole vasodilation in wild type animals (Rungta et al.
2017). This dilatory response to blue light may have competed with pericyte constriction
induced by single photon ChR2-YFP activation with blue light (Hill et al. 2015).
Moreover, by ablating capillary pericytes and observing increased vessel diameter and
RBC flux, we find independent and supporting evidence that pericytes in the native state
apply contractile tone to the capillary bed in a way that shapes blood flow.
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Pericyte constriction in the CNS has been previously observed in response to
vasoconstrictors (Fernandez-Klett et al. 2010; Hall et al. 2014; Mishra et al. 2016),
electrical current (Peppiatt et al. 2006), and disease (Arango-Lievano et al. 2018; LealCampanario et al. 2017; Yaqing Li et al. 2017; Yemisci et al. 2009). In all these studies,
it was not entirely clear if ensheathing or capillary pericytes were examined, and it has
been difficult to disentangle capillary blood flow changes from upstream flow alterations
in vivo (Fernandez-Klett et al. 2010). Ours is not the first evidence of pericyte
contractility, but it does help clarify the field because we utilized the best available
definitions of pericyte types, and ours is the clearest demonstration of an autonomous
ability for capillary pericytes to contract in vivo, because we could directly manipulate
individual vessel segments without coincidently involving upstream vessels.
In contrast to the contractility we observed along the arteriole-capillary axis,
surface venules showed no discernible contractility in response to mural cell ChR2-YFP
activation. We tested venules from 10-60 µm in diameter, making sure to include large
venules that reportedly express aSMA (Armulik, Genové, and Betsholtz 2011; Hill et al.
2015). There was no evidence of contractility at any of the sizes we examined (Fig. 41),
but these are still small vessels. Some of the largest veins in the body, the portal vein
and superior vena cava for example, have concentric rings of SMCs and known
contractile responses to electrical stimulation (Mandel et al. 2013) and vasoconstrictors
like phenylephrine (Raffetto and Khalil 2011; Saphirstein et al. 2015a). Also, we cannot
be sure that venules are inert to our stimulation because our diameter measurements
would be insensitive to an increase in venule wall stiffness, which was shown to occur in
response to vasoconstrictors like phenylephrine (Saphirstein et al. 2015a).
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Figure 41 Negligible constriction for all venule sizes examined: We tested contractility in a range of
venules, and did not find that any ChR2 venule constricted appreciably more than size-matched controls.

Are we observing the effects of upstream, or local, constriction?
Although our transgenic model expressed ChR2-YFP in all mural cell types, we
isolated the role of pericytes in modulating blood flow by using the superior spatial
selectivity of two photon line scans (Helmchen and Denk 2005). This two photon
optogenetics approach theoretically excites only the mural cells within the crosshairs of
the two photon line scan that express ChR2-YFP, with minimal coincident activation of
other cell types, including SMCs outside the path of the line scan. Using this method, our
data are consistent with the ability of pericytes to actively constrict capillaries and
modulate blood flow. However, an alternate interpretation of these data is that coincident
light and direct ChR2-YFP activation, or a conducted contractile signal, triggered
upstream
vasoconstriction,
a venule
passive
deflation
ofWe
downstream
capillary
diameter
Figure 43 Negligible
constrictionand
for all
sizes
examined:
tested contractility
in a range
of
venules, and did not find that any ChR2 venule constricted appreciably more than size-matched controls.

and blood flow (P. W. Sweeney, Walker-Samuel, and Shipley 2018). Although an

upstream conducted response is a plausible explanation for our optogenetic results, this
cannot explain our pericyte ablation findings. In our ablation studies we found increases
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in diameter and RBC flux specifically on vessel segments left uncovered by pericyte
ablation, without any changes in nearby control capillaries that were fed by the same
upstream vessels. If upstream vessels did alter their blood flow, then we would have
observed a more global change in diameter and blood flow across all segments, not just
in the vessel segments where pericytes were ablated. The localized increase in RBC flux
that we observed, and the nonsignificant change in blood cell velocity, were nicely
predicted by a previous study that mathematically modeled the effects of single capillary
dilation on blood flow in a simulated capillary network (Schmid et al. 2015). They argue
that increasing the number of RBC flux in one capillary branch produces a pile-up of
cells that would impose a limit on the velocity of blood cells passing through, like a traffic
jam (Schmid et al. 2015). The agreement between our results and these modeling data
studying highly focal diameter changes make it likely that we are observing local
changes in diameter and flow in our ablation studies, without upstream influence. It is
expected that this increase in RBC flux leads to an increase in local oxygen delivery
(Lyons et al. 2016), but future studies are necessary to confirm this.

Potential mechanisms of capillary pericyte contractility
We separated pericyte types using branch order, treating vessels beyond the 5th
branch order as synonymous with capillaries covered by pericytes that lack aSMA,
based on several previous studies (Grant et al. 2017; Hill et al. 2015; Wei et al. 2016). In
addition to branch order, we also ensured that the morphology of the stimulated
pericytes was longitudinal and spindly, consistent with previous characterizations of
capillary pericytes that lack aSMA (Damisah et al. 2017; Grant et al. 2017; Hill et al.
2015). Further evidence that these cells express minimal aSMA, a single cell
transcriptome study of mural cells showed that brain capillary pericytes express 10
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orders of magnitude fewer aSMA mRNA (acta2) transcripts than SMCs (Vanlandewijck
et al. 2018). Although these findings made it appear that the capillary pericytes we
investigated do not express aSMA, a recent immunohistochemical study in the retina
found aSMA expression in ~50% of capillary pericytes located far beyond the 5th branch
order, but only when using specialized perfusion methods that prevent actin
depolymerization (Alarcon-Martinez et al. 2018). This new finding fits with electron
microscopy studies of pericytes in the brain and retina that showed the presence of actin
filaments of an unidentified isoform at the pericyte-endothelial junction of brain and retina
capillary pericytes (Le Beux and Willemot 1978; Wallow and Burnside 1980). We cannot
verify that the capillary pericytes we stimulated completely lack aSMA, but with gene
expression studies and electron microscopic comparisons between pericytes and SMCs
(Skalli et al. 1989), we maintain that capillary pericytes have much less aSMA than
SMCs and ensheathing pericytes.
This begs the question of how pericytes exhibit contractility with low levels of the
best-studied vascular actin isoform. Cre reporter studies (Berthiaume et al. 2018) and
single cell transcriptomic studies indicate that the myosin heavy chain 11 promoter is
activated in brain capillary pericytes (Vanlandewijck et al. 2018). Single cell
transcriptomic data further shows that capillary pericytes transcribe many genes with
specialized functions for vascular contractility, such as myosin light chain (myl9), myosin
light chain kinase and phosphatase (mylk, ppp1r12a), and a cadre of voltage-gated
calcium channels that play a known role in SMC contractility (Cacna1c) (Tykocki,
Boerman, and Jackson 2017a; Vanlandewijck et al. 2018). Importantly, pericytes
express these genes at higher levels than do putatively non-contractile cells in the brain,
like endothelial cells or astrocytes, but at lower levels than SMCs (Vanlandewijck et al.
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2018). This lower expression of contractile transcripts supports the idea that pericytes
operate on a different time scale than SMCs, and probably respond to different strengths
of stimuli. More in depth, unbiased analyses of the contractile proteins in this
transcriptomic dataset would provide helpful direction for future functional studies. In
addition to these canonical vascular contractile mechanisms, pericytes may polymerize
cytoskeletal actin to achieve contraction, a mechanism known to mediate the cerebral
artery myogenic response (Moreno-Domínguez et al. 2014; Tejani and Rembold 2010).
In support of F-actin polymerization as a mechanism for pericyte control of blood flow, all
pericyte types stain with phalloidin, a marker of polymerized actin that also brightly stains
SMCs (Alarcon-Martinez et al. 2018). Rho kinase inhibitors like fasudil are known to
inhibit both the acto-myosin and actin polymerization mechanisms of contractility
(Moreno-Domínguez et al. 2014). If fasudil is directly acting on pericytes in our study, it
could be affecting either of these contractile mechanisms.

Capillary pericytes are partially constricted in the basal state
In the basal state, brain capillary diameter and blood flow are heterogeneous but
stable over time (Reeson, Choi, and Brown 2018; Tennant and Brown 2013). Capillary
blood flow has also been shown to change in response to rapid stimuli such as neuronal
activity (O’Herron et al. 2016), or slower stimuli such as a change in blood pressure
(Bragin et al. 2011), hypoxia (Hudetz et al. 1997), stenosis of proximal cerebral arteries
(Srinivasan et al. 2015), or pruning of adjacent capillaries (Reeson, Choi, and Brown
2018). The diameter and flow increases that we observed after pericyte ablation provide
strong evidence that pericytes are actively involved in establishing basal blood flow,
possibly to enforce consistency and homeostasis in basal flow patterns (Figs. 35, 36,
and 39D). The decreases in diameter and flow in response to ChR2-YFP activation
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indicate that pericytes can actively modulate capillary hemodynamics on the time scale
of tens of seconds, and also show that capillaries ‘have room to constrict’, i.e. they are
not fully constricted at baseline. The model that emerges from our data is that capillary
pericytes normally exist in a partially constricted state from which they can slowly dilate
or constrict in response to certain stimuli or environmental conditions. This is similar to
SMCs, which are known to exist in a partially constricted state (Dabertrand, Nelson, and
Brayden 2013). Ex vivo studies have shown pericyte constriction to noradrenaline, and
dilation to glutamate, in support of their existence in a partially-constricted state at
baseline (Hall et al. 2014; Mishra et al. 2016). In this working model, pericytes may help
direct the traffic of erythrocytes and leukocytes, which have their own dynamic properties
that influence blood flow (Fukuda 2004; Wei et al. 2016). Because we used isoflurane
anesthesia, a known vasodilator (Lyons et al. 2016), it is possible that intact pericytes
temper the response to isoflurane, rather than play a role in establishing the
physiological setpoint for blood flow. Even with this caveat in mind, these are important
data because they suggest that the capillary bed at any given moment is a mosaic of
vessels in various states of contraction, rather than an array of passive tubes. This
autonomy of the capillary bed may be relevant for previous studies that observed
changes in capillary hemodynamics on slow time scales (Tennant and Brown 2013).

Why would we need pericyte contractility?
With known contractility in nearby pre-capillary arteriole mural cells, is it
necessary to also have pericyte modulation of blood flow in capillaries? There is
considerable evidence saying yes, capillary-level regulation of blood flow is important.
Animals with a genetic deficiency in pericytes show impaired tissue oxygenation and
blood flow early in life, which eventually progresses towards neurodegeneration and
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cognitive decline (Bell et al. 2010; Kisler, Nelson, Rege, et al. 2017). Their observed
reduction in flow and oxygenation in animals with fewer pericytes at first appears
contrary to our our pericyte ablation findings, but actually our results fit nicely when
considering that loss of pericyte tone in multiple capillaries could lead to several
episodes of the “capillary steal” phenomenon. In this scenario, the decreased resistance
through vessels without pericytes would shunt the majority of RBCs through these
dilated vessels, leaving most of the other tissue out in the cold with less RBC flux and
thus less oxygen (Lyons et al. 2016). Over time, many such episodes of capillary steal
would cause “malignant” flow heterogeneity, which has been modeled and empirically
shown to reduce tissue oxygenation in MRI studies of Alzheimer’s patient blood flow
(Eskildsen et al. 2017). Interestingly, the red blood cell flux in neighboring capillaries
becomes more similar across the capillary bed during functional hyperemia, a process
that is hard to explain without the existence of contractile cells regulating local capillary
flow (Gutiérrez-Jiménez et al. 2016). In sum, there is empirical evidence to say that
pericyte regulation of blood flow at the capillary level is important for brain health (Kisler,
Nelson, Rege, et al. 2017), and the requirement for optimum capillary flow distribution
may be why pericytes are so important in perfusing the brain.
Our data are consistent with the ability of pericytes to act as a “check and
balance” for smooth muscle cells, as a means of maintaining steady flow through the
capillary bed. There could be instances when capillary pericytes are trying to mollify or
counteract the flow changes induced by upstream vessels. It is possible that unchanging
capillary diameter, well known to occur at rest and in the face of extreme changes in
upstream flow (Damisah et al. 2017; Hill et al. 2015), is evidence that capillary pericytes
are actively maintaining the rigidity of the vessel wall and preventing large swings in
Page 117

capillary resistance. Pericytes may thus act as a spine for the capillary bed, keeping it in
shape and rigid during times of extreme changes in upstream flow. Testing this role of
pericytes would be greatly facilitated by the development of capillary pericyte-specific
Cre driver mice that can be crossed with extant Cre reporter mice to express DREADD
or optogenetic variants.
However, there are compelling data suggesting that we do not need nor possess
pericyte modulation of capillary blood flow, particularly during functional hyperemia. One
study in cat visual cortex correlated hemodynamic and neural responses to visual
stimuli, and found that penetrating arteriole changes were just as tightly coupled to
neural activity as were capillary velocity changes (O’Herron et al. 2016). This suggests
that the correspondence between neural activity and vessel activity is sufficiently tight at
the level of penetrating arterioles, precluding the need for blood flow control in
capillaries. Another study shows that erythrocytes become more easily deformable in
response to local decreases in oxygen pressure, thus permitting increased rbc flow
through capillaries during functional hyperemia without the need for changes in capillary
diameter (Wei et al. 2016). In light of these data, we think that capillary pericytes
probably help establish the basal geometry and tone of the vasculature, but are not
critical for rapid velocity and diameter changes during functional hyperemia, in line with
previous conclusions (Fernandez-Klett et al. 2010). An additional role for pericytes in
communicating the neural signal to upstream arterioles has also been proposed (Hill et
al. 2015), suggesting that pericytes could also indirectly modulate blood flow (Longden
et al. 2017).
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Disseminating the data for future modeling studies
Independent from the questions of pericyte biology, these studies have created a
large data set containing changes in capillary diameter, velocity, hematocrit, and red
blood cell flux. Although outside the scope of this work, these data could be mined and
modeled in order to determine the interrelationships between these hemodynamic
parameters. These data, and the structural images we collected for every capillary, will
be shared on the Open Science Framework after publication to facilitate future studies
by other groups. These data offer a unique opportunity in studies of capillary blood flow
because they are the first to induce substantial changes in capillary diameter in vivo
while obtaining flow measurements. Disseminating these data will likely be insightful for
many long-lived questions in capillary blood flow modeling, such as, is there a critical
diameter at which RBCs can no longer pass? Do Poiseulle’s Laws hold up at the
capillary level?

Future directions
In the near future, there are a few caveats to these studies that deserve testing
and resolution: 1. Possible activation of upstream vessels during two photon
optogenetics will be tested using independently-controlled stimulating and imaging
lasers so that we can independently manipulate and observe vasodynamics. 2. The use
of isoflurane anesthesia means that pericytes could be preventing the dilatory effects of
isoflurane, and the physiological range of pericyte diameter control is still cloudy. Some
studies should be replicated in awake animals. 3. Optogenetic stimulation might be
simply causing cell edema, in which case optogenetic activation of endothelial cells, not
believed to be contractile, would show even more dramatic hemodynamic changes.
Experiments showing this does not occur would strengthen our case that ChR2-YFP is
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triggering physiological contractile mechanisms. 4. Ablations may cause endothelial
remodeling that causes flow changes. Future studies looking at endothelial cell structure
before and after ablation will help to rule this out.
In the distant future, studies can investigate the impact of pericyte ablation on the
response to hyperemia, blood pressure changes, and vasoactive molecules. It would
also be interesting to see if two photon activation of pericytes could worsen capillary
stalling in sickle cell anemia or other blood cell disorders; this might be alleviated by
fasudil. Other studies can perform two photon hyperpolarization of capillary pericytes to
investigate their capacity to dilate. Finally, calcium imaging studies might inform us when
pericyte changes in voltage are occurring naturally, and the direction in which these
changes occur. One would expect a relationship to emerge between pericyte
hyperpolarization and increases in capillary blood flow velocity and RBC flux, perhaps in
response to sensory stimulation.

SUMMARY AND CONCLUSIONS
In sum, this study advances the field by clarifying the capacity of different mural
cell types to modulate blood flow. We find that the vast majority of the cortical
cerebrovasculature is capable of autonomous blood flow control, though SMCs appear
the best-suited cells for effecting large and rapid changes in flow. These studies
enhance our understanding of pericyte biology, capillary rheology, and will perhaps lead
to new ways of correcting capillary blood flow deficits that plague numerous neurological
diseases.
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METHODS
The Institutional Animal Care and Use Committee at the Medical University of
South Carolina approved the procedures used in this study. The University
has accreditation from the Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC) International, and all experiments were
performed within its guidelines.

Animals
We bred PDGFRBeta-Cre heterozygous males on an FVB/NJ background
(generous gift from Volkhard Lindner (Cuttler et al. 2011)) with Ai32 females (similar
results obtained from Jax ID 012569-B6/129S background, and Jax ID 024109-B6/J
background (Madisen et al. 2012)). For controls, we bred PDGFRBeta-Cre males with
Ai3 females on a B6/J background (Jax ID 007903) (Madisen et al. 2010), or with
mT/mG females on a B6/J background (Jax ID 007676) (Muzumdar et al. 2007). The
offspring (F1) expressed ChR2-YFP (H134R-eYFP), or eYFP, or membrane-bound
eGFP in all mural cells, with some additional expression in meningeal cells, and rare
expression in neurons. All animals showed the same cellular expression pattern that we
reported in a previous characterization of the PDGFRBeta-Cre mouse line, with
pericytes expressing NG2, PDGFRBeta, and CD13 in immunofluorescence staining
(Hartmann, Underly, Grant, et al. 2015). We used male and female offspring aged 3-12
months. The data presented were collected using offspring from at least two separate
orders of breeders from Jax. All mice used in experiments were F1 offspring. The mice
were housed in an AAALAC-approved facility that provided 12 hours of lights on (6a-6p),
and 12 hours of darkness, with ad libitum access to chow and water. We ‘genotyped’
animals by observing which animals within a litter had a green fluorescent tail clipping.
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We did not employ a systematic method of selecting animals for experiments; there was
no randomization. The use of control and ChR2-YFP animals was interleaved over the
course of 18 months of experiments. Importantly, the results obtained from PDGFRBeta
x YFP (n=5) and PDGFRBeta x mT/mG (n=5) animals were equivalent, and so were
combined and referred to as ‘control’ in body of the text (Figure 42).

Figure 42 Responses of different control genotypes to the stimulus paradigm used to activate ChR2-YFP: (a)
Throughout this chapter, “Control” in optogenetic studies is a combination of PDGFRBeta-YFP and
PDGFRBeta mT/mG data. The difference is that mT/mG animals target GFP to the membrane, but YFP
animals have YFP in the cytosol. They show nearly identical diameter (a,c) and velocity (b,d) responses at
branch orders 1-3 (a,c) and 5-9 (b,d). The different controls were designed to test if membrane targeting of a
fluorophore affects a cell damage or cell swelling response to our two photon excitation paradigm.
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For ablation studies, we used 4 PDGFRBeta x mT/mG offspring of both sexes,
and 2 PDGFRBeta x YFP animals of both sexes. There did not appear to be any sex or
genotype differences, and these results were pooled.

Surgery
For optogenetic studies and their controls, we performed an acute craniotomy as
described previously (Shih et al. 2012). Briefly, we induced anesthesia with 4%
isoflurane, used sterile technique to remove the scalp and periosteum, then used
MetaBond dental cement to affix a custom-made metal flange onto the right side of the
skull. This metal flange was screwed in to an imaging post for stable head-fixed imaging.
We then drilled a 3 mm diameter craniotomy over the barrel cortex of the left
hemisphere, centered on 1.5 mm posterior and 3 mm lateral to bregma. We then filled
the craniotomy with warm 1.5% agarose fully dissolved in aCSF (w/v) and covered it with
a 4 mm diameter coverslip. For fasudil experiments, we dissolved the fasudil directly in
1.5% agarose solution before applying the agarose to the brain. Finally, the excess
agarose was removed, and any open surface of the skull or skin was covered in
MetaBond dental cement. A small amount of cement touched the rim of the cover glass
to help seal it in place. Although the brain did often protrude from the craniotomy
because of the use of isoflurane, care was taken not to compress the brain with the
coverglass. The dura was left mostly intact. The surgeon (D.A.H.) was not blind to the
genotype of the animal, nor to the dose of the drug.
Fasudil: The fasudil doses were estimated from previous studies showing that 0.1 mM
fasudil prevented constriction of isolated aorta (Asano et al. 1987), combined with a
study showing that 10% of molecules accumulated in the meninges enter the brain

Page 123

parenchyma (Roth et al. 2013). This gave us our 1mM fasudil dose, and 10mM was
loosely decided based on dilution of the fasudil once it enters the brain.
For ablation experiments, we generated chronic windows using methods
previously described (Holtmaat et al. 2009). Briefly, we injected 40 uL dexamethasone 24 hours prior to surgery, and used a cocktail of 25 uL fentanyl, 25 uL midazolam, and
15uL dexmedetomidine as the anesthesia. After making the craniotomy the same way
as above, we sealed a coverglass onto it with loctite glue. We imaged the animal after a
4 week recovery period, when inflammation has subsided (Holtmaat et al. 2009).
Excluded animals: Three ChR2-YFP and three control animals were not imaged
because of one of the following issues with the window: there was subarachnoid blood, a
large vessel was ruptured, vessels were constricted to the point where MCA-ACA
collaterals were not visible under any magnification with the surgical microscope
indicating substantial vasoconstriction, and/or more than a third of the final window was
occupied by blood of any kind (including extradural). Three animals with implanted
windows were not used for ablation experiments because the window remained cloudy
or bone regrowth was substantial.

Two photon microscopy
For optogenetic studies, immediately after surgery, we brought the animal to a
fixed imaging stage and injected 50 uL of 2.5% (mg/mL) texas red-dextran (70 kDa;
Invitrogen D1830) under 2% MAC isoflurane anesthesia. Texas red injections were
repeated as needed, roughly every 3 hours. After texas red injection, we reduced the
anesthesia to ~0.8% MAC, and imaged the cranial window with a Coherent Ultra II
Ti:Sapphire laser that coursed through a Sutter Moveable Objective Microscope system
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operated by MPScope 2.0 (Nguyen et al. 2009) via an analog-digital converter (National
Instruments BNC-2110). Green and red fluorescence was emitted through 515/30
(Chroma ET510/50m-2P) and 615/60 (Chroma ET605/70m-2P) filters, respectively, and
detected by Hamamatsu PMTs (H10770PA-40). First we took low-resolution maps of the
cranial window, using a 4X (0.16 NA) objective (Olympus UPlanSAPO), and 900 nm
laser excitation. We then switched to a 20X (1.0 NA) water-immersion objective
(Olympus XLUMPLFLN), and 1000 nm excitation, to collect stacks of individual
penetrating arterioles (1x digital zoom, lateral resolution 0.63 µm/pixel, axial resolution 1
µm). We used the YFP channel from this stack to discern branch order, and to target
certain pericytes for stimulation based on these criteria: (1) the branch order can be
calculated, (2) a considerable length of the pericyte is contained within one imaging
plane to make line scanning possible, (3) the pericyte is not downstream, or within 1
branch, of a previously-stimulated pericyte. We stimulated pericytes from highest
(capillaries) to lowest (pre-capillary arterioles) branch order. Up to 15 pericytes within
the domain of one penetrating arteriole were targeted. We only selected penetrating
arterioles that showed a primary branch within the superficial 300 microns of cortex.
After selecting pericytes for imaging and stimulation, we used 900 nm excitation
to navigate to the pericyte with the highest branch order, and greatest depth. Once at
this pericyte, we collected a ‘pre’ stack (2.5x digital zoom, lateral resolution 0.25
microns/pixel, axial resolution 1um) and a brief movie (also 2.5x digital zoom). We used
the images from this movie to draw an arbitrary line scan that transected the vessel five
times, and bisected the vessel once, to acquire diameter and velocity information,
respectively. The pixel dwell time was 1 microsecond, the scan velocity was 7 mm/s (up
to 12 mm/s for branch order 1-3), and the scan acceleration was 140 mm/s^2 (up to 240
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mm/s^2 for branch orders 1-3), combining to make data collection ~ 600 Hz. We then
collected a 60s line scan at 900 nm. If the vessel was not flowing or stopped flowing
during the 60s 900 nm scan, it was skipped, and we moved on to the next pericyte in line
for stimulation. For vessels that flowed at 900 nm, we next switched to 800 nm excitation
as in previous studies (Hill et al. 2015), and scanned for an additional 60 s. It is this 800
nm scan that stimulates ChR2-YFP, perhaps because it is more effective at stimulating
mural cell ChR2-YFP, or perhaps because we delivered it at higher powers than 900nm
(Rickgauer and Tank 2009). At the end of this 60 s of 800 nm scanning, we took a ‘post’
stack at 900 nm using the same coordinates as the ‘pre’ stack. Then we moved on to the
next pericyte within the same penetrating arteriole network until all pre-selected
pericytes within that network were examined. Afterwards, we moved on to select the
next penetrating arteriole. We examined pericytes within 1 to 3 penetrating arteriole
networks per animal.
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The laser powers utilized for the 800 and 900 nm line scans were kept consistent
across animals and groups by adhering to a power-vs-depth chart created using the first
four ChR2-YFP animals that we experimented on (these animals showed signs that
pericyte ChR2-YFP stimulation affected capillary blood flow; Fig. 43). Laser powers
were determined at the 20x objective using 2.5x zoom, with the mirror galvanometer
engaged, using a Thor Labs PM100D. The same PMT gain values were used across all
animals. Imaging could take up to 10 hours, always done by an un-blinded experimenter
(D.A.H.). Every 2 hours of imaging we injected 200 uL of lactated ringer’s solution
subcutaneously. At the conclusion of each experiment, the animals were typically
reactive to a light toe pinch.

Figure 43. Imaging/stimulation power was consistent between groups: A laser power-by-depth curve was
created with pilot studies on ChR2 animals. This curve was adhered to for all optogenetic imaging
studies, including for the fasudil group (not shown). The consistency across groups helps to control for
potential effects of light and heat damage.

For ablation experiments, animals were induced with 4% isoflurane, head-fixed,
then injected with 40 uL of 2.5% texas red. Isoflurane was maintained at 0.9-1.1% MAC.
We used the same imaging equipment as above, using 900 nm excitation at all times
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except during ablations. On the first imaging day, we collected stacks of penetrating
arterioles with the 20x Olympus lens. We used these stacks to select pericytes for later
imaging. Subsequent imaging days, we collected baseline image z stacks and line scan
velocities on 2 control and 2 ablation cells that were more than two vessel segments
away from one another, and both surrounded the same penetrating arteriole. The
linescans were drawn to try and maximize the number of segments that might be
affected by pericyte loss. Other vessels that happened to run in this same plane were
also scanned, as a “near” control (Figure 38). After collecting baseline data, we flipped a
coin to decide which 2 cells would be part of the ablation group, and which 2 cells would
be part of the control group. We stratified this randomization process to make it so that
control and ablation cells were at comparable depths.
To make the ablation, we used techniques previously described (Berthiaume et
al. 2018). Briefly, at 10x digital zoom (15.9 pixels/µm), drew a small arbitrary line scan
within the pericyte cell body, and applied a 725 nm laser at 20-60 mW for 1-3 minutes.
We periodically interrupted the ablation and used 900 nm to check for successful
ablation or damage. Successful ablations often showed effacement of YFP or GFP. We
used the same parameters for controls but drew the linescan 1-3 microns away from the
vessel wall, approximately the same distance from the vessel wall as when targeting the
pericyte soma. Baseline data collection took 1-2 hours, and ablations took an 1-2
additional hours per animal.
For follow-up imaging, we found the same vessels and collected stacks and
linescans using the same imaging parameters as baseline. Importantly, the head stage
of the animal remained fixed throughout all imaging sessions, so vessel orientation
should not be different between days. Follow-up imaging took 1-2 hours.
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Histology
Up to 3 days after imaging, we sacrificed animals with euthasol and transcardially
perfused them first with phosphate-buffered saline (PBS), and then with 4%
paraformaldehyde (PFA) in PBS. After perfusion, the brain was extracted and placed in
4% PFA in PBS overnight. Brains were then transferred to PBS with 0.01% sodium
azide, where they were stored until they were sliced into 50 µm sections using a
Vibratome Series 1000. For collagen IV and αSMA staining, slices were subjected to
antigen retrieval by placing sections into a vial of 0.125% trypsin (Sigma T4049) and 0.5
mg/mL proteinase K (Fisher BP1700) in PBS, and incubating the vial at 37 C for 1 hour.
Collagen IV (anti-rabbit, Abcam ab19808) and αSMA (anti-mouse, Sigma A5228)
antibodies were each diluted 1:200 in an antibody solution composed of 2% TritonX100 (v/v, Sigma-Aldrich; X100), 10% goat serum (v/v, Vector Laboratories; S1000),
and 0.1% sodium azide (w/v, Sigma-Aldrich; S2002) in PBS. Brain sections were
incubated in this primary antibody solution overnight at room temperature. The next day,
we washed the slices in PBS, then incubated the slices for 2 hours at room temperature
in antibody solution with 1:200 concentrations of secondary anti-rabbit Alexa 594
(Invitrogen A31632) and anti-mouse Alexa 647 (Invitrogen A31626). Slices were washed
in PBS, then mounted onto a slide, dried, and sealed with a cover slip using
Fluoromount G (Southern Biotech).
Confocal imaging: We collected confocal images using an Olympus with air 20X and
oil-immersion 60X lenses. The image stacks have a respective lateral resolution of 0.74
pixels/um and 2.2 pixels/um when collected at 512x512 pixels, and a 1um step size.
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Data processing/Image analysis
Determining vessel depth: We calculated the depth of all vessels by browsing the
1000 nm stack of the penetrating arteriole network using Image J. We used the z
distance between the bottom of the dura mater and the plane in which the line scan for a
single vessel was performed. This was facilitated by YFP or GFP labeling of cells in the
dura in our mice.
Automated analysis of capillary diameter and blood cell velocity: For each vessel in
the optogenetic, control, fasudil experiments, we calculated the diameter of all 5
diameter scans using a full-width at half maximum paradigm. We calculated velocity
from line scans using a radon transform method, as previously described (Drew et al.
2009). The radon window used was 20 ms (average of ~12 lines), giving 50 diameter or
velocity measurements per second. We then processed these raw diameter and velocity
values in batches using custom-made MATLAB scripts available online
(theshihlab.com). Briefly, we first filtered out extreme velocity values by converting
values greater than 3 times the standard deviation into the mean. Then, as a means of
unbiased quality control, the mean of the velocity or diameter trace had to be greater
than the standard deviation for the data to be analyzed using automation. Typically 4 of
the 5 collected diameter traces survived this criterion, and were averaged together. A
fold change diameter or velocity was calculated by dividing the average value from 5558s by the average of 0.02-3s, the latter being considered our baseline.
For the ablation experiments, out of 41 attempted ablations, we used data from
29 of them across 6 animals; the disparity is explained by the exclusion criteria below.
From these 29 ablations, there were 47 vessel segments that lacked pericyte coverage
according to image stacks collected 3 days after the ablation. They all had pericyte
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coverage at baseline. We analyzed the velocity in the same manner as for optogenetic
studies, explained above. The baseline velocity was considered the average of the 60 s
900nm line scan collected on day 0. We used a new technique to analyze diameter. We
first registered the baseline and follow up vessel images with randomized pseudocolors
so that we did not know which image was collected on which day. Then we took the fullwidth at half maximum along every 10 pixels of the exact same region where we
collected velocity measurements. This was performed using a new code available here
https://github.com/mcdowellkonnor/VesselDiameter. We monitored the quality of the
output, and re-analyzed many vessels because they initially had noisy intensity profiles.
We only analyzed parts of vessel segments where velocity was collected at baseline.
This is a minimally biased approach, because at baseline we did not know if that pericyte
was destined to be in the ablation or control group. Furthermore, analysis was done
blinded to whether a vessel segment belonged to the control or ablation group.
Exclusion criteria: After all vessels underwent the automated analysis described here,
we visually examined all post-stacks in a blinded and randomized manner. For
optogenetic experiments, all data from vessels with visible texas red extravasation in the
post-stack were excluded (10/213 post-stacks for ChR2-YFP group). Diameter data
were excluded if the baseline diameter was less than 1um (5 instances). If precise depth
could not be calculated, then we did not include that vessel in plotting power vs depth.
For ablation experiments, we excluded data from two different arteriole regions,
each containing 2 control and 2 ablation sites. The reason is that the penetrating
arterioles feeding these cells exhibited wildly different flow between baseline and follow
up imaging days because these arterioles were part of ACA-MCA anastomoses which
are known to exhibit large swings in flow (Toriumi et al. 2009). Of the remaining sampled
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regions, we found 1 vessel that was not flowing 3 days after attempted ablation (1/41
attempted ablations). This was also the only vessel with BBB leakage (1/75 follow up
stacks). We excluded data if ablation was never achieved after 3 days of trying (3/41
attempted ablations). We occasionally couldn’t collect a reliable FWHM (2/47 uncovered
segments, 2/59 segments in the off-pericyte control group). In several cases (7/41
ablations, 18 segments), it was clear that the original pericyte was successfully ablated
and new processes had grown into the region where we collected diameter and velocity-we excluded these data from analysis.
Manual analysis of velocity: In many cases for the ChR2-YFP experiments, the
velocity traces that were deemed unacceptable for automated analysis showed a drastic
decrease in their blood cell velocity. This is in line with limitations of the radon transform
velocity analysis, which has difficulty analyzing vessels with very slow or stalled blood
cells (Drew et al. 2009). We therefore attempted to manually analyze all velocities that
were deemed unfit for automated analysis (44/175 ChR2-YFP vs 2/161 control were
analyzed manually for branch orders 5-9). To do this, we traced the slope of all blood
cells within one frame that was at the beginning, and one frame at the end, of the scan.
We did not know which frame came at the beginning, and which came at the end in
attempts to reduce bias. The slope of the red blood cell, in conjunction with the
micron:pixel ratio of the line scan, and the time per line, was used to calculate rbc
velocity. The velocity from the later frame was divided by the velocity from the earlier
frame to make a fold change velocity that was used in statistical tests alongside the
other values derived from automated analyses.
Calculating blood cell flux: We analyzed flux for the first four animals of the ChR2YFP and control groups (only YFP in this case, no mTmG animals), and all animals in
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each fasudil group, because there were only 3 per group. All of the line scan files from
these animals were collected and assigned a random number, which blinded us to the
group, and randomized the order of flux analysis. In MATLAB, the line scan movies were
cropped to only show the part of the scan where velocity was measured. We then handcounted frames from this scan that occurred at 1s, 30s, and 58 s by clicking on each
blood cell shadow in the frame in a custom-made MATLAB script. Some shadows
appeared bigger than others, which sometimes was because multiple cells were stuck
together. We only counted distinct shadows, meaning we would have counted two cells
stuck together as one, possibly underestimating rbc count. The frames for counting were
randomly and blindly presented so that we did not know if the rbc counts were from the
beginning, middle or end during of the scan. If cells were flowing too quickly and we
could not distinguish one cell from the next, or if flowing cells were too often stuck
together, we did not analyze that scan. In a blind manner, we excluded 23/74 ChR2-YFP
scans, and 40/82 YFP scans from analysis. The counts were then collected and
normalized to the first frame. The fold change in cell count from the 1s frame to the 58s
frame was compared between ChR2-YFP and YFP using a Wilcoxon rank sum test, and
between ChR2-YFP, fasudil 1 mM and fasudil 10mM using a Kruskal Wallis test with
Tukey post-test, at the level of n=1 vessel.
The RBC flux was counted in the same way for ablation experiments, with the
person counting cells blinded to the group (ablation/control), and the day (baseline/follow
up). Frames at the beginning, middle, and end of the 60 s line scan were counted and
averaged together to give a flux value for a given day.
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Figures: Images in figures were contrasted equally across the entire image in either Fiji
ImageJ, Adobe Photoshop, or Imaris in the case of 3D figures. Only raw images were
used for analyses.

Statistics
All calculations and analyses were done in MATLAB unless otherwise noted. All time
course plots are plotting the mean + SEM of individual vessels. For optogenetic studies,
fold changes were calculated by taking the average value from 55-58 seconds of the 800
nm scan, and dividing by the baseline, defined as the average value of the first 3
seconds of the 800 nm scan. For RBC flux, the fold change was the number of cells in a
frame corresponding to the 58 s point, divided by the number of cells in the first frame of
the scan. Fold change values of diameter and velocity were compared across groups
using a Two way ANOVA with repeated measures, using genotype x individual animal.
This incorporates the hierarchical nature of the data, i.e. that 20 vessels come from one
animal and are thus not independent of one another. Flow/no flow in post-stacks was
binarized. The diameter, velocity, and binarized flow/no flow statistics were performed
for the genotype, branch order, and fasudil effects by a statistician blind to the
hypothesis using SAS software. Absolute changes in diameter and RBC flux were
compared using a Kruskal Wallis test.
For the ablation studies, statistics were done at the level of vessel segments, i.e.
not treated as a hierarchy. For more than two groups, we used Kruskal-Wallis tests with
Tukey post-hoc tests that account for multiple comparisons. When comparing ablation to
control, we used Wilcoxon rank sum tests.
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Chapter 4: Overall discussion

What are the main findings?
Our structural studies using transgenically-labeled mural cells provided clear
evidence that mural cells are a diverse group of cells that seamlessly interconnect in
order to cover the entire cerebrovasculature. The general structure of pericytes was
appreciated from previous immunohistochemical and electronic microscopy studies
(Armulik, Genové, and Betsholtz 2011; Takahashi et al. 1997), but the new transgenic
technologies available allowed us to unveil the diversity and distribution of pericytes in
more detail, and on a larger scale, than before. We further showed that the diversity of
mural cells can be categorized into SMCs and two subtypes of pericytes, “ensheathing
pericytes” and “capillary pericytes”. These different cell types have stereotypical shapes,
αSMA expression, and vascular territories (Grant et al. 2017).
When we functionally tested these different mural cell types using two photon
activation of ChR2, we found that SMCs, ensheathing pericytes, and capillary pericytes
are capable of modulating blood vessel diameter. The 20% decrease in relative diameter
that we observed in capillary pericytes decreased the amount of RBC flux by 40%,
indicating that capillary pericyte contractility can influence blood flow through associated
capillaries. In a separate study in which we ablated one or two pericytes, we found a
20% dilation and a doubling of rbc flux in vessel segments that were left uncovered by
pericyte ablation. Altogether, these studies showed that capillary pericytes are
contractile, and they play a role in modulating basal cerebral blood flow through
individual capillaries.
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How does this dissertation advance the field?
It’s amazing that the pericyte field has grappled with the same two questions for
over a century: what is a pericyte? Can it regulate blood flow? (Attwell et al. 2016;
Krueger and Bechmann 2010; Tilton 1991) This dissertation provides answers to both of
these questions. I don’t know if these answers will catch on or be replicated, but I can
sleep knowing that this work is an honest attempt at finding truthful answers to these two
questions.
Structural diversity of mural cells was appreciated long ago (Zimmermann 1923),
but had never been systematically characterized, and so was ignored in many recent
pericyte studies. Chapter 2 provided the first attempts at organizing and quantifying
pericyte diversity, and showed that seemingly contradictory results in the literature are
actually consistent with one another when we start speaking the same language and use
consistent definitions of ‘arteriole’, ‘SMC’, ‘pericyte’, ‘capillary’, etc (Attwell et al. 2016;
Hall et al. 2014; Hill et al. 2015). The mural cell types that we delineated and named
have been used in characterizing the mural cell response to seizures and other
conditions (Arango-Lievano et al. 2018).
What we defined as a capillary pericyte was found to be the only cell type labeled
by an in vivo fluorescent marker called Neurotrace, giving credence, and hopefully
longevity, to our categorization scheme (Damisah et al. 2017). However, our suggested
names are certainly not universally adopted. A single-cell transcriptomic study of brain
mural cells showed that mural cell transcriptomes naturally form 4 main clusters,
suggesting that there are 4 main mural cell types: arterial SMCs, arteriolar SMCs,
capillary pericytes, and venular SMCs (Vanlandewijck et al. 2018). When looking at their
images and certain transcripts such as αSMA, although their names are different, these
cell types very nicely fit our respective categories of SMCs, ensheathing pericytes,
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capillary pericytes, and venular SMCs (Vanlandewijck et al. 2018). The studies in
Chapter 2 of this dissertation therefore provided the field with a timely reminder of the
diversity of mural cell types, and they offer a way forward for the field to start speaking
the same language.
Thanks partly to the studies in Chapter 2, we began the studies for Chapter 3
with general agreement in the field that different mural cell types exist and may have
different functional properties. These functional differences were never rigorously tested
until Hill, et al. used cutting-edge techniques to conclude that only SMCs are capable of
altering blood flow (Hill et al. 2015). Although theirs was a pioneering study, our study
improved upon it by applying identical stimulation parameters to a control group
expressing GFP or YFP in place of ChR2. This control allowed us to uncover pericyte
contractility in response to intense laser stimulation, providing the most direct evidence
to date that pericytes deep in the capillary bed are contractile in vivo. I say this because
the interpretation of previous studies is complicated by 1. Nomenclature (what is a
pericyte?), 2. their unfair assumption that contractility primarily exists at the pericyte
soma (Fernandez-Klett et al. 2010; Hall et al. 2014; Peppiatt et al. 2006; Wei et al.
2016), or 3. by the presence of upstream changes in blood flow that can affect
downstream capillary hemodynamics (Arango-Lievano et al. 2018; Fernandez-Klett et al.
2010). Ours is the first study to address all of these issues. Even if someone doesn’t like
the pericyte naming scheme we used here, our results should remain relevant because
they are organized by mural cell morphology in combination with branching order, a wellestablished means of organizing vascular topology. Juliet said it best: “A rose by any
other name would smell as sweet.”
Although the ChR2 studies provide compelling evidence that pericytes can
modulate blood flow, this involved a very artificial stimulus. To find out what pericytes are
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normally doing in the natural environment, we ablated pericytes, as sort of a ‘knockout’
study. We showed that ablation of one or two pericytes causes dramatic shifts in
diameter and RBC flux selectively in the vessel segments that lost pericyte coverage.
This replicates and advances upon previous findings by Ph.D. student Andree-Anne
Berthiaume in our lab, who, it is worth noting for the sake of replicability, had no role in
these experiments other than teaching me the ablation technique (Berthiaume et al.
2018). The ablation experiments provide the strongest evidence to date that pericytes
apply basal tone to capillaries in a way that influences blood flow in a physiological
context. Hopefully these findings serve as a pivot away from questions of ‘can pericytes
regulate blood flow?’, and towards ‘when and how do pericytes regulate blood flow?’
Previous work has convincingly shown no rapid changes in capillary diameter at rest,
and in response to various stimuli (Damisah et al. 2017; Hill et al. 2015; Wei et al. 2016),
but perhaps pericytes modulate blood flow on longer time scales, to provide proper brain
oxygenation in the basal state. This interpretation is in line with previous studies showing
a decrease in tissue oxygenation in mice with a genetically-induced pericyte deficiency
(Bell et al. 2010; Kisler, Nelson, Rege, et al. 2017).

What are the limitations and loose ends of these experiments?

αSMA turns out to be a complicated story
Since the discovery that αSMA is the most highly expressed muscle actin in
vascular smooth muscle (Gabbiani et al. 1981b), it has been long assumed that αSMA
expression predicts vascular contractile ability. This is initially why we focused on αSMA
for our immunohistochemistry studies. Then Hill, et al. came out with compelling
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functional data in line with this assumption (Hill et al. 2015). Later, Vanlandewijck et al
showed capillary pericytes do not express αSMA mRNA transcripts, supporting the
mounds of immunohistochemistry data that shows capillary pericytes do not express
αSMA protein (Vanlandewijck et al. 2018). We therefore grouped our ChR2 data
according to likelihood that the stimulated cell expresses αSMA: cells at branch order 13 with ensheathing morphology have a high probability of expressing αSMA, while cells
at branch order 5-9 with spindly morphology have essentially zero chance of expressing
αSMA. Or so we thought.
A very recent immunohistochemical study in the retina has made it more
complicated. They found αSMA expression in ~50% of capillary pericytes located far
beyond the 5th branch order, but only when using specialized perfusion methods that
prevent actin depolymerization (Alarcon-Martinez et al. 2018). It is unknown if the same
occurs in the brain, but this new finding fits with electron microscopy studies of pericytes
in the brain and retina that showed the presence of actin filaments in capillary pericytes
(Le Beux and Willemot 1978; Wallow and Burnside 1980). In the electron microscopy
studies, these microfilaments were localized on the pericyte side of the pericyteendothelial border, and they aggregated to form actin-myosin complexes when tissue
sections were incubated with exogenous myosin prior to electron microscopic imaging. It
is unknown if these microfilaments were αSMA or another type of actin, nor is it known
what proportion of pericytes along the vasculature possess these filaments. For
comparison, actin filaments are far more numerous and widespread throughout the
cytosol of SMCs, and possibly ensheathing pericytes (Bandopadhyay et al. 2001; Skalli
et al. 1989), in electron microscopy. Combining this literature, there is at least a
consensus that capillary pericytes express lower levels of αSMA than do ensheathing
pericytes and SMCs. Our division of structural and functional data according to likely
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αSMA content is thus still informative, because it reflects a quantitative difference in
αSMA (i.e. how much actin is in each cell), but we cannot say for certain if there is zero
αSMA in a cell.
Adding to this confusion, it appears that some venules express αSMA (Armulik,
Genové, and Betsholtz 2011; Hill et al. 2015). Exactly which venules, and what their
mural cells look like, is unknown. We are therefore not certain if the venules we
stimulated have αSMA, but we did make a conscious effort to stimulate larger ones,
because these reportedly are more likely to express aSMA (Armulik, Genové, and
Betsholtz 2011; Hill et al. 2015).

The kinetics to mural cell stimulation are slow and confusing
In line with their high certifiably very high expression of αSMA and other
contractile proteins, we observed that two photon optogenetic stimulation of SMCs
produced the fastest and most dramatic constriction of any mural cell type. This matches
the result of Hill, et al. who used one photon stimulation of ChR2 in mice anesthetized
with ketamine and xylazine. A technical reason why SMCs showed more exaggerated
constriction is that the arterioles on the pial surface received less scattered, more
intense laser light than capillaries deeper in the brain. This could occur because light
scatters as it travels deeper into the brain, which would attenuate the light intensity that
reaches the subsurface vessels.
Our observed time course of arteriole constriction is consistent with other studies
that used two photon activation of the smooth muscle wall (Kimbrough et al. 2015), and
studies that applied an electrical current to mural cells with an electrode (Mandel et al.
2013; Peppiatt et al. 2006). We speculate that the slow responses to all of these stimuli
(tens of seconds) is partly because the vasculature is arranged as a syncytium, with gap
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junctions connecting all vascular cell types. The current injected by ChR2 or an
electrode may therefore take a long time to accumulate, because nearby endothelium or
SMCs act as a ‘charge sink’ that dilutes incoming cations and delays the time until
voltage-gated calcium channels are triggered. Although we cannot be sure why the
arteriole constriction is slow compared to neurovascular coupling time scales, the
arteriole response to a ChR2 stimulus gives us a reference point to compare with
pericytes.
Despite constant stimulation of surface arterioles for 1 minute, after about 25 s,
we saw arterioles gradually dilate, almost returning to their baseline diameter. One
potential explanation is that this variant of ChR2 (H134R) is known to inactivate within
milliseconds, after which it passes about 40% of its maximal current if continuously
activated by one photon light (Lin et al. 2009). Channel dynamics cannot explain this
because the arteriole kinetics were remarkably different than the gradual, linear
constriction that we saw with a nearly identical ChR2 activation paradigm in pericytes.
There may also be biological reasons for our observed kinetics of VSMC activation, such
as the activation of ryanodine receptors by CaV3.2, which was shown to be a negative
feedback mechanism that limits vascular constriction (Harraz et al. 2014). In this
mechanism, the voltage-gated CaV3.2 channel funnels calcium into the cell to activate
the RyR, which releases localized calcium that opens up BKCa channels to allow K+
efflux, VSMC relaxation, and dilation (Harraz et al. 2014). Remarkably, this fits with our
observed kinetic differences between SMCs and pericytes, because surface arteriole
SMCs, but not any type of pericyte, express gene transcripts for a ryanodine receptor
(ryr2) and the BkCa channel (kcnma1) (Vanlandewijck et al. 2018).

Page 141

If not αSMA, what are pericytes using to contract?
With the exception of αSMA, vascular contractile mechanisms have not been
studied in brain capillary pericytes. Although recent transcriptomic data collectively
suggest that pericytes have several parts of the machinery for constricting vessels
(Vanlandewijck et al. 2018), one large gap in our understanding is how they can perform
actin-myosin cross-bridging without expressing any transcripts for muscle or smooth
muscle actins. Interestingly, several studies have shown that actin isoforms are
functionally interchangeable, thanks to the 90% or greater similarity between their amino
acid sequences (Perrin and Ervasti 2010). For example, overexpression of cardiac
muscle actin rescues lethality and muscle weakness in mice that are null for skeletal
muscle actin (Nowak et al. 2009). Even cytoskeletal actins can integrate into muscle
sarcomeres and functionally substitute for skeletal muscle actins. There is a limit to this
substitutive ability, because cytoskeletal actin overexpression doesn’t rescue muscle
function in mice null for skeletal muscle actin (Baltgalvis et al. 2011; Jaeger et al. 2009).
In addition to canonical vascular contractile mechanisms, pericytes may utilize
more recently-discovered contractile mechanisms that involve polymerization of
cytoskeletal actins. Multiple studies have found negligible phosphorylation of MLC during
a sustained myogenic response, suggesting actin-myosin cross-bridging did not occur.
However, they observed a large increase in polymerized cytoskeletal actins that was
necessary for cerebral artery myogenic response (Moreno-Domínguez et al. 2014;
Tejani and Rembold 2010). One interpretation of these studies is that actomyosin crossbridging mediates rapid contraction events, whereas sustained contraction involves
cytoskeletal actin polymerization. In support of F-actin polymerization as a mechanism
for pericyte control of blood flow, many capillary pericytes brightly stain with phalloidin, a
marker of polymerized actin that also brightly stains SMCs (Alarcon-Martinez et al.
Page 142

2018). Furthermore, rho kinase inhibitors, the same class of drug as fasudil, have been
shown to block cytoskeletal actin polymerization and prevent this mechanism of VSMC
contractility (Moreno-Domínguez et al. 2014).

Are we damaging vessels?
We were able to see pericyte contractility because of prolonged stimulation
times, at relatively high laser powers (in excess of 100 mW over 100 µm deep). These
parameters come with a risk of damaging vessels. We carefully controlled for the effects
of vessel damage or the effects of light and heat by using the same laser parameters in
animals that expressed YFP or membrane-bound GFP, instead of ChR2, in mural cells.
Moreover, we found that fasudil prevented the constriction induced by optogenetic
stimulation of pericytes, suggesting that vascular mechanisms of contractility are at play,
rather than vessel damage. Although damage does not explain our results, it is worth
noting that we did sometimes observe blood-brain barrier damage during or after our line
scans, as previously reported (Lou et al. 2016). This occurred equally in ChR2 and
control groups, and we excluded any vessels for which we saw overt leakage of the 70
kDa dextran dye during the scan or in the post-scan image stack collected 1-3 minutes
after scanning. Aside from vessel damage, it is possible that pericyte swelling due to
Na+ and concomitant water influx through ChR2 is contributing to the ChR2-specific
decrease in vessel diameter and blood flow. In the ChR2 animals but not the controls,
we observed blebbing in ~%30 of pericytes (64/212) in the post-stimulation image stack,
but this didn’t predict the change in diameter or velocity that we observed (not shown).
Because fasudil is not known to affect cell swelling on the time course of one minute, but
has known vasodilatory effects, the strong fasudil effect we observed makes it more
likely that contractile machinery is triggered by ChR2 stimulation. However, future
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studies should use the same stimulation parameters in endothelial cells, because a lack
of effect with endothelial cell ChR2 stimulation would rule out the effect of ChR2-induced
swelling on our results. Altogether, our use of the control group, and our fasudil data,
make pericyte contractility the most likely explanation for the results of our optogenetic
studies, but we are using high powers and long stimulation times.

Are we observing the effects of upstream, or local, constriction?
One alternate interpretation of our optogenetic data is that pericytes transmit the
optogenetic depolarization to upstream vessels expressing αSMA, which then constrict,
and cause a passive deflation of downstream capillary diameter and blood flow. In fact,
modeling studies suggest that upstream constriction of penetrating arterioles is the most
plausible explanation for the velocity and hematocrit decreases that we observed (P. W.
Sweeney, Walker-Samuel, and Shipley 2018). They reason that focal constriction
without upstream conduction would cause a velocity increase based on Bernoulli’s Laws,
in contrast to our observed decreases in velocity (P. W. Sweeney, Walker-Samuel, and
Shipley 2018). Upstream conduction is biologically plausible in our experimental
paradigm, as mural cells have been shown to conduct voltage changes to other mural
cells that are up- or downstream in the isolated retina (Zhang et al. 2011). Moreover, the
endothelium rapidly transmits vasodilatory signals to upstream arterioles, as part of the
vascular conducted response (Longden et al. 2017). Ruling out optogenetic excitation of
upstream mural cells is an important future direction that we are currently working on.

Fasudil is a dirty drug
So far in our discussion, we see our decrease in blood flow in response to highenergy optogenetic activation could be explained by the following: 1. Damage and
thrombosis from photo-thermal injury, 2. Cell swelling due to cation influx through ChR2,
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3. Activation of upstream arterioles, or, hopefully 4. Cation influx through ChR2 triggers a
contractile mechanism. We experimented with fasudil to help narrow these possibilities.
Fasudil, along with our control group, really minimizes the likelihood of #1, that direct
photo-thermal injury is responsible for the effects of ChR2-YFP activation. Although we
wish that fasudil selectively affected contractile mechanisms, it has been shown to
influence ion flux (Yao Li and Brayden 2017) and swelling on the time scale of hours
(Philip et al. 2017). However, activating ChR2-YFP for 60s is expected to far overpower
endogenous voltage regulatory mechanisms that are modified by fasudil, and fasudil has
never been studied in rapid (1 minute) cell swelling, making #2 a less likely explanation
for our fasudil effect. We thus think that fasudil most likely acts by its best-known
mechanism, which is to prevent the activation of contractile machinery. It is worth noting
that previous kinase inhibition assays demonstrate that the IC50 for fasudil inhibiting
isolated Rho kinase 2 (ROCK2) and ROCK-1 is ~2 µM (Davies et al. 2000; Rikitake et al.
2005). Other targets of fasudil are PRK2, a similar Rho-activated kinase that regulates
the cytoskeleton (4 µM IC50)(Vincent and Settleman 1997), PKA, and other proteins that
are activated by MAP Kinase (5 µM MSK1, 15 µM MAPKAP-1) (Bain et al. 2007; Davies
et al. 2000).
Of course this means that fasudil relaxes SMCs on upstream arterioles, as we
observed in Fig. 31. An alternate explanation of our data is that fasudil acted on
arterioles to increase the perfusion pressure of capillaries, and we observed reductions
in optogenetic capillary constriction because of enhanced intravascular pressure due to
upstream vasodilation. Yet another explanation is that fasudil prevents the conducted
constriction of upstream vessels. These are both very plausible explanations for our
fasudil data. Even though fasudil might not directly affect capillaries or pericytes in our
preparation because of these upstream effects, these are still important data because it
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is currently unknown if increasing perfusion pressure has an effect on capillary
constriction, and this may be useful information when considering the design of clinical
interventions to enhance capillary blood flow. Example applications include capillary
blood flow post-stroke, or in the vascular dementia CADASIL.

Future directions:
These data offer a unique opportunity in studies of capillary blood flow because
they are the first to induce substantial changes in capillary diameter in vivo while
obtaining flow measurements. Several questions come to mind that could be answered
with a combination of prediction models and comparison with these data: is tissue
oxygen changed by single vessel diameter changes? Does the local angioarchitecture,
such as the distance from the nearest branchpoint, determine the extent of response?
Did changes first occur in diameter, velocity, or red blood cell flux?

Will this dissertation improve someone’s life?
The role for pericytes in regulating blood flow is admittedly complicated and
confusing. However, it is quite clear that pericytes are battered, bruised, and/or lost in
many diseases. Pericyte dysfunction is implicated in everything from tumorigenesis and
metastasis (Paiva et al. 2018) to ruptured arteriovenous malformations (Winkler et al.
2018), to Alzheimer’s disease (Montagne et al. 2018; Sengillo et al. 2013). In these
diseases, perhaps we can correct pericyte dysfunction and improve cerebral blood flow.
In other circumstances, we could leverage the ability of pericyte to modulate blood flow,
and instruct them to open capillaries wider – one such disease could be sickle cell
anemia wherein microocclusions are occurring in the capillary bed very frequently.
Perhaps fasudil could improve capillary blood flow in sickle cell anemia.
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Although we are decades away, I do think that an increased understanding of
pericyte regulation of blood flow will enable us to correct flow abnormalities that underlie
many diseases. The blood is the lifesource of the body, and if we learn to control its flow
more precisely, then I think we will gain traction on numerous intractable diseases.
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